
Code;Text
M;Drug substance classification ATC
MA;Digestive organs and metabolism
MA01;medicinal products for diseases of the oral cavity
MA01A;stomatology
MA01AA;anti-caries agents
MA01AA01;sodium fluoride
MA01AA02;sodium monofluorophosphate
MA01AA03;olaflur
MA01AA04;stannous fluoride
MA01AA30;anti-caries agents, combination preparations
MA01AA51;sodium fluoride, comb.
MA01AB;anti-infectives for local use in the oral cavity
MA01AB02;hydrogen peroxide
MA01AB03;chlorhexidine
MA01AB04;amphotericin
MA01AB05;polynoxylin
MA01AB06;domiphene
MA01AB07;oxyquinoline
MA01AB08;neomycin
MA01AB09;miconazole
MA01AB10;natamycin
MA01AB11;various anti-infectives for local use in the oral cavity
MA01AB12;hexetidine
MA01AB13;tetracycline
MA01AB14;benzoxonium chloride
MA01AB15;tibezonium iodide
MA01AB16;mepartrizine
MA01AB17;metronidazole
MA01AB18;clotrimazole
MA01AB19;sodium perborate
MA01AB21;chlortetracycline
MA01AB22;doxycycline
MA01AB23;minocycline
MA01AB24;octenidine
MA01AB25;oxytetracycline
MA01AB53;chlorhexidine and cetylpyridinium
MA01AC;corticosteroids for local use in the oral cavity
MA01AC01;triamcinolone
MA01AC02;dexamethasone
MA01AC03;hydrocortisone
MA01AC04;prednisolone
MA01AC54;prednisolone, combinations
MA01AD;other agents for local treatment of the oral cavity
MA01AD01;adrenaline
MA01AD02;benzydamine
MA01AD05;acetylsalicylic acid
MA01AD06;adrenaline
MA01AD07;amlexanox
MA01AD08;becaplermin
MA01AD11;various agents for local treatment in the oral cavity
MA02;drugs for acid-related disorders
MA02A;antacid
MA02AA;magnesium compounds
MA02AA01;magnesium carbonate
MA02AA02;magnesium oxide
MA02AA03;magnesium peroxide
MA02AA04;magnesium hydroxide
MA02AA05;magnesium silicate
MA02AA10;magnesium compounds, combination preparations
MA02AB;aluminum compounds
MA02AB01;aluminium oxide
MA02AB02;aluminum hydroxide
MA02AB03;aluminum phosphate
MA02AB04;dihydroxyaluminum sodium carbonate
MA02AB05;aluminum acetoacetate
MA02AB06;alloglutamol
MA02AB07;aluminum glycinate
MA02AB10;aluminium compounds, combination preparations
MA02AC;calcium compounds
MA02AC01;calcium carbonate
MA02AC02;calcium silicate
MA02AC10;calcium compounds, combination preparations
MA02AD;combinations and complexes of aluminum, calcium, and magnesium compounds
MA02AD01;combinations of common salts
MA02AD02;magaldrate
MA02AD03;almagat
MA02AD04;hydrotalcite
MA02AD05;almasilat
MA02AF;antacids and antiflatulents
MA02AF01;magaldrate and flatulence agents
MA02AF02;common salt combinations and flatulence remedies
MA02AG;antacids and antispasmodics
MA02AH;antacids and sodium bicarbonate
MA02AX;antacids, other combinations
MA02B;drugs for stomach ulcers and gastro-esophageal reflux (GORD)
MA02BA;H2-receptor antagonists
MA02BA01;cimetidine
MA02BA02;ranitidine
MA02BA03;famotidine
MA02BA04;nizatidine
MA02BA05;niperotidine
MA02BA06;roxatidine
MA02BA07;ranitidine bismuth citrate
MA02BA08;lafutidine
MA02BA51;cimetidine, combination preparations
MA02BA53;famotidine, comb.
MA02BB;prostaglandins
MA02BB01;misoprostol
MA02BB02;enprostil
MA02BC;proton pump inhibitors
MA02BC01;omeprazole
MA02BC02;pantoprazole
MA02BC03;lansoprazole
MA02BC04;rabeprazole
MA02BC05;esomeprazole
MA02BC06;dexlansoprazole
MA02BC07;dexrabeprazole
MA02BC08;vonoprazan
MA02BC09;tegoprazan
MA02BC10;fexuprazan
MA02BC11;ilaprazole
MA02BC51;omeprazole, combinations
MA02BC53;lansoprazole, combinations
MA02BC54;rabeprazole, combinations
MA02BD;comb. for the control of heliobacter pylori
MA02BD01;omeprazole, amoxicillin and metronidazole
MA02BD02;lansoprazole, tetracycline and metronidazole
MA02BD03;lansoprazole, amoxicillin and metronidazole
MA02BD04;pantoprazole, amoxicillin and clarithromycin
MA02BD05;omeprazole, amoxicillin and clarithromycin
MA02BD06;esomeprazole, amoxicillin and clarithromycin
MA02BD07;lansoprazole, amoxicillin and clarithromycin
MA02BD08;bismuth subcitrate, tetracycline and metronidazole
MA02BD09;lansoprazole, clarithromycin and tinidazole
MA02BD10;lansoprazole, amoxicillin and levofloxacin
MA02BD11;pantoprazole, amoxicillin, clarithromycin and metronidazole
MA02BD12;rabeprazole, amoxicillin and clarithromycin
MA02BD13;rabeprazole, amoxicillin and metronidazole
MA02BD14;vonoprazan, amoxicillin and clarithromycin
MA02BD15;vonoprazan, amoxicillin and metronidazole
MA02BD16;omeprazole, amoxicillin and rifabutin
MA02BD17;vonoprazan and amoxicillin
MA02BX;other antiulcer and gastroesophageal reflux (GERD) drugs
MA02BX01;carbenoxolon
MA02BX02;sucralfate
MA02BX03;pirenzepine
MA02BX04;methiosulfonium chloride
MA02BX05;bismuth subcitrate
MA02BX06;proglumide
MA02BX07;gefarnat
MA02BX08;sulglycotide
MA02BX09;acetoxolone
MA02BX10;zolimidine
MA02BX11;troxipide
MA02BX12;bismuth subnitrate
MA02BX13;alginic acid
MA02BX14;rebamipide
MA02BX15;teprenone
MA02BX16;irsogladin
MA02BX51;carbenoxolone, combinations excl. psycholeptics
MA02BX71;carbenoxolone, combinations with psycholeptics
MA02BX77;gefarnat, combinations with psycholeptics
MA02X;other agents for acid-related disorders
MA03;drugs for functional gastrointestinal disorders
MA03A;drugs for functional gastrointestinal disorders
MA03AA;synth. anticholine esters with tertiary amino groups
MA03AA01;oxyphencyclimine
MA03AA03;camylofin
MA03AA04;mebeverine
MA03AA05;trimebutin
MA03AA06;rociverin
MA03AA07;dicycloverine
MA03AA08;dihexyverine
MA03AA09;difemerin
MA03AA30;piperidolate
MA03AB;synthetic anticholinergics, quaternary ammonium compounds
MA03AB01;benzilone
MA03AB02;glycopyrrone
MA03AB03;oxyphenone
MA03AB04;penthienate
MA03AB05;propantheline
MA03AB06;otilonium bromide
MA03AB07;methantheline
MA03AB08;tridihexethyl
MA03AB09;isopropamide
MA03AB10;hexocyclium
MA03AB11;poldin
MA03AB12;mepenzolate
MA03AB13;bevonium
MA03AB14;pipenzolate
MA03AB15;diphemanil
MA03AB16;(2-benzhydryloxyethyl)diethylmethylammonium iodide
MA03AB17;thiemonium iodide
MA03AB18;prifinium bromide
MA03AB19;timepidium bromide
MA03AB21;fenpiverin
MA03AB53;oxyphenone, combination preparations
MA03AC;synthetic antispasmodics, amides with tertiary amines
MA03AC02;dimethylaminopropionylphenothiazine
MA03AC04;nicofetamide
MA03AC05;tiropramide
MA03AD;papaverine and derivatives
MA03AD01;papaverine
MA03AD02;drotaverine
MA03AD30;moxaverine
MA03AE;serotonin receptor antagonists
MA03AE01;alosetron
MA03AE03;cilansetron
MA03AX;other agents for functional gastrointestinal disorders
MA03AX01;fenpipran
MA03AX02;diisopromine
MA03AX03;chlorobenzoxamine
MA03AX04;pinaverine
MA03AX05;fenoverine
MA03AX06;idanpramine
MA03AX07;proxazole
MA03AX08;alverin
MA03AX09;three-button
MA03AX10;isometheptene
MA03AX11;caroverine
MA03AX12;phloroglucinol
MA03AX13;silicones
MA03AX14;valethamat
MA03AX15;peppermint oil
MA03AX30;trimethyldiphenylpropylamine
MA03AX58;alverin, combinations
MA03B;belladonna and derivatives, uncompounded preparations
MA03BA;belladonna alkaloids, tertiary amines
MA03BA01;atropine
MA03BA03;hyoscyamine
MA03BA04;belladonna, total alkaloids
MA03BB;belladonna alkaloids, semisynthetic quaternary ammonium compounds
MA03BB01;butylscopolamine
MA03BB02;methylatropine
MA03BB03;methylscopolamine
MA03BB04;fentonium
MA03BB05;cimetropium bromide
MA03BB06;homatropin methyl bromide
MA03C;antispasmodics in combination with psycholeptics
MA03CA;synthetic anticholinergics in combination with psycholeptics
MA03CA01;isopropamide and psycholeptics
MA03CA02;clidine and psycholeptics
MA03CA03;oxyphencyclimine and psycholeptics
MA03CA04;otilonium bromide and psycholeptics
MA03CA05;glycopyrrone and psycholeptics
MA03CA06;bevonium and psycholeptics
MA03CA07;ambuton and psycholeptics
MA03CA08;diphemanil and psycholeptics
MA03CA09;pipenzolate and psycholeptics
MA03CA30;emeprone and psycholeptics
MA03CA34;propantheline and psycholeptics
MA03CB;belladonna and derivatives in combination with psycholeptics
MA03CB01;methylscopolamine and psycholeptics
MA03CB02;belladonna, total alkaloids and psycholeptics
MA03CB03;atropine and psycholeptics
MA03CB04;homatropin methyl bromide and psycholeptics
MA03CB31;hyoscyamine and psycholeptics
MA03CC;other antispasmodics in combination with psycholeptics
MA03D;antispasmodics in combination with analgesics
MA03DA;synthetic anticholinergics in combination with analgesics
MA03DA01;tropenzilon and analgesics
MA03DA02;pitofenone and analgesics
MA03DA03;bevonium and analgesics
MA03DA04;ciclonium and analgesics
MA03DA05;camylofin and analgesics
MA03DA06;trospium and analgesics
MA03DA07;thiammonium iodide and analgesics
MA03DB;belladonna and derivatives in combination with analgesics
MA03DB04;butylscopolamine and analgesics
MA03DC;other antispasmodics in combination with analgesics
MA03E;antispasmodics and anticholinergics in combination with other substances
MA03EA;antispasmodics, psycholeptics, analgesics in combination
MA03ED;antispasmodics in combination with other substances
MA03F;propulsives
MA03FA;propulsives
MA03FA01;metoclopramide
MA03FA02;cisapride
MA03FA03;domperidone
MA03FA04;bromopride
MA03FA05;alizapride
MA03FA06;clebopride
MA03FA07;itopride
MA03FA08;cinitapride
MA03FA09;mosapride
MA03FA10;acotiamide
MA04;antiemetics and antinausea agents
MA04A;antiemetics and antinausea agents
MA04AA;serotonin (5HT3) antagonists
MA04AA01;ondansetron
MA04AA02;granisetron
MA04AA03;tropical
MA04AA04;dolasetron
MA04AA05;palonosetron
MA04AA55;palonosetron, combinations
MA04AD;other antiemetics
MA04AD01;scopolamine
MA04AD02;cerium oxalate
MA04AD04;chlorobutanol
MA04AD05;metopimazine
MA04AD10;dronabinol
MA04AD11;nabilone
MA04AD12;aprepitant
MA04AD13;casopitant
MA04AD14;role-playing
MA04AD51;scopolamine, combination preparations
MA04AD54;chlorobutanol, combination preparations
MA05;biliary and liver therapy
MA05A;biliary therapy
MA05AA;bile acids and derivatives
MA05AA01;chenodeoxycholic acid
MA05AA02;ursodeoxycholic acid
MA05AA03;cholic acid
MA05AA04;obeticholic acid
MA05AA05;ursodoxycoltaurine
MA05AA06;norucholic acid
MA05AB;biliary tract preparations
MA05AB01;nicotinylmethylamide
MA05AX;other bile preparations
MA05AX01;piprozoline
MA05AX02;hymecromon
MA05AX03;cyclobutyrol
MA05AX04;maralixibat chloride
MA05AX05;odevixibat
MA05AX06;elafibranor
MA05AX07;seladelpar
MA05AX08;linerixibat
MA05B;liver and lipotropics
MA05BA;liver therapy
MA05BA01;arginine glutamate
MA05BA03;silymarin
MA05BA04;citiolon
MA05BA05;epomediol
MA05BA06;ornithine oxoglurate
MA05BA07;thidiacicarginine
MA05BA08;glycyrrhizic acid
MA05BA09;metadoxin
MA05BA10;phospholipids
MA05BA11;resmetirom
MA05C;bile preparations and lipotropics in combination
MA06;anti-constipation
MA06A;anti-constipation agents
MA06AA;softeners
MA06AA01;paraffin oil
MA06AA02;docusate sodium
MA06AA51;paraffin oil, combination preparations
MA06AB;contact laxatives
MA06AB01;oxyphenisatin
MA06AB02;bisacodyl
MA06AB03;dantron
MA06AB04;phenolphthalein
MA06AB05;castor oil
MA06AB06;senna glycosides
MA06AB07;cascara sagrada
MA06AB08;sodium picosulfate
MA06AB09;bisoxatin
MA06AB20;contact laxative in combination
MA06AB30;contact laxative in combination with belladonna alkaloids
MA06AB52;bisacodyl, combination preparations
MA06AB53;dantron, combination preparations
MA06AB56;senna glycosides, combination preparations
MA06AB57;cascara sagrada, combination preparations
MA06AB58;sodium picosulfate, combination preparations
MA06AC;bulking laxative
MA06AC01;ispaghula (flea seed)
MA06AC02;ethulose
MA06AC03;sterculia
MA06AC05;flaxseed
MA06AC06;methylcellulose
MA06AC07;triticum (wheat fiber)
MA06AC08;polycarbophil calcium
MA06AC51;ispaghula, combination preparations
MA06AC53;sterculia, combination preparations
MA06AC55;flaxseed, combination preparations
MA06AD;osmotic laxative
MA06AD01;magnesium carbonate
MA06AD02;magnesium oxide
MA06AD03;magnesium peroxide
MA06AD04;magnesium sulfate
MA06AD10;mineral salts in combination
MA06AD11;lactulose
MA06AD12;lactitol
MA06AD13;sodium sulfate
MA06AD14;pentaerythrityl tetranitrate
MA06AD15;macrogol
MA06AD16;mannitol
MA06AD17;sodium phosphate
MA06AD18;sorbitol
MA06AD19;magnesium citrate
MA06AD21;sodium tartrate
MA06AD61;lactulose, combination preparations
MA06AD65;macrogol, combinations
MA06AG;enema preparations
MA06AG01;sodium phosphate
MA06AG02;bisacodyl
MA06AG03;dantron, incl. combination preparations
MA06AG04;glycerol
MA06AG06;oil
MA06AG07;sorbitol
MA06AG10;docusate sodium, incl. combination preparations
MA06AG11;sodium lauryl sulfoacetate, incl. combination preparations
MA06AG20;enemas, combination preparations
MA06AH;peripheral opioid receptor antagonists
MA06AH01;methylnaltrexone bromide
MA06AH02;alvimopan
MA06AH03;naloxegol
MA06AH04;naloxone
MA06AH05;naldemedine
MA06AX;other anti-constipation agents
MA06AX01;glycerol
MA06AX02;carbon dioxide-generating preparations
MA06AX03;lubiprostone
MA06AX04;linaclotide
MA06AX05;prucalopride
MA06AX06;tegas root
MA06AX07;plecanatide
MA06AX08;tenapanor
MA06AX09;elobixibat
MA07;drugs for diarrhea and intestinal inflammation/infection
MA07A;intestinal anti-infectives
MA07AA;antibiotics
MA07AA01;neomycin
MA07AA02;nystatin
MA07AA03;natamycin
MA07AA04;streptomycin
MA07AA05;polymyxin B
MA07AA06;paromomycin
MA07AA07;amphotericin
MA07AA08;kanamycin
MA07AA09;vancomycin
MA07AA10;colistin
MA07AA11;rifaximin
MA07AA12;fidaxomicin
MA07AA13;rifamycin
MA07AA51;neomycin, combinations
MA07AA54;streptomycin, combinations
MA07AB;sulfonamides
MA07AB02;phthalylsulfathiazole
MA07AB03;sulfaguanidine
MA07AB04;succinylsulfathiazole
MA07AC;imidazole derivatives
MA07AC01;miconazole
MA07AX;other intestinal anti-infectives
MA07AX01;broxyquinoline
MA07AX02;acetarsol
MA07AX03;nifuroxazide
MA07AX04;nifurzide
MA07B;intestinal adsorbents
MA07BA;coal preparations
MA07BA01;activated carbon
MA07BA51;activated carbon, comb.
MA07BB;bismuth preparations
MA07BC;other intestinal adsorbents
MA07BC01;pectin
MA07BC02;kaolin
MA07BC03;crospovidone
MA07BC04;attapulgite
MA07BC05;diosmectite
MA07BC30;other intestinal adsorbents, combination preparations
MA07BC54;attapulgite, combinations
MA07C;electrolytes with carbohydrates
MA07CA;oral rehydration salt formulations
MA07D;antipropulsive
MA07DA;antipropulsive
MA07DA01;diphenoxylate
MA07DA02;opium
MA07DA03;loperamide
MA07DA04;difenoxin
MA07DA05;loperamide oxide
MA07DA06;eluxadoline
MA07DA52;morphine, combinations
MA07DA53;loperamide, combinations
MA07E;intestinal anti-inflammatories
MA07EA;locally acting corticosteroids
MA07EA01;prednisolone
MA07EA02;hydrocortisone
MA07EA03;prednisone
MA07EA04;betamethasone
MA07EA05;tixocortol
MA07EA06;budesonide
MA07EA07;beclometasone
MA07EB;antiallergic drugs, excl. corticosteroids
MA07EB01;cromoglycic acid
MA07EC;aminosalicylic acid and analogues
MA07EC01;sulfasalazine
MA07EC02;mesalazine
MA07EC03;olsalazine
MA07EC04;balsalazide
MA07F;microorganisms with antidiarrheal effect
MA07FA;microorganisms with antidiarrheal effect
MA07FA01;lactic acid producing organisms
MA07FA02;saccharomyces boulardii
MA07FA03;Escherichia coli
MA07FA51;lactic acid producing organisms, combinations
MA07X;other antidiarrheals
MA07XA;other antidiarrheals
MA07XA01;albumin tannate
MA07XA02;ceratonia
MA07XA03;calcium compounds
MA07XA04;racecadotril
MA07XA06;crofelemer
MA07XA51;albumin tannate, comp.
MA08;anti-obesity drugs, excl. dietetic drugs
MA08A;anti-obesity products, excl. dietetic products
MA08AA;centrally acting anorectics
MA08AA01;phentermine
MA08AA02;fenfluramine
MA08AA03;amfepramone
MA08AA04;dexfenfluramine
MA08AA05;mazindol
MA08AA06;ethylamphetamine
MA08AA07;cathin
MA08AA08;clobenzorex
MA08AA09;mefenorex
MA08AA10;sibutramine
MA08AA11;lorcaserin
MA08AA12;setmelanotide
MA08AA51;phentermine and topiramate
MA08AA56;ephedrine, combinations
MA08AA62;bupropion and naltrexone
MA08AB;antiobesity agents with peripheral action
MA08AB01;orlistat
MA08AX;other anti-obesity agents
MA08AX01;rimonabant
MA09;digestives, incl. enzymes
MA09A;digestives, incl. enzymes
MA09AA;enzyme preparations
MA09AA01;diastasis
MA09AA02;multienzymes (lipase, protease etc.)
MA09AA03;pepsin
MA09AA04;tilactase
MA09AB;acid preparations
MA09AB01;glutamic acid
MA09AB02;betaine hydrochloride
MA09AB03;hydrochloric acid
MA09AB04;citric acid
MA09AC;enzyme and acid preparations, combinations
MA09AC01;pepsin and acid preparations
MA09AC02;multienzymes and acid preparations
MA10;antidiabetic
MA10A;insulins and analogues
MA10AB;insulins and analogues for injection, fast-acting
MA10AB01;insulin (human)
MA10AB02;insulin (ox)
MA10AB03;insulin (porcine)
MA10AB04;insulin lispro
MA10AB05;insulin aspart
MA10AB06;insulin glulisine
MA10AB30;combinations of insulins and analogues for injection, fast-acting
MA10AC;insulins and analogues for injection, intermediate-acting
MA10AC01;insulin (human)
MA10AC02;insulin (ox)
MA10AC03;insulin (porcine)
MA10AC04;insulin lispro
MA10AC30;combinations of insulins and analogues for injection, intermediate-acting
MA10AD;insulins and analogues for injection, intermediate and long-acting in combinations with fast-acting
MA10AD01;insulin (human)
MA10AD02;insulin (ox)
MA10AD03;insulin (porcine)
MA10AD04;insulin lispro
MA10AD05;insulin aspart
MA10AD06;insulin degludec and insulin aspart
MA10AD30;combinations of insulins and analogues for injection, intermediate and long-acting in combinations with rapid-acting
MA10AE;insulins and analogues for injection, long-acting
MA10AE01;insulin (human)
MA10AE02;insulin (ox)
MA10AE03;insulin (porcine)
MA10AE04;insulin glargine
MA10AE05;insulin detemir
MA10AE06;insulin degludec
MA10AE07;insulin icodec
MA10AE30;combinations of insulins and analogues for injection, long-acting
MA10AE54;insulin glargine and lixisenatide
MA10AE56;insulin degludec and liraglutide
MA10AE57;insulin icodec and semaglutide
MA10AF;insulins and analogues, for inhalation
MA10AF01;insulin (human)
MA10B;blood-glucose-lowering agents, excl. insulins
MA10BA;biguanides
MA10BA01;phenformin
MA10BA02;metformin
MA10BA03;buformin
MA10BB;sulfonyl urea
MA10BB01;glibenclamide
MA10BB02;chlorpropamide
MA10BB03;tolbutamide
MA10BB04;glibornuride
MA10BB05;tolazamide
MA10BB06;carbutamide
MA10BB07;glipizide
MA10BB08;gliquidone
MA10BB09;gliclazide
MA10BB10;metahexamide
MA10BB11;glisoxepid
MA10BB12;glimepiride
MA10BB31;acetohexamide
MA10BC;sulfonamides (heterocyclic)
MA10BC01;glymidine
MA10BD;comb. of oral blood-glucose-lowering agents
MA10BD01;phenformin and sulfonylureas
MA10BD02;metformin and sulfonylureas
MA10BD03;metformin and rosiglitazone
MA10BD04;glimepiride and rosiglitazone
MA10BD05;metformin and pioglitazone
MA10BD06;glimepiride and pioglitazone
MA10BD07;metformin and sitagliptin
MA10BD08;metformin and vildagliptin
MA10BD09;pioglitazone and alogliptin
MA10BD10;metformin and saxagliptin
MA10BD11;metformin and linagliptin
MA10BD12;pioglitazone and sitagliptin
MA10BD13;metformin and alogliptin
MA10BD14;metformin and repaglinide
MA10BD15;metformin and dapagliflozin
MA10BD16;metformin and canagliflozin
MA10BD17;metformin and acarbose
MA10BD18;metformin and gemigliptin
MA10BD19;linagliptin and empagliflozin
MA10BD20;metformin and empagliflozin
MA10BD21;saxagliptin and dapagliflozin
MA10BD22;metformin and evogliptin
MA10BD23;metformin and ertugliflozin
MA10BD24;sitagliptin and ertugliflozin
MA10BD25;metformin, saxagliptin and dapagliflozin
MA10BD26;metformin and lobeglitazone
MA10BD27;metformin, linagliptin and empagliflozin
MA10BD28;metformin and teneligliptin
MA10BD29;sitagliptin and dapagliflozin
MA10BD30;gemigliptin and dapagliflozin
MA10BD31;metformin, sitagliptin and dapagliflozin
MA10BD32;glimepiride and dapagliflozin
MA10BD33;pioglitazone and dapagliflozin
MA10BF;alpha-glucosidase inhibitors
MA10BF01;acarbose
MA10BF02;miglitol
MA10BF03;voglibose
MA10BG;thiazolindiones
MA10BG01;troglitazone
MA10BG02;rosiglitazone
MA10BG03;pioglitazone
MA10BG04;lobeglitazone
MA10BH;dipeptidyl peptidase 4 (DPP-4) inhibitors
MA10BH01;sitagliptin
MA10BH02;vildagliptin
MA10BH03;saxagliptin
MA10BH04;alogliptin
MA10BH05;linagliptin
MA10BH06;gemigliptin
MA10BH07;evogliptin
MA10BH08;teneligliptin
MA10BH51;sitagliptin and simvastatin
MA10BH52;gemigliptin and rosuvastatin
MA10BJ;glucagon-like peptide-1 receptor (GLP-1) analog
MA10BJ01;exenatide
MA10BJ02;liraglutide
MA10BJ03;lixisenatide
MA10BJ04;albiglutide
MA10BJ05;dulaglutide
MA10BJ06;semaglutide
MA10BJ07;beinaglutide
MA10BK;sodium-glucose co-transporter 2 (SGLT2) inhibitors
MA10BK01;dapagliflozin
MA10BK02;canagliflozin
MA10BK03;empagliflozin
MA10BK04;ertugliflozin
MA10BK05;ipragliflozin
MA10BK06;sotagliflozin
MA10BK07;luseogliflozin
MA10BK08;bexagliflozin
MA10BK09;enavogliflozin
MA10BX;other blood glucose lowering agents, excl. insulins
MA10BX01;guar gum
MA10BX02;repaglinide
MA10BX03;nateglinide
MA10BX05;pramlintid
MA10BX06;benfluorex
MA10BX08;mitiglinide
MA10BX15;imeglimin
MA10BX16;tirzepatid
MA10BX17;carfloglitazar
MA10BX18;dorzagliatin
MA10X;other agents for the treatment of diabetes
MA10XA;aldose reductase inhibitors
MA10XA01;customs tax
MA10XX;other antidiabetic agents
MA10XX01;teplizumab
MA10XX02;donislecel
MA11;vitamins
MA11A;multivitamins, combinations
MA11AA;multivitamins with minerals
MA11AA01;multivitamins and iron
MA11AA02;multivitamins and calcium
MA11AA03;multivitamins and other minerals, incl. comb.
MA11AA04;multivitamins and trace minerals
MA11AB;multivitamins, other combinations
MA11B;multivitamins, uncompounded
MA11BA;multivitamins, uncompounded
MA11C;vitamin A and D, incl. combinations thereof
MA11CA;vitamin A, uncompounded preparations
MA11CA01;retinol (vitamin A)
MA11CA02;betacarotene
MA11CB;vitamin A and D in combination
MA11CC;vitamin D and analogues
MA11CC01;ergocalciferol
MA11CC02;dihydrotachysterol
MA11CC03;alfacalcidol
MA11CC04;calcitriol
MA11CC05;colecalciferol
MA11CC06;calcifediol
MA11CC20;combinations of vitamin D and analogues
MA11CC55;cholecalciferol, combinations
MA11D;vitamin B1, also in comb. with vitamin B6 and B12
MA11DA;thiamine (vitamin B1), uncompounded preparations
MA11DA01;thiamine (vitamin B1)
MA11DA02;sulbutiamine
MA11DA03;benfotiamine
MA11DB;vitamin B1 in combination with vitamin B6 and/or vitamin B12
MA11E;vitamin B-complex, incl. combinations
MA11EA;vitamin B complex, without other substances
MA11EB;vitamin B complex with vitamin C
MA11EC;vitamin B complex with minerals
MA11ED;vitamin B complex with anabolic steroids
MA11EX;vitamin B complex, other combinations
MA11G;ascorbic acid (vitamin C), incl. combinations
MA11GA;ascorbic acid (vitamin C), uncompounded prep.
MA11GA01;ascorbic acid (vitamin C)
MA11GB;ascorbic acid (vitamin C), combinations
MA11GB01;ascorbic acid (vitamin C) and calcium
MA11H;other uncompounded vitamin preparations
MA11HA;other uncompounded vitamin preparations
MA11HA01;nicotinamide
MA11HA02;pyridoxine (vitamin B6)
MA11HA03;tocopherol (vitamin E)
MA11HA04;riboflavin (vitamin B2)
MA11HA05;biotin
MA11HA06;pyridoxal phosphate
MA11HA07;inositol
MA11HA08;tocofersolan
MA11HA30;dexpanthenol
MA11HA31;calcium pantothenate
MA11HA32;pantethine
MA11J;other compound vitamin preparations
MA11JA;combinations of vitamins
MA11JB;vitamins with minerals
MA11JC;vitamins, other combinations
MA12;mineral preparations
MA12A;calcium
MA12AA;calcium
MA12AA01;calcium phosphate
MA12AA02;calcium glubionate
MA12AA03;calcium gluconate
MA12AA04;calcium carbonate
MA12AA05;calcium lactate
MA12AA06;calcium lactogluconate
MA12AA07;calcium chloride
MA12AA08;calcium glyceryl phosphate
MA12AA09;calcium citrate-lysine complex
MA12AA10;calcium glucoheptonate
MA12AA11;calcium pangamate
MA12AA13;calcium citrate
MA12AA20;calcium (various salts in combination)
MA12AA30;calcium laevulate
MA12AX;calcium, combinations with vitamin D and/or other substances
MA12B;potassium
MA12BA;potassium
MA12BA01;potassium chloride
MA12BA02;potassium citrate
MA12BA03;potassium hydrogen tartrate
MA12BA04;potassium bicarbonate
MA12BA05;potassium gluconate
MA12BA30;potassium (various salts in combination)
MA12BA51;potassium, combinations
MA12C;other mineral preparations
MA12CA;sodium
MA12CA01;sodium chloride
MA12CA02;sodium sulfate
MA12CB;zinc
MA12CB01;zinc sulfate
MA12CB02;zinc gluconate
MA12CB03;zinc protein complex
MA12CB04;zincorotate
MA12CC;magnesium
MA12CC01;magnesium chloride
MA12CC02;magnesium sulfate
MA12CC03;magnesium gluconate
MA12CC04;magnesium citrate
MA12CC05;magnesium aspartate
MA12CC06;magnesium lactate
MA12CC07;magnesium levulinate
MA12CC08;magnesium pidolate
MA12CC09;magnesium orotate
MA12CC10;magnesium oxide
MA12CC30;magnesium (various salts in combination)
MA12CD;fluoride
MA12CD01;sodium fluoride
MA12CD02;sodium monofluorophosphate
MA12CD51;fluoride, combinations
MA12CE;selenium
MA12CE01;sodium selenate
MA12CE02;sodium selenite
MA12CX;various mineral preparations
MA13;tonic
MA13A;tonic
MA14;anabolic agents for systemic use
MA14A;anabolic steroids
MA14AA;androstane derivatives
MA14AA01;androstanolone
MA14AA02;stanozolol
MA14AA03;methandienone
MA14AA04;methenolone
MA14AA05;oxymetholone
MA14AA06;quinbolone
MA14AA07;prasterone
MA14AA08;oxandrolone
MA14AA09;norethandrolone
MA14AB;estrene derivatives
MA14AB01;nandrolone
MA14AB02;ethylestrenol
MA14AB03;oxabolone cipionate
MA14B;other anabolic agents
MA15;appetite stimulants
MA16;other digestive and metabolic agents
MA16A;other digestive and metabolic agents
MA16AA;amino acids and derivatives
MA16AA01;levocarnitine
MA16AA02;ademetionine
MA16AA03;levoglutamide
MA16AA04;mercaptamine
MA16AA05;carglumic acid
MA16AA06;betaine
MA16AA07;metreleptin
MA16AB;enzymes
MA16AB01;alglucerase
MA16AB02;imiglucerase
MA16AB03;agalsidase alfa
MA16AB04;agalsidase beta
MA16AB05;laronidase
MA16AB06;sacrosidase
MA16AB07;alglucosidase alfa
MA16AB08;galsulfase
MA16AB09;idursulfase
MA16AB10;velaglucerase alfa
MA16AB11;taliglucerase alfa
MA16AB12;elosulfase alfa
MA16AB13;asfotase alfa
MA16AB14;sebelipase alfa
MA16AB15;velmanase alfa
MA16AB16;idursulfase beta
MA16AB17;cerliponase alfa
MA16AB18;vestronidase alfa
MA16AB19;pegvaliase
MA16AB20;pegunigalsidase Alfa
MA16AB21;atidarsagene autotemcel
MA16AB22;avalglucosidase alfa
MA16AB23;cipaglucosidase alfa
MA16AB24;pegzilarginase
MA16AB25;olipudase alpha
MA16AB26;eladocagene exuparvovec
MA16AB27;pabinafusp alfa
MA16AB28;verenafusp alpha
MA16AX;miscellaneous agents for digestive organs and metabolism
MA16AX01;thiotic acid
MA16AX02;anethole trithion
MA16AX03;sodium phenylbutyrate
MA16AX04;nitisinone
MA16AX05;zinc acetate
MA16AX06;miglustat
MA16AX07;sapropterin
MA16AX08;teduglutide
MA16AX09;glycerol phenylbutyrate
MA16AX10;eliglustat
MA16AX11;sodium benzoate
MA16AX12;trientine
MA16AX13;uridine triacetate
MA16AX14;migalastat
MA16AX15;telotristat
MA16AX16;givosiran
MA16AX17;triheptanoin
MA16AX18;lumasiran
MA16AX19;phosdenopterin
MA16AX20;lonafarnib
MA16AX21;elivaldogen autotemcel
MA16AX22;thiomolybdic acid
MA16AX23;leriglitazone
MA16AX24;govorestat
MA16AX25;underdosed
MA16AX26;glepaglutide
MA16AX27;apraglutide
MA16AX28;sepiapterin
MA16AX29;doxicitin and doxribtimin
MA16AX30;sodium benzoate and sodium phenylacetate
MB;Blood and blood-forming organs
MB01;antithrombotic agents
MB01A;antithrombotic agents
MB01AA;vitamin K antagonists
MB01AA01;dicoumarol
MB01AA02;phenindione
MB01AA03;warfarin
MB01AA04;phenprocoumon
MB01AA07;acenocoumarol
MB01AA08;ethyl biscoum acetate
MB01AA09;clorindione
MB01AA10;diphenadione
MB01AA11;thioclomarol
MB01AA12;fluindione
MB01AB;heparin group
MB01AB01;heparin
MB01AB02;antithrombin
MB01AB04;dalteparin
MB01AB05;enoxaparin
MB01AB06;nadroparin
MB01AB07;parnaparin
MB01AB08;reviparin
MB01AB09;danaparoid
MB01AB10;tinzaparin
MB01AB11;sulodexide
MB01AB12;bemiparin
MB01AB51;heparin, combinations
MB01AC;platelet aggregation inhibitors excl. heparin
MB01AC01;ditazole
MB01AC02;cloricromene
MB01AC03;picotamide
MB01AC04;clopidogrel
MB01AC05;ticlopidine
MB01AC06;acetylsalicylic acid
MB01AC07;dipyridamole
MB01AC08;carbasalate calcium
MB01AC09;epoprostenol
MB01AC10;indobufen
MB01AC11;iloprost
MB01AC13;abciximab
MB01AC15;aloxiprin
MB01AC16;eptifibatide
MB01AC17;tirofiban
MB01AC18;triflusal
MB01AC19;beraprost
MB01AC21;treprostinil
MB01AC22;prasugrel
MB01AC23;cilostazol
MB01AC24;ticagrelor
MB01AC25;cangrelor
MB01AC26;vorapaxar
MB01AC27;selexipag
MB01AC28;limaprost
MB01AC30;combinations of platelet aggregation inhibitors excl. heparin
MB01AC56;acetylsalicylic acid, combinations with proton pump inhibitors
MB01AD;enzymes
MB01AD01;streptokinase
MB01AD02;alteplase
MB01AD03;anistreplase
MB01AD04;urokinase
MB01AD05;fibrinolysin
MB01AD06;brinase
MB01AD07;reteplase
MB01AD08;saruplase
MB01AD09;ancrod
MB01AD10;drotrecogin alfa (activated)
MB01AD11;tenecteplase
MB01AD12;protein C
MB01AD13;apadamtase alfa and cinaxadamtase alfa
MB01AE;direct-acting thrombin inhibitors
MB01AE01;desirudin
MB01AE02;lepirudin
MB01AE03;argatroban
MB01AE04;melagatran
MB01AE05;ximelagatran
MB01AE06;bivalirudin
MB01AE07;dabigatran etexilate
MB01AF;direct factor Xa inhibitors
MB01AF01;rivaroxaban
MB01AF02;apixaban
MB01AF03;edoxaban
MB01AF04;betrixaban
MB01AF51;rivaroxaban and acetylsalicylic acid
MB01AX;other antithrombotic agents
MB01AX01;defibrotide
MB01AX04;dermatan sulfate
MB01AX05;fondaparinux
MB01AX07;caplacizumab
MB02;hemostatics
MB02A;antifibrinolytics
MB02AA;amino acids
MB02AA01;aminocaproic acid
MB02AA02;tranexamic acid
MB02AA03;aminomethylbenzoic acid
MB02AB;proteinase inhibitors
MB02AB01;aprotinin
MB02AB02;alpha1 antitrypsin
MB02AB04;camostat
MB02AB05;ulinastatin
MB02B;vitamin K and other haemostatics
MB02BA;vitamin K
MB02BA01;phytomenadione
MB02BA02;menadione
MB02BB;fibrinogen
MB02BB01;human fibrinogen
MB02BC;hemostatics for local use
MB02BC01;absorbable gelatin sponge
MB02BC02;oxidized cellulose
MB02BC03;tetragalacturonic acid hydroxymethyl ester
MB02BC05;adrenaline
MB02BC06;thrombin
MB02BC07;collagen
MB02BC08;calcium alginate
MB02BC09;adrenaline
MB02BC30;combinations of haemostatics for local use
MB02BD;blood clotting factors
MB02BD01;coagulation factor IX, II, VII and X in combination
MB02BD02;coagulation factor VIII
MB02BD03;factor VIII inhibitor passing coagulation factor
MB02BD04;coagulation factor IX
MB02BD05;coagulation factor VII
MB02BD06;von Willebrand factor and coagulation factor VIII in combination.
MB02BD07;coagulation factor XIII
MB02BD08;coagulation factor VIIa
MB02BD10;von Willebrand factor
MB02BD11;catridecacog
MB02BD13;coagulation factor X
MB02BD14;susoctocog alfa
MB02BD15;valoctocogene roxaparvovec
MB02BD16;etranacogen dezaparvovec
MB02BD17;fidanacogen elaparvovec
MB02BD18;arvenacogene sanparvovec
MB02BD30;thrombin
MB02BX;other systemic haemostatics
MB02BX01;etamsylate
MB02BX02;carbazochrome
MB02BX03;batroxobin
MB02BX04;romiplostim
MB02BX05;eltrombopag
MB02BX06;emicizumab
MB02BX07;lusutrombopag
MB02BX08;avatrombopag
MB02BX09;fostamatinib
MB02BX10;concizumab
MB02BX11;marstacimab
MB02BX12;fitusiran
MB03;anti-anemic agents
MB03A;iron preparations
MB03AA;iron(II), oral agents
MB03AA01;ferroglycine sulfate
MB03AA02;ferrous fumarate
MB03AA03;ferrous gluconate
MB03AA04;ferrocarbonate
MB03AA05;ferrochloride
MB03AA06;ferrosuccinate
MB03AA07;ferrous sulfate
MB03AA08;ferro tartrate
MB03AA09;ferroaspartate
MB03AA10;ferroascorbate
MB03AA11;ferro iodide
MB03AA12;ferrous sodium citrate
MB03AB;iron(III), oral agents
MB03AB01;ferric sodium citrate
MB03AB02;ferric oxide saccharate
MB03AB03;sodium feredetate
MB03AB04;ferric hydroxide
MB03AB05;ferric oxide-polymaltose complexes
MB03AB07;chondroitin sulfate-iron complex
MB03AB08;ferriacetyltransferrin
MB03AB09;ferriprotein succinylate
MB03AB10;ferrimaltol
MB03AC;iron, parenteral agents
MB03AD;iron in combination with folic acid
MB03AD01;ferroamino acid complex and folic acid
MB03AD02;ferrous fumarate and folic acid
MB03AD03;ferrous sulfate and folic acid
MB03AD04;ferric oxide-polymaltose complexes and folic acid
MB03AD05;ferrous gluconate and folic acid
MB03AE;iron in other combinations
MB03AE01;iron, vitamin B12 and folic acid
MB03AE02;iron, multivitamins and folic acid
MB03AE03;iron and multivitamins
MB03AE04;iron, multivitamins and minerals
MB03AE10;various combinations, including iron
MB03B;vitamin B12 and folic acid
MB03BA;vitamin B12 (cyanocobalamin and derivatives)
MB03BA01;cyanocobalamin
MB03BA02;cyanocobalamin-tannin complex
MB03BA03;hydroxocobalamin
MB03BA04;cobamamide
MB03BA05;mecobalamin
MB03BA51;cyanocobalamin, combinations
MB03BA53;hydroxocobalamin, comb.
MB03BB;folic acid and derivatives
MB03BB01;folic acid
MB03BB51;folic acid, combinations
MB03X;other anaesthetics
MB03XA;other anaesthetics
MB03XA01;erythropoietin
MB03XA02;darbepoetin alfa
MB03XA03;methoxypolyethylene glycol-epoetin beta
MB03XA04;peginesatide
MB03XA05;roxadustat
MB03XA06;luspatercept
MB03XA07;daprodustat
MB03XA08;vadadustat
MB03XA09;molidustat
MB03XA10;ephepoetin alfa
MB05;blood substitutes and perfusion fluids
MB05A;blood and related products
MB05AA;blood substitutes and plasma protein fractions
MB05AA01;albumin
MB05AA02;other plasma protein fractions
MB05AA03;fluorocarbon blood substitutes
MB05AA05;dextran
MB05AA06;gelatin compounds
MB05AA07;hydroxyethyl starch
MB05AA08;hemoglobin-crosfumaryl
MB05AA09;hemoglobin refiner
MB05AA10;hemoglobin glutamers (bovine)
MB05AX;other blood products
MB05AX01;erythrocytes
MB05AX02;platelets
MB05AX03;blood plasma
MB05AX04;cord blood stem cells
MB05B;infusion fluids
MB05BA;solutions for parenteral nutrition
MB05BA01;amino acids
MB05BA02;fat emulsions
MB05BA03;carbohydrates
MB05BA04;protein hydrolysates
MB05BA10;combinations of solutions for parenteral nutrition
MB05BB;solutions affecting electrolyte balance
MB05BB01;electrolytes
MB05BB02;electrolytes with carbohydrates
MB05BB03;trometamol
MB05BB04;electrolytes in combination with other substances
MB05BC;solutions for osmotic diuresis
MB05BC01;mannitol
MB05BC02;carbamide
MB05C;flushing fluids
MB05CA;anti-infectives
MB05CA01;cetylpyridine
MB05CA02;chlorhexidine
MB05CA03;nitrofural
MB05CA04;sulfamethizole
MB05CA05;taurolidine
MB05CA06;mandelic acid
MB05CA07;noxythiolin
MB05CA08;ethacridine lactate
MB05CA09;neomycin
MB05CA10;combinations of anti-infectives
MB05CB;salt solutions
MB05CB01;sodium chloride
MB05CB02;sodium citrate
MB05CB03;magnesium citrate
MB05CB04;sodium bicarbonate
MB05CB10;combinations of salt solutions
MB05CX;other flushing fluids
MB05CX01;glucose
MB05CX02;sorbitol
MB05CX03;glycine
MB05CX04;mannitol
MB05CX10;combinations of other flushing fluids
MB05D;peritoneal dialysis fluids
MB05DA;isotonic solutions
MB05DB;hypertonic solutions
MB05X;infusion concentrates
MB05XA;electrolyte solutions
MB05XA01;potassium chloride
MB05XA02;sodium bicarbonate
MB05XA03;sodium chloride
MB05XA04;ammonium chloride
MB05XA05;magnesium sulfate
MB05XA06;potassium phosphate, incl. combination with other potassium salts
MB05XA07;calcium chloride
MB05XA08;sodium acetate
MB05XA09;sodium phosphate
MB05XA10;magnesium phosphate
MB05XA11;magnesium chloride
MB05XA12;zinc chloride
MB05XA13;hydrochloric acid
MB05XA14;sodium glycerophosphate
MB05XA15;potassium lactate
MB05XA16;cardioplegia solutions
MB05XA17;potassium acetate
MB05XA18;zinc sulfate
MB05XA19;calcium gluconate
MB05XA20;sodium selenite
MB05XA30;combinations of electrolytes
MB05XA31;electrolytes in combination with other substances
MB05XB;amino acids
MB05XB01;arginine hydrochloride
MB05XB02;alanylglutamine
MB05XB03;lysine
MB05XC;vitamins
MB05XX;other infusion concentrates
MB05XX02;trometamol
MB05Z;hemodialysis fluids and hemofiltrates
MB05ZA;hemodialysis concentrates
MB05ZB;hemofiltrates
MB06;other haematological agents
MB06A;other haematological agents
MB06AA;enzymes
MB06AA02;fibrinolysin and deoxyribonuclease
MB06AA03;hyaluronidase
MB06AA04;chymotrypsin
MB06AA07;trypsin
MB06AA10;deoxyribonuclease
MB06AA55;streptokinase, combinations
MB06AB;heme products
MB06AB01;hemin
MB06AC;hereditary angioedema agents
MB06AC01;C1 inhibitor, from plasma
MB06AC02;icatibant
MB06AC03;ecallantide
MB06AC04;conestat alfa
MB06AC05;lanadelumab
MB06AC06;berotralstat
MB06AC07;garadacimab
MB06AC08;sebetarstat
MB06AC09;donidalorsen
MB06AX;other haematological agents
MB06AX01;crizanlizumab
MB06AX02;betibeglogen autotemcel
MB06AX03;voxelator
MB06AX04;mitapivat
MB06AX05;exagamglogene autotemcel
MB06AX06;lovotibeglogene autotemcel
MB06AX07;mozafancogene autotemcel
MC;Cardiovascular system
MC01;cardiac therapy
MC01A;cardiac glycosides
MC01AA;digitalis glycosides
MC01AA01;acetyldigitoxin
MC01AA02;acetyldigoxin
MC01AA03;digitalis leaf
MC01AA04;digitoxin
MC01AA05;digoxin
MC01AA06;lanatoside C
MC01AA07;deslanoside
MC01AA08;methyldigoxin
MC01AA09;git format
MC01AA52;acetyl digoxin, comp.
MC01AB;scilla glycosides
MC01AB01;proscillaridin
MC01AB51;proscillaridin, combinations
MC01AC;strophanthus glycosides
MC01AC01;g-strophanthin
MC01AC03;cymarin
MC01AX;other cardiac glycosides
MC01AX02;peruvoside
MC01B;antiarrhythmics, class I and III
MC01BA;antiarrhythmic, class I a
MC01BA01;quinidine
MC01BA02;procainamide
MC01BA03;disopyramide
MC01BA04;sparteine
MC01BA05;ajmaline
MC01BA08;prajmaline
MC01BA12;lorajmin
MC01BA13;hydroquinidine
MC01BA51;quinidine, combinations
MC01BA71;quinidine, combination with psycholeptics
MC01BB;antiarrhythmic, class I b
MC01BB01;lidocaine
MC01BB02;mexiletine
MC01BB03;tocainide
MC01BB04;aprindine
MC01BC;antiarrhythmic, class I c
MC01BC03;propafenone
MC01BC04;flecainide
MC01BC07;lorcainide
MC01BC08;encainide
MC01BC09;ethacizin
MC01BD;antiarrhythmic, class III
MC01BD01;amiodarone
MC01BD02;bretylium tosylate
MC01BD03;bunaftine
MC01BD04;dofetilide
MC01BD05;ibutilide
MC01BD06;tedisamil
MC01BD07;dronedarone
MC01BG;other antiarrhythmics, class I and III
MC01BG01;moracizin
MC01BG07;cibenzoline
MC01BG11;vernakalant
MC01C;cardiac stimulants excl. cardiac glycosides
MC01CA;adrenergic and dopaminergic agents
MC01CA01;ethylephrine
MC01CA02;isoprenaline
MC01CA03;noradrenaline
MC01CA04;dopamine
MC01CA05;norfenephrine
MC01CA06;phenylephrine
MC01CA07;dobutamine
MC01CA08;oxedrine
MC01CA09;metaraminol
MC01CA10;methoxamine
MC01CA11;mephentermine
MC01CA12;dimethofrine
MC01CA13;prenalterol
MC01CA14;dopexamine
MC01CA15;gepefrin
MC01CA16;ibopamine
MC01CA17;midodrine
MC01CA18;octopamine
MC01CA19;fenoldopam
MC01CA21;cafedrine
MC01CA22;arbutamine
MC01CA23;theodrenaline
MC01CA24;adrenaline
MC01CA25;amezinium methylsulfate
MC01CA26;ephedrine
MC01CA27;droxidopa
MC01CA28;centhaquin
MC01CA30;combinations of adrenergic and dopaminergic agents
MC01CA51;ethylephrine, comb.
MC01CE;phosphodiesterase inhibitors
MC01CE01;amrinone
MC01CE02;milrinone
MC01CE03;enoximone
MC01CE04;bucladesin
MC01CX;other cardiac stimulants
MC01CX06;angiotensinamide
MC01CX07;xamoterol
MC01CX08;levosimendan
MC01CX09;angiotensin II
MC01CX10;omecamtiv mecarbil
MC01D;vasodilators used in heart disease
MC01DA;organic nitrates
MC01DA02;glyceryl trinitrate
MC01DA04;methylpropylpropanediol dinitrate
MC01DA05;pentaerythrityl tetranitrate
MC01DA07;propatyl nitrate
MC01DA08;isosorbide dinitrate
MC01DA09;trol nitrate
MC01DA13;erythrityl tetranitrate
MC01DA14;isosorbide mononitrate
MC01DA20;organic nitrates in combinations
MC01DA38;tenitramine
MC01DA52;glyceryl trinitrate, combinations
MC01DA54;methylpropylpropanediol dinitrate, combinations
MC01DA55;pentaerythrityl tetranitrate, combinations
MC01DA57;propethyl nitrate, combinations
MC01DA58;isosorbide dinitrate, combinations
MC01DA59;trol nitrate, combinations
MC01DA63;erythrityl tetranitrate, combinations
MC01DA70;combinations with psycholeptics
MC01DB;quinolone vasodilators
MC01DB01;flosequinane
MC01DX;other vasodilators used in heart disease
MC01DX01;itramintosilate
MC01DX02;prenylamine
MC01DX03;oxyphedrine
MC01DX04;benziodarone
MC01DX05;carbocromene
MC01DX06;hexobendin
MC01DX07;etafenone
MC01DX08;heptaminol
MC01DX09;imolamine
MC01DX10;dilazep
MC01DX11;trapidil
MC01DX12;molsidomine
MC01DX13;efloxat
MC01DX14;cinepazet
MC01DX15;cloridarol
MC01DX16;nicorandil
MC01DX18;linsidomine
MC01DX19;nesiritid
MC01DX21;serelaxin
MC01DX22;vericiguat
MC01DX51;itramine tosylate, combination preparations
MC01DX52;prenylamine, combination preparations
MC01DX53;oxyphedrine, combination preparations
MC01DX54;benziodarone, combination preparations
MC01E;other agents for cardiac therapy
MC01EA;prostaglandins
MC01EA01;alprostadil
MC01EB;other cardiac drugs
MC01EB02;camphor
MC01EB03;indomethacin
MC01EB04;crataegus glycosides
MC01EB05;creatinol phosphate
MC01EB06;phosphocreatine
MC01EB07;fructose 1,6-diphosphate
MC01EB09;ubidecarenone
MC01EB10;adenosine
MC01EB11;tiracizin
MC01EB13;acadesin
MC01EB15;trimetazidine
MC01EB16;ibuprofen
MC01EB17;ivabradine
MC01EB18;ranolazine
MC01EB21;regadenoson
MC01EB22;meldonium
MC01EB23;thiazotic acid
MC01EB24;mavacamten
MC01EB25;acoramidis
MC01EX;other cardiac agents, combinations
MC02;antihypertensives
MC02A;antiadrenergic agents, centrally acting
MC02AA;rauwolfia alkaloids
MC02AA01;rescinnamine
MC02AA02;reserpine
MC02AA03;rauwolfia alkaloids in mixture
MC02AA04;rauwolfia alkaloids, whole root
MC02AA05;deserpidine
MC02AA06;methoserpidine
MC02AA07;bietaserpin
MC02AA52;reserpine, combination preparations
MC02AA53;rauwolfia alkaloids in mixture, combination preparation.
MC02AA57;bietaserpine, combination preparations
MC02AB;methyldopa
MC02AB01;methyldopa (L-form)
MC02AB02;methyldopa (racemic)
MC02AC;imidazoline receptor agonists
MC02AC01;clonidine
MC02AC02;guanfacine
MC02AC04;tolonidine
MC02AC05;moxonidine
MC02AC06;rilmenidine
MC02B;antiadrenergic agents, ganglion blocking
MC02BA;sulfonium derivatives
MC02BA01;trimetaphan
MC02BB;secondary and tertiary amines
MC02BB01;mecamylamine
MC02BC;bis-quaternary ammonium compounds
MC02C;antiadrenergic agents, peripherally acting
MC02CA;alpha-adrenoceptor blocking agents
MC02CA01;prazosin
MC02CA02;indoramine
MC02CA03;trimazosine
MC02CA04;doxazosin
MC02CA06;urapidil
MC02CC;guanidine derivatives
MC02CC01;betanidin
MC02CC02;guanethidine
MC02CC03;guanoxane
MC02CC04;debrisoquin
MC02CC05;guanoclor
MC02CC06;guanazodine
MC02CC07;guanoxabenz
MC02D;arteriolar smooth muscle, agents acting on
MC02DA;thiazide derivatives
MC02DA01;diazoxide
MC02DB;hydrazinophthalazine derivatives
MC02DB01;dihydralazine
MC02DB02;hydralazine
MC02DB03;endralazine
MC02DB04;cadralazine
MC02DC;pyrimidine derivatives
MC02DC01;minoxidil
MC02DD;nitroferricyanide derivatives
MC02DD01;nitroprusside
MC02DG;guanidine derivatives
MC02DG01;pinacidil
MC02K;other antihypertensives
MC02KA;alkaloids, excl. rauwolfia
MC02KA01;veratrum
MC02KB;tyrosine hydroxylase inhibitors
MC02KB01;metyrosine
MC02KC;mao inhibitors
MC02KC01;pargyline
MC02KD;serotonin antagonists
MC02KD01;ketanserin
MC02KN;other antihypertensives
MC02KN01;aprocitentan
MC02KX;antihypertensives for pulmonary arterial hypertension
MC02KX01;bosentan
MC02KX02;ambrisentan
MC02KX03;sitaxentan
MC02KX04;macitentan
MC02KX05;riociguat
MC02KX06;sotatercept
MC02KX52;ambrisentan and tadalafil
MC02KX54;macitentan and tadalafil
MC02L;antihypertensives and diuretics in combination
MC02LA;rauwolfia alkaloids and diuretics in combination
MC02LA01;reserpine and diuretics
MC02LA02;rescinnamine and diuretics
MC02LA03;deserpidine and diuretics
MC02LA04;Methoserpidine and Diuretics
MC02LA07;bietaserpine and diuretics
MC02LA08;rauwolfia alkaloids (whole root) and diuretics
MC02LA09;syrosingopin and diuretics
MC02LA50;comb. of rauwolfia alkaloids and diuretics incl. other combinations
MC02LA51;reserpine and diuretics including other combinations
MC02LA52;rescinnamine and diuretics including other combinations
MC02LA71;reserpine and diuretics incl. combinations with psycholeptics
MC02LB;methyldopa and diuretics in combination
MC02LB01;methyldopa (levorotatory) and diuretics
MC02LC;imidazoline receptor agonists in combination with diuretics
MC02LC01;clonidine and diuretics
MC02LC05;moxonidine and diuretics
MC02LC51;clonidine and diuretics including other combinations
MC02LE;alpha-adrenoceptor blocking agents and diuretics
MC02LE01;prazosin and diuretics
MC02LF;guanidine derivatives and diuretics
MC02LF01;guanethidine and diuretics
MC02LG;hydrazinophthalazine derivatives and diuretics
MC02LG01;dihydralazine and diuretics
MC02LG02;hydralazine and diuretics
MC02LG03;picodralazine and diuretics
MC02LG51;dihydralazine and diuretics, combinations with other drugs
MC02LG73;picodralazine and diuretics, combinations with psycholeptics
MC02LK;alkaloids, excl. rauwolfia, in combination with diuretics
MC02LK01;veratrum and diuretics
MC02LL;MAO inhibitors and diuretics
MC02LL01;pargyline and diuretics
MC02LN;serotonin antagonists and diuretics
MC02LX;other antihypertensives and diuretics
MC02LX01;pinacidil and diuretics
MC02N;combinations of antihypertensives in ATC group C02
MC03;diuretics
MC03A;low-ceiling diuretics, thiazides
MC03AA;thiazides, uncompounded preparations
MC03AA01;bendroflumethiazide
MC03AA02;hydroflumethiazide
MC03AA03;hydrochlorothiazide
MC03AA04;chlorothiazide
MC03AA05;polythiazide
MC03AA06;trichloromethiazide
MC03AA07;cyclopenthiazide
MC03AA08;methyclothiazide
MC03AA09;cyclothiazide
MC03AA13;mebutizide
MC03AB;thiazides and potassium in combination
MC03AB01;bendroflumethiazide and potassium
MC03AB02;hydroflumethiazide and potassium
MC03AB03;hydrochlorothiazide and potassium
MC03AB04;chlorothiazide and potassium
MC03AB05;polythiazide and potassium
MC03AB06;trichlormethiazide and potassium
MC03AB07;cyclopenthiazide and potassium
MC03AB08;methyclothiazide and potassium
MC03AB09;cyclothiazide and potassium
MC03AH;thiazides, combinations with psycholeptics and/or analgesics
MC03AH01;chlorothiazide, combination preparations
MC03AH02;hydroflumethiazide, combinations
MC03AX;thiazides, comb. with other substances
MC03AX01;hydrochlorothiazide, combinations
MC03B;low-ceiling diuretics, excl. thiazides
MC03BA;sulfonamides, uncompounded
MC03BA02;quinethazone
MC03BA03;clopamide
MC03BA04;chlorthalidone
MC03BA05;mefruside
MC03BA07;clofenamide
MC03BA08;metolazone
MC03BA09;metricran
MC03BA10;xipamide
MC03BA11;indapamide
MC03BA12;clorexolone
MC03BA13;fenquizone
MC03BA82;clorexolone, combinations with psycholeptics
MC03BB;sulfonamides and potassium in combination
MC03BB02;quinethazone and potassium
MC03BB03;clopamide and potassium
MC03BB04;chlorthalidone and potassium
MC03BB05;mefruside and potassium
MC03BB07;clofenamide and potassium
MC03BC;mercuric diuretics
MC03BC01;mersalyl
MC03BD;xanthine derivatives
MC03BD01;theobromine
MC03BK;sulfonamides, comb. with other substances
MC03BX;other low-ceiling diuretics
MC03BX03;cicletanine
MC03C;high-ceiling diuretics
MC03CA;sulfonamides, uncompounded
MC03CA01;furosemide
MC03CA02;bumetanide
MC03CA03;piretanide
MC03CA04;torasemide
MC03CB;sulfonamides and potassium in combination
MC03CB01;furosemide and potassium
MC03CB02;bumetanide and potassium
MC03CC;aryloxyacetic acid derivatives
MC03CC01;ethacrynic acid
MC03CC02;thienilinic acid
MC03CD;pyrazolone derivatives
MC03CD01;muzolimin
MC03CX;other high-ceiling diuretics
MC03CX01;etozoline
MC03D;aldosterone antagonists and other potassium-sparing agents
MC03DA;aldosterone antagonists
MC03DA01;spironolactone
MC03DA02;potassium canrenoate
MC03DA03;canrenon
MC03DA04;eplerenone
MC03DA05;finerenone
MC03DB;other potassium-sparing agents
MC03DB01;amiloride
MC03DB02;triamterene
MC03E;diuretics and potassium-sparing agents in combination
MC03EA;low-ceiling diuretics and potassium-sparing agents
MC03EA01;hydrochlorothiazide and potassium-sparing agents
MC03EA02;trichlormethiazide and potassium-sparing agents
MC03EA03;epiticide and potassium-sparing agents
MC03EA04;altizide and potassium-sparing agents
MC03EA05;mebutizide and potassium-sparing agents
MC03EA06;chlorthalidone and potassium-sparing agents
MC03EA07;cyclopenthiazide and potassium-sparing agents
MC03EA12;metolazone and potassium-sparing agents
MC03EA13;bendroflumethiazide and potassium-sparing agents
MC03EA14;butizide and potassium-sparing agents
MC03EB;high-ceiling diuretics and potassium-sparing agents
MC03EB01;furosemide and potassium-sparing agents
MC03EB02;bumetanide and potassium-sparing agents
MC03EB03;torasemide and potassium-sparing agents
MC03X;other diuretics
MC03XA;vasopressin antagonists
MC03XA01;tolvaptan
MC03XA02;conivaptan
MC04;peripheral vasodilators
MC04A;peripheral vasodilators
MC04AA;2-amino-1-phenylethanol derivatives
MC04AA01;isoxsuprine
MC04AA02;buphenine
MC04AA31;bamethane
MC04AB;imidazoline derivatives
MC04AB01;phentolamine
MC04AB02;tolazoline
MC04AC;nicotinic acid and derivatives
MC04AC01;nicotinic acid
MC04AC02;nicotinyl alcohol (pyridylcarbinol)
MC04AC03;inositol nicotinate
MC04AC07;cyclonic acid
MC04AD;purine derivatives
MC04AD01;pentifylline
MC04AD02;xanthinol nicotinate
MC04AD03;pentoxifylline
MC04AD04;ethophylline nicotinate
MC04AE;rye alkaloids
MC04AE01;ergoloid mesylates
MC04AE02;nicergoline
MC04AE04;dihydroergocristine
MC04AE51;ergoloid mesylates, combinations
MC04AE54;dihydroergocristine, combinations
MC04AF;enzymes
MC04AF01;kallidinogenase
MC04AX;other peripheral vasodilators
MC04AX01;cyclandelate
MC04AX02;phenoxybenzamine
MC04AX06;betahistine
MC04AX07;vincamin
MC04AX09;cinnarizine
MC04AX10;moxisylyte
MC04AX11;bencyclane
MC04AX17;wineburmin
MC04AX19;sulcotidyl
MC04AX20;buflomedil
MC04AX21;naftidrofuryl
MC04AX22;flunarizine
MC04AX23;butalamine
MC04AX24;visnadin
MC04AX26;cetiedil
MC04AX27;cinepazid
MC04AX28;ifenprodil
MC04AX30;azapetine
MC04AX32;fasudil
MC04AX33;clazosentan
MC05;vasoprotectants
MC05A;preparations for treating hemorrhoids and anal fissures for local use
MC05AA;corticosteroids
MC05AA01;hydrocortisone
MC05AA04;prednisolone
MC05AA05;betamethasone
MC05AA06;fluorometholone
MC05AA08;fluocortolone
MC05AA09;dexamethasone
MC05AA10;fluocinolone acetonide
MC05AA11;fluocinonide
MC05AA12;triamcinolone
MC05AB;antibiotics
MC05AD;local anesthetics
MC05AD01;lidocaine
MC05AD02;tetracaine
MC05AD03;benzocaine
MC05AD04;cinchocaine
MC05AD05;procaine
MC05AD06;oxetacaine
MC05AD07;pramocaine
MC05AE;muscle relaxants
MC05AE01;glyceryl trinitrate
MC05AE02;isosorbide dinitrate
MC05AE03;diltiazem
MC05AX;other agents for the treatment of hemorrhoids and anal fissures for local use
MC05AX01;aluminum preparations
MC05AX02;bismuth preparations, combinations
MC05AX03;other preparations, combinations
MC05AX04;zinc preparations
MC05AX05;tribenoside
MC05AX06;phenylephrine
MC05B;antivaricose therapy
MC05BA;heparins or heparinoids for local use
MC05BA01;organo-heparinoid
MC05BA02;sodium apolate
MC05BA03;heparin
MC05BA04;pentosan polysulfate sodium
MC05BA51;heparinoid, comb.
MC05BA53;heparin, combinations
MC05BB;sclerosing agents for local injection
MC05BB01;monoethanolaminoleate
MC05BB02;polidocanol
MC05BB03;invertose
MC05BB04;sodium tetradecyl sulfate
MC05BB05;phenol
MC05BB56;glucose, comb.
MC05BX;other sclerosing agents
MC05BX01;calcium dobesilate
MC05BX51;calcium dobesilate, combinations
MC05C;capillary stabilizers
MC05CA;bioflavonoids
MC05CA01;rutoside
MC05CA02;monoxerutin
MC05CA03;diosmin
MC05CA04;troxerutin
MC05CA05;hidrosmin
MC05CA51;rutoside, combinations
MC05CA53;diosmin, combinations
MC05CA54;troxerutin, combinations
MC05CX;other capillary stabilizers
MC05CX01;tribenoside
MC05CX02;naphthazone
MC05CX03;horse chestnut seeds
MC05X;other vasoprotectants
MC05XX;other vasoprotectants
MC05XX01;beperminogenic perplasmid
MC07;beta-blockers
MC07A;beta-blocking agents, uncompounded
MC07AA;beta-blocking agents, uncompounded, non-selective.
MC07AA01;alprenolol
MC07AA02;oxprenolol
MC07AA03;pindolol
MC07AA05;propranolol
MC07AA06;timolol
MC07AA07;sotalol
MC07AA12;nadolol
MC07AA14;mepindolol
MC07AA15;carteolol
MC07AA16;tertatolol
MC07AA17;bopindolol
MC07AA19;bupranolol
MC07AA23;penbutolol
MC07AA27;cloranolol
MC07AB;beta-blocking agents, uncompounded, selective
MC07AB01;practolol
MC07AB02;metoprolol
MC07AB03;atenolol
MC07AB04;acebutolol
MC07AB05;betaxolol
MC07AB06;bevantolol
MC07AB07;bisoprolol
MC07AB08;celiprolol
MC07AB09;esmolol
MC07AB10;epanolol
MC07AB11;s-atenolol
MC07AB12;nebivolol
MC07AB13;talinolol
MC07AB14;landiolol
MC07AG;alpha and beta-blocking agents
MC07AG01;labetalol
MC07AG02;carvedilol
MC07B;beta-blockers and thiazides
MC07BA;beta-blockers, non-selective and thiazides
MC07BA02;oxprenolol and thiazides
MC07BA05;propranolol and thiazides
MC07BA06;timolol and thiazides
MC07BA07;sotalol and thiazides
MC07BA12;nadolol and thiazides
MC07BA68;metipranolol and thiazides, comb.
MC07BB;beta-blockers, selective, and thiazides
MC07BB02;metoprolol and thiazides
MC07BB03;atenolol and thiazides
MC07BB04;acebutolol and thiazides
MC07BB06;bevantolol and thiazides
MC07BB07;bisoprolol and thiazides
MC07BB12;nebivolol and thiazides
MC07BB52;metoprolol and thiazides, comb.
MC07BG;alpha and beta blockers and thiazides
MC07BG01;labetalol and thiazides
MC07C;beta blockers and other diuretics
MC07CA;beta-blockers, non-selective, and other diuretics
MC07CA02;oxprenolol and other diuretics
MC07CA03;pindolol and other diuretics
MC07CA17;bopindolol and other diuretics
MC07CA23;penbutolol and other diuretics
MC07CB;beta-blockers, selective, and other diuretics
MC07CB02;metoprolol and other diuretics
MC07CB03;atenolol and other diuretics
MC07CB53;atenolol and other diuretics, combinations
MC07CG;alpha and beta blockers and other diuretics
MC07CG01;labetalol and other diuretics
MC07D;beta blockers, thiazides and other diuretics
MC07DA;beta-blocker. non-selective, thiazides+other diuretics.
MC07DA06;timolol, thiazides and other diuretics
MC07DB;beta-blockers, selective, thiazides and other diuretics
MC07DB01;atenolol, thiazides and other diuretics
MC07E;beta blockers and vasodilators
MC07EA;beta-blockers, non-selective, and vasodilators
MC07EB;beta-blockers, selective, and vasodilators
MC07F;beta-blockers, other combinations
MC07FB;beta-blockers and calcium channel blockers
MC07FB02;metoprolol and felodipine
MC07FB03;atenolol and nifedipine
MC07FB07;bisoprolol and amlodipine
MC07FB12;nevibolol and amlodipine
MC07FB13;metoprolol and amlodipine
MC07FX;beta-blockers, other combinations
MC07FX01;propranolol and other combinations
MC07FX02;sotalol and acetylsalicylic acid
MC07FX03;metoprolol and acetylsalicylic acid
MC07FX04;bisoprolol and acetylsalicylic acid
MC07FX05;metoprolol and ivabradine
MC07FX06;carvedilol and ivabradine
MC08;calcium antagonists
MC08C;selective calcium antagonists with vascular effects
MC08CA;dihydropyridine derivatives
MC08CA01;amlodipine
MC08CA02;felodipine
MC08CA03;isradipine
MC08CA04;nicardipine
MC08CA05;nifedipine
MC08CA06;nimodipine
MC08CA07;nisoldipine
MC08CA08;nitrendipine
MC08CA09;lacidipine
MC08CA10;nilvadipine
MC08CA11;manidipine
MC08CA12;barnidipin
MC08CA13;lercanidipine
MC08CA14;cilnidipine
MC08CA15;benidipine
MC08CA16;clevidipine
MC08CA17;levamlodipine
MC08CA51;amlodipine and celecoxib
MC08CA55;nifedipine, combinations
MC08CX;other selective calcium antagonists with primarily vascular effect
MC08CX01;mibefradil
MC08D;selective calcium antagonists with direct cardiac effect
MC08DA;phenylalkylamine derivatives
MC08DA01;verapamil
MC08DA02;gallopamil
MC08DA03;etripamil
MC08DA51;verapamil, combinations
MC08DB;benzothiazepine derivatives
MC08DB01;diltiazem
MC08E;non-selective calcium antagonists
MC08EA;phenylalkylamine derivatives
MC08EA01;fendiline
MC08EA02;bepridil
MC08EX;other non-selective calcium antagonists
MC08EX01;lidoflazine
MC08EX02;perhexiline
MC08G;calcium antagonists and diuretics
MC08GA;calcium antagonists and diuretics
MC08GA01;nifedipine and diuretics
MC08GA02;amlodipine and diuretics
MC09;agents acting on the renin-angiotensin system
MC09A;ACE inhibitors, uncompounded
MC09AA;ACE inhibitors, uncompounded
MC09AA01;captopril
MC09AA02;enalapril
MC09AA03;lisinopril
MC09AA04;perindopril
MC09AA05;ramipril
MC09AA06;quinapril
MC09AA07;benazepril
MC09AA08;cilazapril
MC09AA09;fosinopril
MC09AA10;trandolapril
MC09AA11;spirapril
MC09AA12;April
MC09AA13;moexipril
MC09AA14;temocapril
MC09AA15;zofenopril
MC09AA16;imidapril
MC09B;ACE inhibitors, combinations
MC09BA;ACE inhibitors and diuretics
MC09BA01;captopril and diuretics
MC09BA02;enalapril and diuretics
MC09BA03;lisinopril and diuretics
MC09BA04;perindopril and diuretics
MC09BA05;ramipril and diuretics
MC09BA06;quinapril and diuretics
MC09BA07;benazepril and diuretics
MC09BA08;cilazapril and diuretics
MC09BA09;fosinopril and diuretics
MC09BA12;delapril and diuretics
MC09BA13;moexepril and diuretics
MC09BA15;zofenopril and diuretics
MC09BB;ACE inhibitors and calcium channel blockers
MC09BB02;enalapril and lercanidipine
MC09BB03;lisinopril and amlodipine
MC09BB04;perindopril and amlodipine
MC09BB05;ramipril and felodipine
MC09BB06;enalapril and nitrendipine
MC09BB07;ramipril and amlodipine
MC09BB10;trandolapril and verapamil
MC09BB12;delapril and manidipine
MC09BB13;benazepril and amlodipine
MC09BB14;zofenopril and amlodipine
MC09BX;ace inhibitors, other combinations
MC09BX01;perindopril, amlodipine and indapamide
MC09BX02;perindopril and bisoprolol
MC09BX03;ramipril, amlodipine and hydrochlorothiazide
MC09BX04;perindopril, bisoprolol and amlodipine
MC09BX05;ramipril and bisoprolol
MC09BX06;perindopril, bisoprolol, amlodipine and indapamide
MC09BX07;zofenopril and nebivolol
MC09C;angiotensin II receptor blockers (ARBS), uncompounded
MC09CA;angiotensin II receptor blockers (ARBS), uncompounded
MC09CA01;losartan
MC09CA02;eprosartan
MC09CA03;valsartan
MC09CA04;irbesartan
MC09CA05;tasosartan
MC09CA06;candesartan
MC09CA07;telmisartan
MC09CA08;olmesartan medoxomil
MC09CA09;azilsartan medoxomil
MC09CA10;fimasartan
MC09D;angiotensin II receptor blockers (ARBS), combinations
MC09DA;angiotensin II receptor blockers (ARBS) and diuretics
MC09DA01;losartan and diuretics
MC09DA02;eprosartan and diuretics
MC09DA03;valsartan and diuretics
MC09DA04;irbesartan and diuretics
MC09DA06;candesartan and diuretics
MC09DA07;telmisartan and diuretics
MC09DA08;olmesartan medoxomil and diuretics
MC09DA09;azilsartan medoxomil and diuretics
MC09DA10;fimasartan and diuretics
MC09DB;angiotensin II receptor blockers (ARBS) and calcium antagonists (CCB)
MC09DB01;valsartan and amlodipine
MC09DB02;olmesartan medoxomil and amlodipine
MC09DB04;telmisartan and amlodipine
MC09DB05;irbesartan and amlodipine
MC09DB06;losartan and amlodipine
MC09DB07;candesartan and amlodipine
MC09DB08;valsartan and lercanidipine
MC09DB09;fimasartan and amlodipine
MC09DX;angiotensin II receptor blockers (arbs), other combinations
MC09DX01;valsartan, amlodipine and hydrochlorothiazide
MC09DX02;valsartan and aliskiren
MC09DX03;olmesartan medoxomil, amlodipine and hydrochlorothiazide
MC09DX04;valsartan and sacubitril
MC09DX05;valsartan and nebivolol
MC09DX06;candesartan, amlodipine and hydrochlorothiazide
MC09DX07;irbesartan, amlodipine and hydrochlorothiazide
MC09DX08;telmisartan, amlodipine and hydrochlorothiazide
MC09X;other agents with effects on the renin-angiotensin system
MC09XA;renin inhibitors
MC09XA01;the remixer
MC09XA02;aliskiren
MC09XA52;aliskiren and hydrochlorothiazide
MC09XA53;aliskiren and amlodipine
MC09XA54;aliskiren, amlodipine and hydrochlorothiazide
MC09XX;other agents acting on the renin-angiotensin system
MC09XX01;sparsentan
MC10;lipid-modifying agents
MC10A;lipid-modifying agents, uncompounded
MC10AA;HMG COA reductase inhibitors
MC10AA01;simvastatin
MC10AA02;lovastatin
MC10AA03;pravastatin
MC10AA04;fluvastatin
MC10AA05;atorvastatin
MC10AA06;cerivastatin
MC10AA07;rosuvastatin
MC10AA08;pitavastatin
MC10AB;fibrates
MC10AB01;clofibrate
MC10AB02;bezafibrate
MC10AB03;aluminum clofibrate
MC10AB04;gemfibrozil
MC10AB05;fenofibrate
MC10AB06;simfibrate
MC10AB07;ronifibrate
MC10AB08;ciprofibrate
MC10AB09;etofibrate
MC10AB10;clofibride
MC10AB11;choline fenofibrate
MC10AB12;pemafibrate
MC10AC;bile acid sequestrants
MC10AC01;cholestyramine
MC10AC02;colestipol
MC10AC03;colextran
MC10AC04;colesevelam
MC10AD;nicotinic acid and derivatives
MC10AD01;niceritrol
MC10AD02;nicotinic acid
MC10AD03;nicofuranose
MC10AD04;aluminum nicotinate
MC10AD05;nicotinyl alcohol (pyridylcarbinol)
MC10AD06;acipimox
MC10AD52;nicotinic acid, combinations
MC10AX;other lipid-modifying agents
MC10AX01; dextrothyroxine
MC10AX02;probucol
MC10AX03;tiadenol
MC10AX05;meglutol
MC10AX06;omega-3 triglycerides including other esters and acids
MC10AX07;magnesium pyridoxal 5-phosphate glutamate
MC10AX08;policosanol
MC10AX09;ezetimibe
MC10AX10;alipogen tiparvovec
MC10AX11;mipomersene
MC10AX12;lomitapide
MC10AX13;evolocumab
MC10AX14;alirocumab
MC10AX15;bempedoic acid
MC10AX16;inclisiran
MC10AX17;evinacumab
MC10AX18;volanesorsen
MC10B;lipid-modifying agents, comb.
MC10BA;lipid-modifying agents, combinations
MC10BA01;lovastatin and nicotinic acid
MC10BA02;simvastatin and ezetimibe
MC10BA03;pravastatin and fenofibrate
MC10BA04;simvastatin and fenofibrate
MC10BA05;atorvastatin and ezetimibe
MC10BA06;rosuvastatin and ezetimibe
MC10BA07;rosuvastatin and omega-3 fatty acids
MC10BA08;atorvastatin and omega-3 fatty acids
MC10BA09;rosuvastatin and fenofibrate
MC10BA10;bempedoic acid and ezetimibe
MC10BA11;pravastatin and ezetimibe
MC10BA12;pravastatin, ezetimibe and fenofibrate
MC10BA13;pitavastatin and ezetimibe
MC10BA14;pitavastatin and fenofibrate
MC10BX;lipid-modifying agents in combination with other drugs
MC10BX01;simvastatin and acetylsalicylic acid
MC10BX02;pravastatin and acetylsalicylic acid
MC10BX03;atorvastatin and amlodipine
MC10BX04;simvastatin, acetylsalicylic acid and ramipril
MC10BX05;rosuvastatin and acetylsalicylic acid
MC10BX06;atorvastatin, acetylsalicylic acid and ramipril
MC10BX07;rosuvastatin, amlodipine and lisinopril
MC10BX08;atorvastatin and acetylsalicylic acid
MC10BX09;rosuvastatin and amlodipine
MC10BX10;rosuvastatin and valsartan
MC10BX11;atorvastatin, amlodipine and perindopril
MC10BX12;atorvastatin, acetylsalicylic acid and perindopril
MC10BX13;rosuvastatin, perindopril and indapamide
MC10BX14;rosuvastatin, amlodipine and perindopril
MC10BX15;atorvastatin and perindopril
MC10BX16;rosuvastatin and fimasartan
MC10BX17;rosuvastatin and ramipril
MC10BX18;atorvastatin, amlodipine and ramipril
MC10BX19;atorvastatin, amlodipine and candesartan
MC10BX20;rosuvastatin and telmisartan
MC10BX21;rosuvastatin and perindopril
MC10BX22;rosuvastatin and nebivolol
MC10BX23;rosuvastatin, amlodipine and ramipril
MC10BX24;rosuvastatin, amlodipine and telmisartan
MD;Dermatological agents
MD01;fungicides for dermatological use
MD01A;fungicides for external use
MD01AA;antibiotics
MD01AA01;nystatin
MD01AA02;natamycin
MD01AA03;hachimycin
MD01AA04;pecilocin
MD01AA06;mepartricin
MD01AA07;pyrrolnitrin
MD01AA08;griseofulvin
MD01AA20;antibiotics in combination with corticosteroids
MD01AC;imidazole and triazole derivatives
MD01AC01;clotrimazole
MD01AC02;miconazole
MD01AC03;econazole
MD01AC04;clomidazole
MD01AC05;isoconazole
MD01AC06;thiabendazole
MD01AC07;tioconazole
MD01AC08;ketoconazole
MD01AC09;sulconazole
MD01AC10;bifonazole
MD01AC11;oxiconazole
MD01AC12;fenticonazole
MD01AC13;omoconazole
MD01AC14;sertaconazole
MD01AC15;fluconazole
MD01AC16;flutrimazole
MD01AC17;eberconazole
MD01AC18;luliconazole
MD01AC19;efinaconazole
MD01AC20;imidazoles/triazoles in combination with corticosteroids
MD01AC21;neticonazole
MD01AC22;lanoconazole
MD01AC52;miconazole, combinations
MD01AC60;bifonazole combinations
MD01AE;other fungicides for external use
MD01AE01;bromochlorosalicylanilide
MD01AE02;methylrosaniline
MD01AE03;tribromometacresol
MD01AE04;undecylenic acid
MD01AE05;polynoxylin
MD01AE06;2-(4-chlorophenoxy)-ethanol
MD01AE07;chlorphenesin
MD01AE08;ticlaton
MD01AE09;sulbentine
MD01AE10;ethylhydroxybenzoate
MD01AE11;haloprogin
MD01AE12;salicylic acid
MD01AE13;selenium sulfide
MD01AE14;ciclopirox
MD01AE15;terbinafine
MD01AE16;amorolphine
MD01AE17;dimazole
MD01AE18;tolnaftate
MD01AE19;tolciclate
MD01AE20;combinations of other fungicides for external use
MD01AE21;flucytosine
MD01AE22;naphthyfine
MD01AE23;butenafine
MD01AE24;tavaborole
MD01AE25;liranaftate
MD01AE54;undecylenic acid, comb.
MD01B;fungicides for systemic use
MD01BA;fungicides for systemic use
MD01BA01;griseofulvin
MD01BA02;terbinafine
MD01BA03;fosravuconazole
MD02;emollients and skin protectants
MD02A;emollients and skin protectants
MD02AA;silicone preparations
MD02AB;zinc oxide preparations
MD02AC;vaseline and fats
MD02AD;liquid plaster
MD02AE;carbamide preparations
MD02AE01;carbamide
MD02AE51;carbamide, comb.
MD02AF;salicylic acid preparations
MD02AX;other emollients and skin protectants
MD02B;UV protection agents
MD02BA;UV radiation protective agents, external use
MD02BA01;aminobenzoic acid
MD02BA02;octinoxate
MD02BB;UV radiation protective agents, systemic use
MD02BB01;betacarotene
MD02BB02;afamelanotide
MD03;wound treatment agents
MD03A;wound healing agents
MD03AA;liver transalver
MD03AX;other wound healing agents
MD03AX01;cadexomer iodine
MD03AX02;dextranomer
MD03AX03;dexpanthenol
MD03AX04;calcium pantothenate
MD03AX05;hyaluronic acid
MD03AX06;becaplermin
MD03AX09;crilanomer
MD03AX10;enoxolon
MD03AX11;sodium chlorite
MD03AX12;trolamine
MD03AX13;birch bark
MD03AX14;asian centella herb, incl. combinations
MD03AX15;trafermin
MD03AX16;beremagen geperpavec
MD03AX17;diperoxochloric acid
MD03B;enzymes
MD03BA;proteolytic enzymes
MD03BA01;trypsin
MD03BA02;collagenase
MD03BA03;bromelains
MD03BA52;collagenase, combinations
MD04;antipruritic agents, incl. antihistamines, anesthetics, etc.
MD04A;antipruritic agents, incl. antihistamines, anesthetics, etc.
MD04AA;antihistamines for dermatological use
MD04AA01;thonzylamine
MD04AA02;mepyramine
MD04AA03;thenalidine
MD04AA04;tripelennamine
MD04AA09;chloropyramine
MD04AA10;promethazine
MD04AA12;tolpropamine
MD04AA13;dimethindene
MD04AA14;clemastine
MD04AA15;bamipin
MD04AA16;pheniramine
MD04AA22;isothipendyl
MD04AA32;diphenhydramine
MD04AA33;diphenhydramine methyl bromide
MD04AA34;chlorphenoxamine
MD04AB;local anesthetics for dermatological use
MD04AB01;lidocaine
MD04AB02;cinchocaine
MD04AB03;oxybuprocaine
MD04AB04;benzocaine
MD04AB05;quinisocaine
MD04AB06;tetracaine
MD04AB07;pramocaine
MD04AX;other antipruritic agents
MD04AX01;doxepin
MD05;anti-psoriasis drugs
MD05A;anti-psoriasis agents for external use
MD05AA;tar-containing preparations
MD05AC;anthracene derivatives
MD05AC01;dithranol
MD05AC51;dithranol, combinations
MD05AD;psoralens for topical use
MD05AD01;trioxysalen, topical
MD05AD02;methoxalene, topical
MD05AX;other antipsoriasis agents for external use
MD05AX01;fumaric acid
MD05AX02;calcipotriol
MD05AX03;calcitriol
MD05AX04;tacalcitol
MD05AX05;tazarotene
MD05AX06;roflumilast
MD05AX07;tapinarof
MD05AX52;calcipotriol, combinations
MD05AX55;tazarotene and ulobetasol
MD05B;antipsoriasis agents for systemic use
MD05BA;psoralens for systemic use
MD05BA01;trioxysalen, systemic
MD05BA02;methoxalene, systemic
MD05BA03;bergapten
MD05BB;retinoids for psoriasis treatment
MD05BB01;etretinate
MD05BB02;acitretin
MD05BX;other antipsoriasis agents for systemic use
MD05BX01;fumaric acid
MD05BX51;fumaric acid derivatives, comb.
MD06;antibiotics and chemotherapeutics for dermatological use
MD06A;antibiotics for external use
MD06AA;tetracycline and derivatives
MD06AA01;demeclocycline
MD06AA02;chlortetracycline
MD06AA03;oxytetracycline
MD06AA04;tetracycline
MD06AX;other antibiotics for external use
MD06AX01;fusidic acid
MD06AX02;chloramphenicol
MD06AX04;neomycin
MD06AX05;bacitracin
MD06AX07;gentamicin
MD06AX08;tyrothricin
MD06AX09;mupirocin
MD06AX10;virginiamycin
MD06AX11;rifaximin
MD06AX12;amikacin
MD06AX13;retapamulin
MD06AX14;ozenoxacin
MD06AX15;rifamycin
MD06B;chemotherapeutics for external use
MD06BA;sulfonamides
MD06BA01;silver sulfadiazine
MD06BA02;sulfathiazole
MD06BA03;mafenide
MD06BA04;sulfamethizole
MD06BA05;sulfanilamide
MD06BA06;sulfamerazine
MD06BA51;silver sulfadiazine, combinations
MD06BB;antiviral agents
MD06BB01;idoxuridine
MD06BB02;tromantadine
MD06BB03;acyclovir
MD06BB04;podophyllotoxin
MD06BB05;inosine
MD06BB06;penciclovir
MD06BB07;lysozyme
MD06BB08;ibacitabine
MD06BB09;edoxudin
MD06BB10;imiquimod
MD06BB11;docosanol
MD06BB12;sinecatechins
MD06BB13;sodium berdazim
MD06BB53;aciclovir, combinations
MD06BX;other chemotherapeutic agents
MD06BX01;metronidazole
MD06BX02;ingenol mebutate
MD06BX03;tirbanibulin
MD06C;antibiotics and chemotherapeutics in combination
MD07;corticosteroids for dermatological use
MD07A;corticosteroids for topical use, uncompounded
MD07AA;corticosteroids, weakly acting (group I)
MD07AA01;methylprednisolone
MD07AA02;hydrocortisone
MD07AA03;prednisolone
MD07AB;corticosteroids, intermediate-acting (group II)
MD07AB01;clobetasone
MD07AB02;hydrocortisone butyrate
MD07AB03;flumethasone
MD07AB04;fluocortin
MD07AB05;fluperolone
MD07AB06;fluorometholone
MD07AB07;fluprednide
MD07AB08;desonide
MD07AB09;triamcinolone
MD07AB10;alclometasone
MD07AB11;hydrocortisone buteprat
MD07AB19;dexamethasone
MD07AB21;clocortolone
MD07AB30;combinations of corticosteroids
MD07AC;corticosteroids, potent (group III)
MD07AC01;betamethasone
MD07AC02;fluclorolon
MD07AC03;desoximetasone
MD07AC04;fluocinolone
MD07AC05;fluocortolone
MD07AC06;diflucortolone
MD07AC07;fludroxycortide
MD07AC08;fluocinonide
MD07AC09;budesonide
MD07AC10;diflorasone
MD07AC11;amcinonide
MD07AC12;halometasone
MD07AC13;mometasone
MD07AC14;methylprednisolone aceponate
MD07AC15;beclometasone
MD07AC16;hydrocortisone aceponate
MD07AC17;fluticasone
MD07AC18;prednicarbate
MD07AC19;difluprednate
MD07AC21;ulobetasol
MD07AD;corticosteroids, extra potent (group IV)
MD07AD01;clobetasol
MD07AD02;halcinonide
MD07B;corticosteroids in combination with antiseptics
MD07BA;corticosteroids (group I) and antiseptics
MD07BA01;prednisolone and antiseptics
MD07BA04;hydrocortisone and antiseptics
MD07BB;corticosteroids (group II) and antiseptics
MD07BB01;flumethasone and antiseptics
MD07BB02;desonide and antiseptics
MD07BB03;triamcinolone and antiseptics
MD07BB04;hydrocortisone butyrate and antiseptics
MD07BC;corticosteroids (group III) and antiseptics
MD07BC01;betamethasone and antiseptics
MD07BC02;fluocinolone and antiseptics
MD07BC03;fluocortolone and antiseptics
MD07BC04;diflucortolone and antiseptics
MD07BD;corticosteroids (group IV) and antiseptics
MD07C;corticosteroids in combination with antibiotics
MD07CA;corticosteroids (group I) and antibiotics
MD07CA01;hydrocortisone and antibiotics
MD07CA02;methylprednisolone and antibiotics
MD07CA03;prednisolone and antibiotics
MD07CB;corticosteroids (group II) and antibiotics
MD07CB01;triamcinolone and antibiotics
MD07CB02;fluprednidine and antibiotics
MD07CB03;fluorometholone and antibiotics
MD07CB04;dexamethasone and antibiotics
MD07CB05;flumethasone and antibiotics
MD07CC;corticosteroids (group III) and antibiotics
MD07CC01;betamethasone and antibiotics
MD07CC02;fluocinolone and antibiotics
MD07CC03;fludroxycortide and antibiotics
MD07CC04;beclomethasone and antibiotics
MD07CC05;fluocinonide and antibiotics
MD07CC06;fluocortolone and antibiotics
MD07CD;corticosteroids (group IV) and antibiotics
MD07CD01;clobetasol and antibiotics
MD07X;corticosteroids, other combinations
MD07XA;corticosteroids (group I), other combinations
MD07XA01;hydrocortisone
MD07XA02;prednisolone
MD07XB;corticosteroids (group II), other combinations
MD07XB01;flumethasone
MD07XB02;triamcinolone
MD07XB03;flupredniden
MD07XB04;fluorometholone
MD07XB05;dexamethasone
MD07XB30;combinations of corticosteroids
MD07XC;corticosteroids (group III), other combinations
MD07XC01;betamethasone
MD07XC02;desoximetasone
MD07XC03;mometasone
MD07XC04;biphenylol
MD07XC05;fluocortolone
MD07XD;corticosteroids (group IV), other combinations
MD08;antiseptics and disinfectants
MD08A;antiseptics and disinfectants
MD08AA;acridine derivatives
MD08AA01;ethacridine lactate
MD08AA02;aminoacridine
MD08AA03;euflavin
MD08AB;aluminum compounds
MD08AC;biguanides and amidines
MD08AC01;dibromopropamidine
MD08AC02;chlorhexidine
MD08AC03;propamidine
MD08AC04;hexamidine
MD08AC05;polyhexanide
MD08AC52;chlorhexidine, combinations
MD08AD;boric acid preparations
MD08AE;phenol and derivatives
MD08AE01;hexachlorophene
MD08AE02;metacresol sulfonic acid formaldehyde
MD08AE03;phenol
MD08AE04;triclosan
MD08AE05;chloroxylenol
MD08AE06;biphenylol
MD08AF;furan derivatives
MD08AF01;nitrofural
MD08AG;iodine preparations
MD08AG01;iodine/octylphenoxypolyglycol ether
MD08AG02;iodine/polyvidone
MD08AG03;iodine
MD08AG04;diiodohydroxypropane
MD08AH;quinoline derivatives
MD08AH01;dequalinium
MD08AH02;chlorquinaldol
MD08AH03;oxyquinoline
MD08AH30;clioquinol
MD08AJ;quaternary ammonium compounds
MD08AJ01;benzalcone
MD08AJ02;cetrimon
MD08AJ03;cetylpyridine
MD08AJ04;cetrimide
MD08AJ05;benzoxonium chloride
MD08AJ06;didecyldimethylammonium chloride
MD08AJ08;benzethonium chloride
MD08AJ10;decamethoxin
MD08AJ57;octenidine, comb.
MD08AJ58;Benzetonium chloride, comp.
MD08AJ59;dodeclonium bromide, comp.
MD08AK;mercury compounds
MD08AK01;mercuriamidochloride
MD08AK02;phenyl mercuriborate
MD08AK03;mercuric chloride
MD08AK04;merbromine
MD08AK05;mercury, metallic
MD08AK06;thiomersal
MD08AK30;mercury iodide
MD08AL;silver compounds
MD08AL01;silver nitrate
MD08AL30;silver
MD08AX;other antiseptics and disinfectants
MD08AX01;hydrogen peroxide
MD08AX02;eosin
MD08AX03;propanol
MD08AX04;tosylchloramide sodium
MD08AX05;isopropanol
MD08AX06;potassium permanganate
MD08AX07;sodium hypochlorite
MD08AX08;ethanol
MD08AX53;propanol, comb.
MD09;medical dressings
MD09A;medical dressings
MD09AA;ointment compresses with anti-infectives
MD09AA01;framycetin
MD09AA02;fusidic acid
MD09AA03;nitrofural
MD09AA04;phenyl mercuric nitrate
MD09AA05;benzododecine
MD09AA06;triclosan
MD09AA07;cetylpyridine
MD09AA08;aluminum chloride hydrate
MD09AA09;povidone-iodine
MD09AA10;clioquinol
MD09AA11;benzalcone
MD09AA12;chlorhexidine
MD09AA13;iodoform
MD09AB;zinc bandages
MD09AB01;zinc bandage without additives
MD09AB02;zinc bandage with additives
MD09AX;vaseline compresses
MD10;anti-acne drugs
MD10A;anti-acne preparations for external use
MD10AA;corticosteroids, combinations for acne treatment
MD10AA01;fluorometholone
MD10AA02;methylprednisolone
MD10AA03;dexamethasone
MD10AB;sulfur-containing acne remedies
MD10AB01;bithionol
MD10AB02;sulfur
MD10AB03;thioxolone
MD10AB05;mesulfen
MD10AD;retinoids for topical use against acne
MD10AD01;tretinoin
MD10AD02;retinol
MD10AD03;adapalene
MD10AD04;isotretinoin
MD10AD05;motretinide
MD10AD06;trifaroten
MD10AD51;tretinoin, comb.
MD10AD53;adapalen, combinations
MD10AD54;isotretinoin, comb.
MD10AE;peroxides
MD10AE01;benzoyl peroxide
MD10AE51;benzoyl peroxide, comp.
MD10AF;anti-infectives for acne treatment
MD10AF01;clindamycin
MD10AF02;erythromycin
MD10AF03;chloramphenicol
MD10AF04;meclocycline
MD10AF05;nadifloxacin
MD10AF06;sulfacetamide
MD10AF07;minocycline
MD10AF51;clindamycin, comb.
MD10AF52;erythromycin, combinations
MD10AX;other anti-acne products for external use
MD10AX01;aluminum chloride
MD10AX02;resorcinol
MD10AX03;azelaic acid
MD10AX04;aluminum oxide
MD10AX05;dapsone
MD10AX06;clascoteron
MD10AX30;various combinations including other topical anti-acne agents
MD10B;anti-acne agents for systemic use
MD10BA;retinoids for the treatment of acne
MD10BA01;isotretinoin
MD10BX;other anti-acne agents for systemic use
MD10BX01;ichthammol
MD11;other dermatological agents
MD11A;other dermatological agents
MD11AA;antihidrotics
MD11AA01;glycopyrronium
MD11AA02;sofpyronium bromide
MD11AC;medicated shampoo
MD11AC01;cetrimide
MD11AC02;cadmium compounds
MD11AC03;selenium compounds
MD11AC06;iodine/polyvidone
MD11AC08;sulfur compounds
MD11AC09;xeny salad
MD11AC30;medical shampoo, other
MD11AE;androgens for topical use
MD11AE01;methandienone
MD11AF;remedies against warts and corns
MD11AH;dermatitis drugs, excl. corticosteroids
MD11AH01;tacrolimus
MD11AH02;pimecrolimus
MD11AH03;cromoglycic acid
MD11AH04;alitretinoin
MD11AH05;dupilumab
MD11AH06;crisaborole
MD11AH07;tralokinumab
MD11AH08;abrocitinib
MD11AH09;ruxolitinib
MD11AH10;lebrikizumab
MD11AH11;delgocitinib
MD11AH12;nemolizumab
MD11AX;other dermatological agents
MD11AX01;minoxidil, topical
MD11AX02;gamolenic acid
MD11AX03;calcium gluconate
MD11AX04;lithium succinate
MD11AX05;magnesium sulfate
MD11AX06;mequinol
MD11AX08;tiratricol
MD11AX09;oxaceprol
MD11AX10;finasteride
MD11AX11;hydroquinone
MD11AX12;zinc pyrithione
MD11AX13;monobenzone
MD11AX16;eflornithine
MD11AX18;diclofenac
MD11AX21;brimonidine
MD11AX22;ivermectin
MD11AX23;aminobenzoate potassium
MD11AX24;deoxycholic acid
MD11AX25;hydrogen peroxide
MD11AX26;caffeine
MD11AX27;oxymetazoline
MD11AX52;gamolenic acid, combinations
MD11AX57;collagen, combinations
MG;Urogenital system and sex hormones
MG01;gynecological anti-infectives and antiseptics
MG01A;anti-infectives/antiseptics, excl. combinations with corticosteroids
MG01AA;antibiotics
MG01AA01;nystatin
MG01AA02;natamycin
MG01AA03;amphotericin
MG01AA04;candicidin
MG01AA05;chloramphenicol
MG01AA06;trichomycin
MG01AA07;oxytetracycline
MG01AA08;carfecillin
MG01AA09;mepartricin
MG01AA10;clindamycin
MG01AA11;pentamycin
MG01AA51;nystatin, comb.
MG01AB;arsenic compounds
MG01AB01;acetarsol
MG01AC;quinoline derivatives
MG01AC01;diiodohydroxyquinoline
MG01AC02;clioquinol
MG01AC03;chlorquinaldol
MG01AC05;dequalone
MG01AC06;broxyquinoline
MG01AC30;oxyquinoline
MG01AD;organic acids
MG01AD01;lactic acid
MG01AD02;acetic acid
MG01AD03;ascorbic acid
MG01AE;sulfonamides
MG01AE01;sulfatolamide
MG01AE10;combinations of sulfonamides
MG01AF;imidazole derivatives
MG01AF01;metronidazole
MG01AF02;clotrimazole
MG01AF04;miconazole
MG01AF05;econazole
MG01AF06;ornidazole
MG01AF07;isoconazole
MG01AF08;tioconazole
MG01AF11;ketoconazole
MG01AF12;fenticonazole
MG01AF13;azanidazole
MG01AF14;propenidazole
MG01AF15;butoconazole
MG01AF16;omoconazole
MG01AF17;oxiconazole
MG01AF18;flutrimazole
MG01AF19;sertaconazole
MG01AF20;combinations of imidazole derivatives
MG01AF21;tinidazole
MG01AF55;econazole, combinations
MG01AG;triazole derivatives
MG01AG02;terconazole
MG01AX;other anti-infectives and antiseptics
MG01AX01;clodantoin
MG01AX02;inosine
MG01AX03;metacresol sulfonic acid formaldehyde
MG01AX05;nifuratel
MG01AX06;furazolidone
MG01AX09;methylrosaniline
MG01AX11;iodine/polyvidone
MG01AX12;ciclopirox
MG01AX13;prothiophate
MG01AX14;lactobacillus
MG01AX15;copper rust night
MG01AX16;hexetidine
MG01AX17;dapivirine
MG01AX66;octenidine, combinations
MG01B;anti-infectives/antiseptics in combination with corticosteroids
MG01BA;antibiotics and corticosteroids
MG01BC;quinoline derivatives and corticosteroids
MG01BD;antiseptics and corticosteroids
MG01BE;sulfonamides and corticosteroids
MG01BF;imidazole derivatives and corticosteroids
MG02;other gynecological agents
MG02A;uterotonics
MG02AB;secale alkaloids
MG02AB01;methylergometrine
MG02AB02;secale alkaloids
MG02AB03;ergometrine
MG02AC;secale alkaloids and oxytocin incl. derivatives in combination
MG02AC01;methylergometrine and oxytocin
MG02AD;prostaglandins
MG02AD01;dinoprost
MG02AD02;dinoprostone
MG02AD03;gemeprost
MG02AD04;carboprost
MG02AD05;sulprostone
MG02AD06;misoprostol
MG02AX;other uterotonics
MG02B;contraceptives for local application
MG02BA;intrauterine contraceptives
MG02BA01;plastic intrauterine device
MG02BA02;plastic intrauterine device with copper
MG02BA03;plastic intrauterine device with progestin
MG02BB;intravaginal contraceptives
MG02BB01;vaginal ring with progestin and estrogen
MG02BB02;vaginal ring with progestin
MG02C;other gynecological agents
MG02CA;sympathomimetics, anxiolytic
MG02CA01;ritodrine
MG02CA02;buphenin
MG02CA03;fenoterol
MG02CB;prolactin inhibitors
MG02CB01;bromocriptine
MG02CB02;lisurid
MG02CB03;cabergoline
MG02CB04;quinagolide
MG02CB05;metergoline
MG02CB06;tergurid
MG02CC;anti-inflammatory agents for vaginal administration
MG02CC01;ibuprofen
MG02CC02;naproxen
MG02CC03;benzydamine
MG02CC04;flunoxaprofen
MG02CX;other gynecological agents
MG02CX01;atosiban
MG02CX02;flibanserin
MG02CX03;chastity tree fruit
MG02CX04;silver rhizome
MG02CX05;bremelanotide
MG02CX06;fezolinetant
MG02CX07;elinazanetant
MG03;sex hormones and modulators of the genital system
MG03A;hormonal contraceptives for systemic use
MG03AA;gestagens and estrogens, fixed combinations
MG03AA01;ethynodiol and estradiol
MG03AA02;quingestanol and ethinylestradiol
MG03AA03;lynestrenol and ethinylestradiol
MG03AA04;megestrol and ethinylestradiol
MG03AA05;norethisterone and ethinylestradiol
MG03AA06;norgestrel and ethinylestradiol
MG03AA07;levonorgestrel and ethinylestradiol
MG03AA08;medroxyprogesterone and ethinylestradiol
MG03AA09;desogestrel and ethinylestradiol
MG03AA10;gestodene and ethinylestradiol
MG03AA11;norgestimate and ethinylestradiol
MG03AA12;drospirenone and ethinylestradiol
MG03AA13;norelgestromin and ethinylestradiol
MG03AA14;nomegestrol and estradiol
MG03AA15;chlormadinone and ethinylestradiol
MG03AA16;dienogest and ethinylestradiol
MG03AA17;medroxyprogesterone and estradiol
MG03AA18;drospirenone and estetrol
MG03AB;gestagens and estrogens, sequential preparations
MG03AB01;megestrol and ethinylestradiol
MG03AB02;lynestrenol and ethinylestradiol
MG03AB03;levonorgestrel and ethinylestradiol
MG03AB04;norethisterone and ethinylestradiol
MG03AB05;desogestrel and ethinylestradiol
MG03AB06;gestodene and ethinylestradiol
MG03AB07;chlormadinone and ethinylestradiol
MG03AB08;dienogest and estradiol
MG03AB09;norgestimate and ethinylestradiol
MG03AC;gestagens
MG03AC01;norethisterone
MG03AC02;lynestrenol
MG03AC03;levonorgestrel
MG03AC04;quingestanol
MG03AC05;megestrol
MG03AC06;medroxyprogesterone
MG03AC07;norgestrienone
MG03AC08;etonogestrel
MG03AC09;desogestrel
MG03AC10;drospirenone
MG03AD;emergency contraception
MG03AD01;levonorgestrel
MG03AD02;ulipristal
MG03B;androgens
MG03BA;3-oxoandrostene(4) derivatives
MG03BA01;fluoxymesterone
MG03BA02;methyltestosterone
MG03BA03;testosterone
MG03BB;5-androstanone(3) derivatives
MG03BB01;mesterolone
MG03BB02;androstanolone
MG03C;estrogens
MG03CA;natural and semi-synthetic estrogens, uncompounded
MG03CA01;ethinylestradiol
MG03CA03;estradiol
MG03CA04;estriol
MG03CA06;chlorotrianisene
MG03CA07;estrone
MG03CA09;promestrian
MG03CA53;estradiol, combinations
MG03CA57;conjugated estrogens
MG03CB;synthetic estrogens, uncompounded
MG03CB01;dienestrol
MG03CB02;diethylstilbestrol
MG03CB03;methylnestriol
MG03CB04;moxestrol
MG03CC;estrogens, combinations with other substances
MG03CC02;dienestrol
MG03CC03;methylnestriol
MG03CC04;estrone
MG03CC05;diethylstilbestrol
MG03CC06;estriol
MG03CC07;conjugated estrogens and bazedoxifene
MG03CX;other estrogens
MG03CX01;tibolone
MG03D;gestagens
MG03DA;pregnene(4) derivatives
MG03DA01;gestonorone
MG03DA02;medroxyprogesterone
MG03DA03;hydroxyprogesterone
MG03DA04;progesterone
MG03DB;pregnadiene derivatives
MG03DB01;dydrogesterone
MG03DB02;megestrol
MG03DB03;medrogestone
MG03DB04;nomegestrol
MG03DB05;demegeston
MG03DB06;chlormadinone
MG03DB07;promegestone
MG03DB08;dienogest
MG03DC;estrene derivatives
MG03DC01;allylestrenol
MG03DC02;norethisterone
MG03DC03;lynestrenol
MG03DC04;ethisterone
MG03DC06;ethynodiol
MG03DC31;methylestrenolone
MG03E;androgens and female sex hormones in combination.
MG03EA;androgens and estrogens
MG03EA01;methyltestosterone and estrogen
MG03EA02;testosterone and estrogen
MG03EA03;prasterone and estrogen
MG03EB;androgen, progestogen and estrogen in combination
MG03EK;androgens and female sex hormones in combination with other substances
MG03EK01;methyltestosterone
MG03F;progestogens and estrogens in combination
MG03FA;gestagens and estrogens, combinations
MG03FA01;norethisterone and estrogen
MG03FA02;hydroxyprogesterone and estrogen
MG03FA03;ethisterone and estrogen
MG03FA04;progesterone and estrogen
MG03FA05;methylnortestosterone and estrogen
MG03FA06;ethynodiol and estrogen
MG03FA07;lynestrenol and estrogen
MG03FA08;megestrol and estrogen
MG03FA09;noretynodrel and estrogen
MG03FA10;norgestrel and estrogen
MG03FA11;levonorgestrel and estrogen
MG03FA12;medroxyprogesterone and estrogen
MG03FA13;norgestimate and estrogen
MG03FA14;dydrogesterone and estrogen
MG03FA15;dienogest and estrogen
MG03FA16;trimegestone and estrogen
MG03FA17;drospirenone and estrogen
MG03FB;gestagens and estrogens, sequential preparations
MG03FB01;norgestrel and estrogen
MG03FB02;lynestrenol and estrogen
MG03FB03;chlormadinone and estrogen
MG03FB04;megestrol and estrogen
MG03FB05;norethisterone and estrogen
MG03FB06;medroxyprogesterone and estrogen
MG03FB07;medrogestone and estrogen
MG03FB08;dydrogesterone and estrogen
MG03FB09;levonorgestrel and estrogen
MG03FB10;desogestrel and estrogen
MG03FB11;trimegestone and estrogen
MG03FB12;nomegestrol and estrogen
MG03G;gonadotropin and other ovulation stimulants
MG03GA;gonadotropins
MG03GA01;chorionic gonadotropin
MG03GA02;gonadotropin, human menopausal
MG03GA03;serum gonadotropin
MG03GA04;urofollitropin
MG03GA05;follitropin alfa
MG03GA06;follitropin beta
MG03GA07;lutropin alfa
MG03GA08;chorionic gonadotropin alfa
MG03GA09;corifollitropin alfa
MG03GA10;follitropin delta
MG03GA30;combinations of gonadotropins
MG03GB;ovulation stimulants, synthetic
MG03GB01;cyclophenyl
MG03GB02;clomiphene
MG03GB03;epimestrol
MG03H;antiandrogens
MG03HA;antiandrogens, uncompounded
MG03HA01;cyproterone
MG03HB;antiandrogens and estrogens
MG03HB01;cyproterone and estrogen
MG03X;other sex hormones and modulators of the genital system.
MG03XA;antigonadotropins and similar substances
MG03XA01;danazol
MG03XA02;gestrinone
MG03XB;progesterone receptor modulators
MG03XB01;mifepristone
MG03XB02;ulipristal
MG03XB51;mifepristone, combinations
MG03XC;selective estrogen receptor modulators
MG03XC01;raloxifene
MG03XC02;bazedoxifene
MG03XC03;lasofoxifene
MG03XC04;ormeloxifene
MG03XC05;ospemifene
MG03XX;other sex hormones and modulators of the genital system
MG03XX01;prasterone
MG04;urology
MG04B;urological agents
MG04BA;acidifying agents
MG04BA01;ammonium chloride
MG04BA03;calcium chloride
MG04BC;agents for dissolving uric acid stones
MG04BD;drugs for frequent urination and incontinence
MG04BD01;emepron
MG04BD02;flavoxate
MG04BD03;meladrazine
MG04BD04;oxybutynin
MG04BD05;terodiline
MG04BD06;propiverine
MG04BD07;tolterodine
MG04BD08;solifenacin
MG04BD09;trospium
MG04BD10;darifenacin
MG04BD11;fesoterodine
MG04BD12;mirabegron
MG04BD13;desfesoterodine
MG04BD14;imidafenacin
MG04BD15;vibegron
MG04BE;drugs used for erectile dysfunction
MG04BE01;alprostadil
MG04BE02;papaverine
MG04BE03;sildenafil
MG04BE04;yohimbine
MG04BE06;moxisylyte
MG04BE07;apomorphine
MG04BE08;tadalafil
MG04BE09;vardenafil
MG04BE10;avanafil
MG04BE11;without file
MG04BE30;combinations of agents used in erectile dysfunction
MG04BE52;papaverine, combinations
MG04BX;other urology
MG04BX01;magnesium hydroxide
MG04BX03;acetohydroxamic acid
MG04BX06;phenazopyridine
MG04BX10;succinimide
MG04BX11;collagen
MG04BX12;phenyl salicylate
MG04BX13;dimethyl sulfoxide
MG04BX14;dapoxetine
MG04BX15;pentosan polysulfate sodium
MG04BX16;tiopronin
MG04BX17;sodium salicylate and methenamine
MG04C;agents used in benign prostatic hypertrophy
MG04CA;alpha-adrenoreceptor antagonists
MG04CA01;alfuzosin
MG04CA02;tamsulosin
MG04CA03;terazosin
MG04CA04;silodosin
MG04CA51;alfuzosin and finasteride
MG04CA52;tamsulosin and dutasteride
MG04CA53;tamsulosin and solifenacin
MG04CA54;tamsulosin and tadalafil
MG04CA55;doxazosin and finasteride
MG04CB;testosterone-5-alpha-reductase inhibitors
MG04CB01;finasteride
MG04CB02;dutasteride
MG04CB51;finasteride and tadalafil
MG04CX;other agents for benign prostatic hypertrophy
MG04CX01;African plum bark
MG04CX02;saw palmetto fruit
MG04CX03;mepartricin
MG04CX04;fexapotide
MH;Systemic hormone preparations, excl. sex hormones
MH01;pituitary and hypothalamic hormones and analogues
MH01A;anterior pituitary hormones and analogues
MH01AA;acth
MH01AA01;corticotropin
MH01AA02;tetracosactide
MH01AB;thyrotropin
MH01AB01;thyrotropin alfa
MH01AC;somatropin and somatropin agonists
MH01AC01;somatropin
MH01AC02;somatrem
MH01AC03;mecasermin
MH01AC04;sermorelin
MH01AC05;mecasermin rinfabate
MH01AC06;tesamorelin
MH01AC07;somapacitan
MH01AC08;somatrogon
MH01AC09;lonapegsomatropin
MH01AX;other anterior pituitary hormones and analogues
MH01AX01;pegvisomant
MH01B;retropituitary hormones
MH01BA;vasopressin and analogues
MH01BA01;vasopressin (argipressin)
MH01BA02;desmopressin
MH01BA03;lypressin
MH01BA04;terlipressin
MH01BA05;ornipressin
MH01BB;oxytocin and analogues
MH01BB01;demoxytocin
MH01BB02;oxytocin
MH01BB03;carbetocin
MH01C;hypothalamic hormones
MH01CA;gonadotropin-releasing hormones
MH01CA01;gonadorelin
MH01CA02;nafarelin
MH01CB;somatostatin and analogues
MH01CB01;somatostatin
MH01CB02;octreotide
MH01CB03;lanreotide
MH01CB04;vapreotid
MH01CB05;pasireotide
MH01CC;anti gonadotropin releasing hormones
MH01CC01;ganirelix
MH01CC02;cetrorelix
MH01CC03;elagolix
MH01CC04;linzagolix
MH01CC53;elagolix, estradiol and norethisterone
MH01CC54;relugolix, estradiol and norethisterone
MH02;corticosteroids for systemic use
MH02A;corticosteroids for systemic use, uncompounded
MH02AA;mineralocorticoids
MH02AA01;aldosterone
MH02AA02;fludrocortisone
MH02AA03;desoxycortone
MH02AB;glucocorticoids
MH02AB01;betamethasone
MH02AB02;dexamethasone
MH02AB03;fluocortolone
MH02AB04;methylprednisolone
MH02AB05;paramethasone
MH02AB06;prednisolone
MH02AB07;prednisone
MH02AB08;triamcinolone
MH02AB09;hydrocortisone
MH02AB10;cortisone
MH02AB11;prednylidene
MH02AB12;rimexolone
MH02AB13;deflazacort
MH02AB14;cloprednol
MH02AB15;meprednisone
MH02AB17;cortivazole
MH02AB18;vamorolone
MH02B;corticosteroids for systemic use, combinations
MH02BX;corticosteroids for systemic use, combinations
MH02BX01;methylprednisolone, combinations
MH02C;antiadrenal preparations
MH02CA;anticorticosteroids
MH02CA01;trilostane
MH02CA02;osilodrostat
MH02CA03;ketoconazole
MH02CA04;levoketoconazole
MH03;thyroid therapy
MH03A;thyroid preparations
MH03AA;thyroid hormones
MH03AA01;levothyroxine sodium
MH03AA02;liothyronine sodium
MH03AA03;levothyroxine and liothyronine in combination
MH03AA04;tiratricol
MH03AA05;thyroid preparations
MH03AA51;levothyroxine sodium and iodine compounds
MH03B;antithyroid preparations
MH03BA;thiouracils
MH03BA01;methylthiouracil
MH03BA02;propylthiouracil
MH03BA03;benzylthiouracil
MH03BB;sulfur-containing imidazole derivatives
MH03BB01;carbimazole
MH03BB02;thiamazole
MH03BB52;thiamazole, combinations
MH03BC;perchlorates
MH03BC01;potassium perchlorate
MH03BX;other antithyroid preparations
MH03BX01;diiodotyrosine
MH03BX02;dibromotyrosine
MH03C;iodine therapy
MH03CA;iodine therapy
MH04;pancreatic hormones
MH04A;glycogenolytic hormones
MH04AA;glycogenolytic hormones
MH04AA01;glucagon
MH04AA02;dasiglucagon
MH05;calcium homeostasis
MH05A;parathyroid hormones and analogues
MH05AA;parathyroid hormones and analogues
MH05AA01;parathyroid gland extract
MH05AA02;teriparatide
MH05AA03;parathyroid hormone
MH05AA04;abaloparatide
MH05AA05;palopegteriparatide
MH05B;anti-parathyroid agents
MH05BA;calcitonin preparations
MH05BA01;calcitonin (salmon, synthetic)
MH05BA02;calcitonin (porcine, natural)
MH05BA03;calcitonin (human, synthetic)
MH05BA04;elcatonin
MH05BX;other anti-parathyroid agents
MH05BX01;cinacalcet
MH05BX02;paricalcitol
MH05BX03;doxercalciferol
MH05BX04;etelcalcetide
MH05BX05;calcifediol
MH05BX06;evocalcet
MJ;Anti-infectives for systemic use
MJ01;antibacterials for systemic use
MJ01A;tetracyclines
MJ01AA;tetracyclines
MJ01AA01;demeclocycline
MJ01AA02;doxycycline
MJ01AA03;chlortetracycline
MJ01AA04;lymecycline
MJ01AA05;metacycline
MJ01AA06;oxytetracycline
MJ01AA07;tetracycline
MJ01AA08;minocycline
MJ01AA09;rolitetracycline
MJ01AA10;penimepicycline
MJ01AA11;clomocycline
MJ01AA12;tigecycline
MJ01AA13;eravacycline
MJ01AA14;sarecycline
MJ01AA15;omadacycline
MJ01AA20;combinations of tetracyclines
MJ01AA56;oxytetracycline, combinations
MJ01B;amphenicols
MJ01BA;amphenicols
MJ01BA01;chloramphenicol
MJ01BA02;thiamphenicol
MJ01BA52;thiamphenicol, comb.
MJ01C;beta-lactam antibacterials, penicillins
MJ01CA;extended spectrum penicillins
MJ01CA01;ampicillin
MJ01CA02;pivampicillin
MJ01CA03;carbenicillin
MJ01CA04;amoxicillin
MJ01CA05;carindacillin
MJ01CA06;bacampicillin
MJ01CA07;epicilline
MJ01CA08;pivmecillinam
MJ01CA09;azlocillin
MJ01CA10;mezlocillin
MJ01CA11;mecillinam
MJ01CA12;piperacillin
MJ01CA13;ticarcillin
MJ01CA14;metampicillin
MJ01CA15;talampicillin
MJ01CA16;sulbenicillin
MJ01CA17;temocilline
MJ01CA18;hetacillin
MJ01CA19;aspoxicillin
MJ01CA20;combinations of extended-spectrum penicillins
MJ01CA51;ampicillin, combinations
MJ01CE;beta-lactamase sensitive penicillins
MJ01CE01;benzylpenicillin
MJ01CE02;phenoxymethylpenicillin
MJ01CE03;propicillin
MJ01CE04;azidocillin
MJ01CE05;pheneticillin
MJ01CE06;penamecillin
MJ01CE07;clomethocillin
MJ01CE08;benzathine benzylpenicillin
MJ01CE09;procaine penicillin
MJ01CE10;benzathine phenoxymethylpenicillin
MJ01CE30;combinations of beta-lactamase sensitive penicillins
MJ01CF;beta-lactamase resistant penicillins
MJ01CF01;dicloxacillin
MJ01CF02;cloxacillin
MJ01CF03;methicillin
MJ01CF04;oxacillin
MJ01CF05;flucloxacillin
MJ01CF06;nafcillin
MJ01CG;beta-lactamase inhibitors
MJ01CG01;sulbactam
MJ01CG02;tazobactam
MJ01CR;combination of penicillins, incl. beta-lactamase inhib.
MJ01CR01;ampicillin and beta-lactamase inhibitor
MJ01CR02;amoxicillin and beta-lactamase inhibitor
MJ01CR03;ticarcillin and beta-lactamase inhibitor
MJ01CR04;sultamicillin and enzyme inhibitor
MJ01CR05;piperacillin and beta-lactamase inhibitor
MJ01CR50;combinations of penicillins
MJ01D;other beta-lactam antibacterials
MJ01DB;cephalosporins, 1st generation
MJ01DB01;cephalexin
MJ01DB02;cephaloridine
MJ01DB03;cephalothin
MJ01DB04;cefazolin
MJ01DB05;cefadroxil
MJ01DB06;cefazedone
MJ01DB07;cefatrizine
MJ01DB08;cephapirin
MJ01DB09;cephradine
MJ01DB10;cefacetril
MJ01DB11;cefroxadine
MJ01DB12;ceftezol
MJ01DC;cephalosporins, 2nd generation
MJ01DC01;cefoxitin
MJ01DC02;cefuroxime
MJ01DC03;cefamandole
MJ01DC04;cefaclor
MJ01DC05;cefotetan
MJ01DC06;cefonicide
MJ01DC07;cefotiam
MJ01DC08;loracarbef
MJ01DC09;cefmetazole
MJ01DC10;cefprozil
MJ01DC11;ceforanid
MJ01DC12;cefminox
MJ01DC13;cefbuperazone
MJ01DC14;flomoxef
MJ01DC52;cefuroxime and beta-lactamase inhibitor
MJ01DD;cephalosporins, 3rd generation
MJ01DD01;cefotaxime
MJ01DD02;ceftazidime
MJ01DD03;cefsulodin
MJ01DD04;ceftriaxone
MJ01DD05;cefmenoxime
MJ01DD06;latamoxef
MJ01DD07;ceftizoxime
MJ01DD08;cefixime
MJ01DD09;cefodizime
MJ01DD10;cefetamet
MJ01DD11;cefpiramide
MJ01DD12;cefoperazone
MJ01DD13;cefpodoxime
MJ01DD14;ceftibuten
MJ01DD15;cefdinir
MJ01DD16;cefditoren
MJ01DD17;cefcapen
MJ01DD18;cefteram
MJ01DD51;cefotaxime and beta-lactamase inhibitor
MJ01DD52;ceftazidime and beta-lactamase inhibitor
MJ01DD54;ceftriaxone, combinations
MJ01DD58;cefixime and beta-lactamase inhibitor
MJ01DD62;cefoperazone and beta-lactamase inhibitor
MJ01DD63;ceftriaxone and beta-lactamase inhibitor
MJ01DD64;cefpodoxime and beta-lactamase inhibitor
MJ01DE;cephalosporins, 4th generation
MJ01DE01;cefepime
MJ01DE02;cefpirome
MJ01DE03;cefozopran
MJ01DE51;cefepime and beta-lactamase inhibitor
MJ01DF;monobactams
MJ01DF01;aztreonam
MJ01DF02;carumonam
MJ01DF51;aztreonam and beta-lactamase inhibitor
MJ01DH;carbapenems
MJ01DH02;meropenem
MJ01DH03;ertapenem
MJ01DH04;doripenem
MJ01DH05;biapenem
MJ01DH06;tebipenem pivoxil
MJ01DH51;imipenem and cilastatin
MJ01DH52;meropenem and vaborbactam
MJ01DH55;panipenem and betamiprone
MJ01DH56;imipenem, cilastatin and relebactam
MJ01DI;other cephalosporins and penems
MJ01DI01;ceftobiprolmedocaril
MJ01DI02;ceftaroline fosamil
MJ01DI03;faropenem
MJ01DI04;cefiderocol
MJ01DI54;ceftolozane and beta-lactamase inhibitor
MJ01E;sulfonamides and trimethoprim
MJ01EA;trimethoprim and derivatives
MJ01EA01;trimethoprim
MJ01EA02;brodimoprim
MJ01EA03;iclaprim
MJ01EB;short-acting sulfonamides
MJ01EB01;sulfaisodimidine
MJ01EB02;sulfamethizole
MJ01EB03;sulfadimidine
MJ01EB04;sulfapyridine
MJ01EB05;sulfafurazole
MJ01EB06;sulfanilamide
MJ01EB07;sulfathiazole
MJ01EB08;sulfathiourea
MJ01EB20;combinations of short-acting sulfonamides
MJ01EC;medium-acting sulfonamides
MJ01EC01;sulfamethoxazole
MJ01EC02;sulfadiazine
MJ01EC03;sulfamoxol
MJ01EC20;combinations of sulfonamides with intermediate duration of action
MJ01ED;long-acting sulfonamides
MJ01ED01;sulfadimethoxine
MJ01ED02;sulfalen
MJ01ED03;sulfamethomidine
MJ01ED04;sulfamethoxydiazine
MJ01ED05;sulfamethoxypyridazine
MJ01ED06;sulfaperine
MJ01ED07;sulfamerazine
MJ01ED08;sulfaphenazole
MJ01ED09;sulfamazole
MJ01ED20;long-acting sulfonamide combinations
MJ01EE;sulfonamide and trimethoprim incl. derivatives in comb.
MJ01EE01;sulfamethoxazole and trimethoprim
MJ01EE02;sulfadiazine and trimethoprim
MJ01EE03;sulfametrol and trimethoprim
MJ01EE04;sulfamoxol and trimethoprim
MJ01EE05;sulfadimidine and trimethoprim
MJ01EE06;sulfadiazine and tetroxoprim
MJ01EE07;sulfamerazine and trimethoprim
MJ01F;macrolides, lincosamides and streptogramins
MJ01FA;macrolides
MJ01FA01;erythromycin
MJ01FA02;spiramycin
MJ01FA03;midecamycin
MJ01FA05;oleandomycin
MJ01FA06;roxithromycin
MJ01FA07;josamycin
MJ01FA08;troleandomycin
MJ01FA09;clarithromycin
MJ01FA10;azithromycin
MJ01FA11;miocamycin
MJ01FA12;rokitamycin
MJ01FA13;dirithromycin
MJ01FA14;flurithromycin
MJ01FA15;telithromycin
MJ01FA16;solithromycin
MJ01FA17;nafithromycin
MJ01FF;lincosamides
MJ01FF01;clindamycin
MJ01FF02;lincomycin
MJ01FG;streptogramins
MJ01FG01;pristinamycin
MJ01FG02;quinupristin/dalfopristin
MJ01G;aminoglycoside antibacterial
MJ01GA;streptomycins
MJ01GA01;streptomycin
MJ01GA02;streptoduocin
MJ01GB;other aminoglycosides
MJ01GB01;tobramycin
MJ01GB03;gentamicin
MJ01GB04;kanamycin
MJ01GB05;neomycin
MJ01GB06;amikacin
MJ01GB07;netilmycin
MJ01GB08;sisomicin
MJ01GB09;dibekacin
MJ01GB10;ribostamycin
MJ01GB11;isepamycin
MJ01GB12;arbecacin
MJ01GB13;bekanamycin
MJ01GB14;plazomicin
MJ01M;quinolone antibacterial
MJ01MA;fluoroquinolones
MJ01MA01;ofloxacin
MJ01MA02;ciprofloxacin
MJ01MA03;pefloxacin
MJ01MA04;enoxacin
MJ01MA05;temafloxacin
MJ01MA06;norfloxacin
MJ01MA07;lomefloxacin
MJ01MA08;fleroxacin
MJ01MA09;sparfloxacin
MJ01MA10;rufloxacin
MJ01MA11;grepafloxacin
MJ01MA12;levofloxacin
MJ01MA13;trovafloxacin
MJ01MA14;moxifloxacin
MJ01MA15;gemifloxacin
MJ01MA16;gatifloxacin
MJ01MA17;prulifloxacin
MJ01MA18;pazufloxacin
MJ01MA19;garenoxacin
MJ01MA21;sitafloxacin
MJ01MA22;tosufloxacin
MJ01MA23;delafloxacin
MJ01MA24;levonadifloxacin
MJ01MA25;lascufloxacin
MJ01MB;other quinolones
MJ01MB01;rosoxacin
MJ01MB02;nalidixic acid
MJ01MB03;pyromidic acid
MJ01MB04;pipemidic acid
MJ01MB05;oxolinic acid
MJ01MB06;cinoxacin
MJ01MB07;flumequine
MJ01MB08;nemonoxacin
MJ01R;combinations of antibacterials
MJ01RA;combinations of antibacterials
MJ01RA01;penicillins, comb. with other antibacterials
MJ01RA02;sulfonamides, combinations with other antibacterials excl. trimethoprim
MJ01RA03;cefuroxime and metronidazole
MJ01RA04;spiramycin and metronidazole
MJ01RA05;levofloxacin and ornidazole
MJ01RA06;cefepime and amikacin
MJ01RA07;azithromycin, fluconazole and secnidazole
MJ01RA08;tetracycline and oleandomycin
MJ01RA09;ofloxacin and ornidazole
MJ01RA10;ciprofloxacin and metronidazole
MJ01RA11;ciprofloxacin and tinidazole
MJ01RA12;ciprofloxacin and ornidazole
MJ01RA13;norfloxacin and tinidazole
MJ01RA14;norfloxacin and metronidazole
MJ01RA15;cefixime and ornidazole
MJ01RA16;cefixime and azithromycin
MJ01RA17;ofloxacin and nitazoxanide
MJ01RA18;ofloxacin and tinidazole
MJ01RA19;tetracycline and nystatin
MJ01X;other antibacterials
MJ01XA;glycopeptide antibacterial
MJ01XA01;vancomycin
MJ01XA02;teicoplanin
MJ01XA03;telavancin
MJ01XA04;dalbavancin
MJ01XA05;oritavancin
MJ01XB;polymyxins
MJ01XB01;colistin
MJ01XB02;polymyxin B
MJ01XC;steroid antibacterial
MJ01XC01;fusidic acid
MJ01XD;imidazole derivatives
MJ01XD01;metronidazole
MJ01XD02;tinidazole
MJ01XD03;ornidazole
MJ01XE;nitrofuran derivatives
MJ01XE01;nitrofurantoin
MJ01XE02;nifurtoinol
MJ01XE03;furazidine
MJ01XE51;nitrofurantoin, combinations
MJ01XX;other antibacterials
MJ01XX01;fosfomycin
MJ01XX02;xibornol
MJ01XX03;clofoctol
MJ01XX04;spectinomycin
MJ01XX05;methenamine
MJ01XX06;mandelic acid
MJ01XX07;nitroxoline
MJ01XX08;linezolid
MJ01XX09;daptomycin
MJ01XX10;bacitracin
MJ01XX11;tedizolid
MJ01XX12;lefamulin
MJ01XX13;gepotidacin
MJ02;antimycotics for systemic use
MJ02A;antimycotics for systemic use
MJ02AA;antibiotics
MJ02AA01;amphotericin
MJ02AA02;hachimycin
MJ02AB;imidazole derivatives
MJ02AB01;miconazole
MJ02AB02;ketoconazole
MJ02AC;triazole and tetrazole derivatives
MJ02AC01;fluconazole
MJ02AC02;itraconazole
MJ02AC03;voriconazole
MJ02AC04;posaconazole
MJ02AC05;isavuconazole
MJ02AC06;oteseconazole
MJ02AX;other antifungals for systemic use
MJ02AX01;flucytosine
MJ02AX04;caspofungin
MJ02AX05;micafungin
MJ02AX06;anidulafungin
MJ02AX07;ibrexafungerp
MJ02AX08;rezafungin acetate
MJ04;antimycobacterial
MJ04A;drugs for the treatment of tuberculosis
MJ04AA;aminosalicylic acid and derivatives
MJ04AA01;aminosalicylic acid
MJ04AA02;sodium aminosalicylate
MJ04AA03;calcium aminosalicylate
MJ04AB;antibiotics
MJ04AB01;cycloserine
MJ04AB02;rifampicin
MJ04AB03;rifamycin
MJ04AB04;rifabutin
MJ04AB05;rifapentine
MJ04AB06;enviomycin
MJ04AB30;capreomycin
MJ04AC;hydrazides
MJ04AC01;isoniazid
MJ04AC02;ftivazide
MJ04AC51;isoniazid, combinations
MJ04AD;thiourea derivatives
MJ04AD01;prothionamide
MJ04AD02;thiocarlide
MJ04AD03;ethionamide
MJ04AK;other drugs for the treatment of tuberculosis
MJ04AK01;pyrazinamide
MJ04AK02;ethambutol
MJ04AK03;terizidone
MJ04AK04;morinamide
MJ04AK05;bedaquiline
MJ04AK06;delamanid
MJ04AK07;thioacetazone
MJ04AK08;pretomanid
MJ04AM;combination of drugs for the treatment of tuberculosis
MJ04AM01;streptomycin and isoniazid
MJ04AM02;rifampicin and isoniazid
MJ04AM03;ethambutol and isoniazid
MJ04AM04;thioacetazone and isoniazid
MJ04AM05;rifampicin, pyrazinamide and isoniazid
MJ04AM06;rifampicin, pyrazinamide, ethambutol and isoniazid
MJ04AM07;rifampicin, ethambutol and isoniazid
MJ04AM08;isoniazid, sulfamethoxazole and trimethoprim
MJ04AM09;pyrazinamide, ethambutol, isoniazid and lomefloxacin
MJ04AM10;pyrazinamide, ethambutol, prothionamide and lomefloxacin
MJ04AM11;rifabutin, pyrazinamide and prothionamide
MJ04AM12;rifampicin, pyrazinamide, isoniazid and levofloxacin
MJ04B;agents for the treatment of leprosy
MJ04BA;agents for the treatment of leprosy
MJ04BA01;clofazimine
MJ04BA02;dapsone
MJ04BA03;aldesulfone sodium
MJ04BA50;dapsone and rifampicin
MJ04BA51;dapsone, rifampicin and clofazimine
MJ05;antiviral agents for systemic use
MJ05A;direct-acting antivirals
MJ05AA;thiosemicarbazones
MJ05AA01;methisazone
MJ05AB;nucleosides and nucleotides excl. reverse transcriptase inhibitors
MJ05AB01;acyclovir
MJ05AB02;idoxuridine
MJ05AB03;vidarabine
MJ05AB06;ganciclovir
MJ05AB09;famciclovir
MJ05AB11;valacyclovir
MJ05AB12;cidofovir
MJ05AB13;penciclovir
MJ05AB14;valganciclovir
MJ05AB15;brivudine
MJ05AB16;remdesivir
MJ05AB17;brincidofovir
MJ05AB18;molnupiravir
MJ05AC;cyclic amines
MJ05AC02;rimantadine
MJ05AC03;tromantadine
MJ05AD;phosphonic acid derivatives
MJ05AD01;foscarnet
MJ05AD02;phosphonet
MJ05AE;protease inhibitors
MJ05AE01;saquinavir
MJ05AE02;indinavir
MJ05AE03;ritonavir
MJ05AE04;nelfinavir
MJ05AE05;amprenavir
MJ05AE07;fosamprenavir
MJ05AE08;atazanavir
MJ05AE09;tipranavir
MJ05AE10;darunavir
MJ05AE16;ensitrelvir
MJ05AE30;nirmatrelvir and ritonavir
MJ05AF;nucleoside and nucleotide reverse transcriptase inhibitors
MJ05AF01;zidovudine
MJ05AF02;didanosine
MJ05AF03;zalcitabine
MJ05AF04;stavudine
MJ05AF05;lamivudine
MJ05AF06;abacavir
MJ05AF07;tenofovir disoproxil
MJ05AF08;adefovir dipivoxil
MJ05AF09;emtricitabine
MJ05AF10;entecavir
MJ05AF11;telbivudine
MJ05AF12;clevudine
MJ05AF13;tenofovir alafenamide
MJ05AG;non-nucleoside reverse transcriptase inhibitors
MJ05AG01;nevirapine
MJ05AG02;delavirdine
MJ05AG03;efavirenz
MJ05AG04;etravirine
MJ05AG05;rilpivirine
MJ05AG06;doravirine
MJ05AG07;elsulfavirin
MJ05AH;neuraminidase inhibitors
MJ05AH01;zanamivir
MJ05AH02;oseltamivir
MJ05AH03;peramivir
MJ05AH04;laninamivir
MJ05AJ;integrase inhibitors
MJ05AJ01;raltegravir
MJ05AJ02;elvitegravir
MJ05AJ03;dolutegravir
MJ05AJ04;cabotegravir
MJ05AP;antiviral agents for the treatment of HCV infections
MJ05AP01;ribavirin
MJ05AP02;telaprevir
MJ05AP03;boceprevir
MJ05AP04;faladaprevir
MJ05AP05;simeprevir
MJ05AP06;asunaprevir
MJ05AP07;daclatasvir
MJ05AP08;sofosbuvir
MJ05AP09;dasabuvir
MJ05AP10;electric bass
MJ05AP11;grazoprevir
MJ05AP12;coblopasvir
MJ05AP13;ravidasvir
MJ05AP14;narlaprevir
MJ05AP51;sofosbuvir and ledipasvir
MJ05AP52;dasabuvir, ombitasvir, paritaprevir and ritonavir
MJ05AP53;ombitasvir, paritaprevir and ritonavir
MJ05AP54;elbasvir and grazoprevir
MJ05AP55;sofosbuvir and velpatasvir
MJ05AP56;sofosbuvir, velpatasvir and voxilaprevir
MJ05AP57;glecaprevir and pibrentasvir
MJ05AP58;daclatasvir, asunaprevir and beclabuvir
MJ05AR;antiviral agents for the treatment of HIV infections, comb.
MJ05AR01;zidovudine and lamivudine
MJ05AR02;lamivudine and abacavir
MJ05AR03;tenofovir disoproxil and emtricitabine
MJ05AR04;zidovudine, lamivudine and abacavir
MJ05AR05;zidovudine, lamivudine and nevirapine
MJ05AR06;emtricitabine, tenofovir disoproxil and efavirenz
MJ05AR07;stavudine, lamivudine and nevirapine
MJ05AR08;emtricitabine, tenofovir disoproxil and rilpivirine
MJ05AR09;emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat
MJ05AR10;lopinavir and ritonavir
MJ05AR11;lamivudine, tenofovir disoproxil and efavirenz
MJ05AR12;lamivudine and tenofovir disoproxil
MJ05AR13;lamivudine, abacavir and dolutegravir
MJ05AR14;darunavir and cobicistat
MJ05AR15;atazanavir and cobicistat
MJ05AR16;lamivudine and raltegravir
MJ05AR17;emtricitabine and tenofovir alafenamide
MJ05AR18;emtricitabine, tenofovir alafenamide, elvitegravir, cobicistat
MJ05AR19;emtricitabine, tenofovir alafenamide and rilpivirine
MJ05AR20;emtricitabine, tenofovir alafenamide and bictegravir
MJ05AR21;dolutegravir and rilpivirine
MJ05AR22;emtricitabine, tenofovir alafenamide, darunavir and cobicistat
MJ05AR23;atazanavir and ritonavir
MJ05AR24;lamivudine, tenofovir disoproxil and doravirine
MJ05AR25;lamivudine and dolutegravir
MJ05AR26;darunavir and ritonavir
MJ05AR27;lamivudine, tenofovir disoproxil and dolutegravir
MJ05AR28;stavudine and lamivudine
MJ05AR29;emtricitabine, tenofovir alafenamide and dolutegravir
MJ05AX;other antiviral agents
MJ05AX01;moroxydine
MJ05AX02;lysozyme
MJ05AX05;inosine pranobex
MJ05AX06;pleconaril
MJ05AX07;enfuvirtide
MJ05AX09;maraviroc
MJ05AX10;maribavir
MJ05AX13;umifenovir
MJ05AX17;enisamium iodide
MJ05AX18;letermovir
MJ05AX19;tilorone
MJ05AX21;pentanedioic acid imidazolyl ethanamide
MJ05AX23;ibalizumab
MJ05AX24;tecovirimat
MJ05AX25;baloxavirmarboxil
MJ05AX26;amenamevir
MJ05AX27;favipiravir
MJ05AX28;bulevirtide
MJ05AX29;fostemsavir
MJ05AX31;lenacapavir
MJ05AX32;riamilovir
MJ05AX33;labuvirtid
MJ06;immune sera and immunoglobulins
MJ06A;immune sera
MJ06AA;immune sera
MJ06AA01;diphtheria antitoxin
MJ06AA02;tetanus antitoxin
MJ06AA03;snake venom antiserum
MJ06AA04;botulinum antitoxin
MJ06AA05;gas gangrene sera
MJ06AA06;rabies serum
MJ06B;immunoglobulins
MJ06BA;immunoglobulins, normal human
MJ06BA01;immunoglobulins, normal human for extravas. use
MJ06BA02;immunoglobulins, normal human for intravas. use
MJ06BB;specific immunoglobulins
MJ06BB01;anti-D (Rh) immunoglobulin
MJ06BB02;tetanus immunoglobulin
MJ06BB03;varicella/zoster immunoglobulin
MJ06BB04;hepatitis B immunoglobulin
MJ06BB05;rabies immunoglobulin
MJ06BB06;rubella immunoglobulin
MJ06BB07;vaccinia immunoglobulin
MJ06BB08;staphylococcus immunoglobulin
MJ06BB09;cytomegalovirus immunoglobulin
MJ06BB10;diphtheria immunoglobulin
MJ06BB11;hepatitis A immunoglobulin
MJ06BB12;encephalitis, tick borne immunoglobulin
MJ06BB13;pertussis immunoglobulin
MJ06BB14;morbilli immunoglobulin
MJ06BB15;parotitis immunoglobulin
MJ06BB19;anthrax immunoglobulin
MJ06BB30;combinations of specific immunoglobulins
MJ06BC;antibacterial monoclonal antibodies
MJ06BC01;nebacumab
MJ06BC02;raxibacumab
MJ06BC03;bezlotoxumab
MJ06BC04;obiltoxaximab
MJ06BD;antiviral monoclonal antibodies
MJ06BD01;palivizumab
MJ06BD02;motavizumab
MJ06BD03;tixagevimab and cilgavimab
MJ06BD04;ansuvimab
MJ06BD05;sotrovimab
MJ06BD06;regdanvimab
MJ06BD07;casirivimab and imdevimab
MJ06BD08;nirsevimab
MJ06BD09;sipavibart
MJ07;vaccines
MJ07A;bacterial vaccines
MJ07AC;anthrax vaccines
MJ07AC01;anthrax antigen
MJ07AD;brucellosis vaccines
MJ07AD01;brucella antigen
MJ07AE;cholera vaccines
MJ07AE01;cholera, inactivated, whole cells
MJ07AE02;cholera, live attenuated
MJ07AE51;cholera, comb. with typhoid vac., inact., whole cells
MJ07AF;diphtheria vaccines
MJ07AF01;diphtheria toxoid
MJ07AG;haemophilus influenzae B vaccines
MJ07AG01;haemophilus influenzae B, purified antigen conjugate
MJ07AG51;haemophilus influenzae B, combinations with toxoids
MJ07AG52;haemophilus influenzae B, combinations with pertussis and toxoids
MJ07AG53;haemophilus influenzae B, combinations with meningococcus C, conjugated
MJ07AG54;haemophilus influenzae B, combinations with meningococcus C,Y, conjugated
MJ07AH;meningococcal vaccines
MJ07AH01;meningococcus A, purified polysaccharide antigen
MJ07AH02;other meningococcal monovalent, purified polysaccharide antigen
MJ07AH03;meningococcus A,C, bivalent purified polysaccharide antigen
MJ07AH04;meningococcus A,C,Y,W-135, tetravalent purified polysaccharide antigen
MJ07AH05;other meningococcal polyvalent purified polysaccharide antigen
MJ07AH06;meningococcus B, outer membrane vesicle vaccine
MJ07AH07;meningococcus C, purified polysaccharide antigen conj.
MJ07AH08;meningococcus A,C,Y,W-135, tetravalent purified polysaccharide antigen conj.
MJ07AH09;meningococcus B, multicomponent vaccine
MJ07AH10;meningococcus A, purified polysaccharide antigen conjugate
MJ07AH11;meningococcus A,B,C,Y,W-135, pentavalent purified polysaccharide antigen conjugate and factor H-binding protein
MJ07AJ;pertussis vaccines
MJ07AJ01;pertussis, inactivated, whole cells
MJ07AJ02;pertussis, purified antigen
MJ07AJ51;pertussis, inact., whole cells, combinations with toxoids
MJ07AJ52;pertussis, purified antigen, combinations with toxoids
MJ07AK;plague vaccines
MJ07AK01;plague, inactivated, whole cells
MJ07AL;pneumococcal vaccines
MJ07AL01;pneumococcus, purified polysaccharide antigen
MJ07AL02;pneumococcus, purified polysaccharide antigen conjugated
MJ07AL52;pneumococcus, purified polysaccharide antigen and haemophillus influenzae, conjugate
MJ07AM;tetanus vaccines
MJ07AM01;tetanus toxoid
MJ07AM51;tetanus toxoid, comb. with diphtheria toxoid
MJ07AM52;tetanus toxoid, comb. with tetanus immunoglobulin
MJ07AN;tuberculosis vaccines
MJ07AN01;tuberculosis, live attenuated
MJ07AP;typhoid vaccines
MJ07AP01;typhoid, oral, live attenuated
MJ07AP02;typhoid, inactivated, whole cells
MJ07AP03;typhoid, purified polysaccharide antigen
MJ07AP10;typhoid, combinations with paratyphoid types
MJ07AR;typhoid exanthematicus vaccines
MJ07AR01;typhoid exanthematicus, inactivated, whole cells
MJ07AX;other bacterial vaccines
MJ07AX01;leptospira vaccines
MJ07B;viral vaccines
MJ07BA;encephalitis vaccines
MJ07BA01;encephalitis, tick borne, inactivated, whole virus
MJ07BA02;encephalitis, Japanese, inactivated, whole virus
MJ07BA03;encephalitis, Japanese, live attenuated
MJ07BB;flu vaccines
MJ07BB01;influenza, inactivated, whole virus
MJ07BB02;influenza, purified antigen
MJ07BB03;influenza, live attenuated
MJ07BB04;influenza, virus-like particles
MJ07BB05;influenza, RNA-based vaccine
MJ07BB55;influenza and COVID-19, RNA-based vaccine
MJ07BC;hepatitis vaccines
MJ07BC01;hepatitis B, purified antigen
MJ07BC02;hepatitis A, inactivated, whole virus
MJ07BC20;combinations of hepatitis vaccines
MJ07BD;measles vaccines
MJ07BD01;measles, live attenuated
MJ07BD51;measles, combined with mumps, live attenuated
MJ07BD52;measles, combined with mumps and rubella, live attenuated
MJ07BD53;measles, combined with rubella, live attenuated
MJ07BD54;measles, combined with mumps, rubella and varicella, live attenuated
MJ07BE;mumps vaccines
MJ07BE01;mumps, live attenuated
MJ07BF;poliomyelitis vaccines
MJ07BF01;poliomyelitis oral, monovalent, live attenuated
MJ07BF02;poliomyelitis oral, trivalent, live attenuated
MJ07BF03;poliomyelitis, trivalent, inactivated, whole virus
MJ07BF04;poliomyelitis oral, bivalent, live attenuated
MJ07BG;rabies vaccines
MJ07BG01;rabies, inactivated, whole virus
MJ07BH;rota virus diarrhea vaccines
MJ07BH01;rota virus, live attenuated
MJ07BH02;rota virus, pentavalent, live, reassorted
MJ07BJ;rubella vaccines
MJ07BJ01;rubella, live attenuated
MJ07BJ51;rubella, combined with mumps, live attenuated
MJ07BK;varicella zoster vaccines
MJ07BK01;varicella, live attenuated
MJ07BK02;zoster virus, live attenuated
MJ07BK03;zoster, purified antigen
MJ07BL;yellow fever vaccines
MJ07BL01;yellow fever, live attenuated
MJ07BM;papillomavirus vaccines
MJ07BM01;papillomavirus (human type 6, 11, 16, 18)
MJ07BM02;papillomavirus (human type 16, 18)
MJ07BM03;papillomavirus (human type 6, 11, 16, 18, 31, 33, 45, 52,58)
MJ07BN;COVID-19 vaccines
MJ07BN01;COVID-19, RNA-based vaccine
MJ07BN02;COVID-19, viral vector, non-replicating
MJ07BN03;COVID-19, inactivated virus
MJ07BN04;COVID-19, protein subunit
MJ07BN05;COVID-19, virus-like particles
MJ07BX;other viral vaccines
MJ07BX01;smallpox vaccine and monkeypox vaccine
MJ07BX02;ebola vaccines
MJ07BX04;dengue fever vaccines
MJ07BX05;respiratory syncytial virus vaccines
MJ07BX06;enterovirus 71 vaccines
MJ07C;bacterial and viral vaccines, combined
MJ07CA;bacterial and viral vaccines, combined
MJ07CA01;diphtheria-poliomyelitis-tetanus
MJ07CA02;diphtheria-pertussis-poliomyelitis-tetanus
MJ07CA03;diphtheria-rubella-tetanus
MJ07CA04;haemophilus influenzae B and poliomyelitis
MJ07CA05;diphtheria-hepatitis B-pertussis-tetanus
MJ07CA06;diphtheria-haemophilus influenzae B-pertussis-polio-tetanus
MJ07CA07;diphtheria-hepatitis B-tetanus
MJ07CA08;haemophilus influenzae and hepatitis B
MJ07CA09;diphtheria-haemophilus influenzae B-pertussis-polio-tetanus-hepatitis B
MJ07CA10;typhoid - hepatitis A
MJ07CA11;diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B
MJ07CA12;diphtheria-pertussis-polio-tetanus-hepatitis B
MJ07CA13;diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A+C
MJ07X;other vaccines
MJ07XA;parasitic vaccines
MJ07XA01;malaria vaccines
ML;Antineoplastic and immunomodulatory agents
ML01;antineoplastic agents
ML01A;alkylating agents
ML01AA;nitrogen mustard gas analogues
ML01AA01;cyclophosphamide
ML01AA02;chlorambucil
ML01AA03;melphalan
ML01AA05;chlormethine
ML01AA06;ifosfamide
ML01AA07;trofosfamide
ML01AA08;prednimustine
ML01AA09;bendamustine
ML01AA10;melphalanflufenamide
ML01AB;alkyl sulfonates
ML01AB01;busulfan
ML01AB02;treosulfan
ML01AB03;mannosulfan
ML01AC;ethyleneimines
ML01AC01;thiotepa
ML01AC02;triaziquone
ML01AC03;carboquone
ML01AD;nitrosourea substances
ML01AD01;carmustine
ML01AD02;lomustine
ML01AD03;semustine
ML01AD04;streptozocin
ML01AD05;fotemustine
ML01AD06;nimustine
ML01AD07;ranimustine
ML01AD08;uramustine
ML01AG;epoxides
ML01AG01;etoglucid
ML01AX;other alkylating agents
ML01AX01;mitobronitol
ML01AX02;pipobroman
ML01AX03;temozolomide
ML01AX04;dacarbazine
ML01B;antimetabolites
ML01BA;folic acid analogues
ML01BA01;methotrexate
ML01BA03;raltitrexed
ML01BA04;pemetrexed
ML01BA05;pralatrexate
ML01BB;purine analogues
ML01BB02;mercaptopurine
ML01BB03;thioguanine
ML01BB04;cladribine
ML01BB05;fludarabine
ML01BB06;clofarabine
ML01BB07;nelarabine
ML01BC;pyrimidine analogues
ML01BC01;cytarabine
ML01BC02;fluorouracil
ML01BC03;tegafur
ML01BC04;carmofur
ML01BC05;gemcitabine
ML01BC06;capecitabine
ML01BC07;azacitidine
ML01BC08;decitabine
ML01BC09;floxuridine
ML01BC52;fluorouracil, combinations
ML01BC53;tegafur, comb.
ML01BC58;decitabine, combinations
ML01BC59;trifluridine, combinations
ML01C;plant alkaloids and other natural products
ML01CA;vinca alkaloids and analogues
ML01CA01;vinblastine
ML01CA02;vincristine
ML01CA03;windesin
ML01CA04;vinorelbine
ML01CA05;vinflunine
ML01CA06;vintafolide
ML01CB;podophyllotoxin derivatives
ML01CB01;etoposide
ML01CB02;teniposide
ML01CC;colchicine derivatives
ML01CC01;demecolcine
ML01CD;taxanes
ML01CD01;paclitaxel
ML01CD02;docetaxel
ML01CD03;paclitaxel poliglumex
ML01CD04;cabazitaxel
ML01CD51;paclitaxel and encequidar
ML01CE;topoisomerase 1 inhibitors
ML01CE01;topotecan
ML01CE02;irinotecan
ML01CE03;etirinotecan pegol
ML01CE04;belotecan
ML01CX;other plant alkaloids and natural products
ML01CX01;trabectedin
ML01D;cytotoxic antibiotics and related substances
ML01DA;actinomycins
ML01DA01;dactinomycin
ML01DB;anthracyclines and related substances
ML01DB01;doxorubicin
ML01DB02;daunorubicin
ML01DB03;epirubicin
ML01DB04;aclarubicin
ML01DB05;zorubicin
ML01DB06;idarubicin
ML01DB07;mitoxantrone
ML01DB08;pirarubicin
ML01DB09;valrubicin
ML01DB10;amrubicin
ML01DB11;pixantron
ML01DC;other cytotoxic antibiotics
ML01DC01;bleomycin
ML01DC02;plicamycin
ML01DC03;mitomycin
ML01DC04;ixabepilone
ML01DC05;utidelon
ML01E;protein kinase inhibitors
ML01EA;BCR-ABL tyrosine kinase inhibitors
ML01EA01;imatinib
ML01EA02;dasatinib
ML01EA03;nilotinib
ML01EA04;bosutinib
ML01EA05;ponatinib
ML01EA06;asciminib
ML01EB;epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
ML01EB01;gefitinib
ML01EB02;erlotinib
ML01EB03;afatinib
ML01EB04;osimertinib
ML01EB05;rociletinib
ML01EB06;olmutinib
ML01EB07;dacomitinib
ML01EB08;icotinib
ML01EB09;lazertinib
ML01EB10;mobocertinib
ML01EB11;aumolertinib
ML01EB12;firmonertinib
ML01EC;B-Raf serine-threonine kinase (BRAF) inhibitors
ML01EC01;vemurafenib
ML01EC02;dabrafenib
ML01EC03;encorafenib
ML01EC04;tovafenib
ML01ED;anaplastic lymphoma kinase (ALK) inhibitors
ML01ED01;crizotinib
ML01ED02;ceritinib
ML01ED03;alectinib
ML01ED04;brigatinib
ML01ED05;lorlatinib
ML01EE;mitogen-activated protein kinase (MEK) inhibitors
ML01EE01;trametinib
ML01EE02;cobimetinib
ML01EE03;binimetinib
ML01EE04;selumetinib
ML01EE05;mirdametinib
ML01EE06;tunlametinib
ML01EF;cyclin-dependent kinase (CDK) inhibitors
ML01EF01;palbociclib
ML01EF02;ribociclib
ML01EF03;abemaciclib
ML01EG;mammalian target of rapamycin (mTOR) kinase inhibitors
ML01EG01;temsirolimus
ML01EG02;everolimus
ML01EG03;ridaforolimus
ML01EG04;sirolimus
ML01EH;human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors
ML01EH01;lapatinib
ML01EH02;neratinib
ML01EH03;tucatinib
ML01EH04;zongertinib
ML01EJ;janus associated kinase (JAK) inhibitors
ML01EJ01;ruxolitinib
ML01EJ02;fedratinib
ML01EJ03;pacritinib
ML01EJ04;momelotinib
ML01EK;vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors
ML01EK01;axitinib
ML01EK02;cediranib
ML01EK03;tivozanib
ML01EK04;fruquintinib
ML01EK05;rivoceranib
ML01EL;Bruton's tyrosine kinase (BTK) inhibitors
ML01EL01;ibrutinib
ML01EL02;acalabrutinib
ML01EL03;zanubrutinib
ML01EL04;orelabrutinib
ML01EL05;pirtobrutinib
ML01EL06;tirabrutinib
ML01EM;phosphatidylinositol-3-kinase (Pi3K) inhibitors
ML01EM01;idelalisib
ML01EM02;copanlisib
ML01EM03;alpelisib
ML01EM04;duvelisib
ML01EM05;parsaclisib
ML01EN;fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors
ML01EN01;erdafitinib
ML01EN02;pemigatinib
ML01EN03;infigratinib
ML01EN04;futibatinib
ML01EP;cellular-mesenchymal-epithelial transition factor (c-MET) kinase inhibitors
ML01EP03;savolitinib
ML01EX;other protein kinase inhibitors
ML01EX01;sunitinib
ML01EX02;sorafenib
ML01EX03;pazopanib
ML01EX04;vandetanib
ML01EX0 5;regorafenib
ML01EX06;masitinib
ML01EX07;cabozantinib
ML01EX08;lenvatinib
ML01EX09;nintedanib
ML01EX10;midostaurin
ML01EX11;quizartinib
ML01EX12;larotrectinib
ML01EX13;gilteritinib
ML01EX14;entrectinib
ML01EX15;pexidartinib
ML01EX17;capmatinib
ML01EX18;avapritinib
ML01EX19;ripretinib
ML01EX21;tepotinib
ML01EX22;selpercatinib
ML01EX23;pralsetinib
ML01EX24;surufatinib
ML01EX25;umbralisib
ML01EX26;sitravatinib
ML01EX27;capivasertib
ML01EX28;repotrectinib
ML01EX29;vimseltinib
ML01F;monoclonal antibodies and antibody-drug conjugates
ML01FA;anti-CD20 monoclonal antibodies
ML01FA01;rituximab
ML01FA02;ofatumumab
ML01FA03;obinutuzumab
ML01FB;anti-CD22 monoclonal antibodies
ML01FB01;inotuzumab ozogamicin
ML01FB02;moxetumomab pasudotox
ML01FC;anti-CD38 monoclonal antibodies
ML01FC01;daratumumab
ML01FC02;isatuximab
ML01FD;human epidermal growth factor receptor 2 (HER2) inhibitors
ML01FD01;trastuzumab
ML01FD02;pertuzumab
ML01FD03;trastuzumab emtansine
ML01FD04;trastuzumab deruxtecan
ML01FD05;trastuzumab duocarmazine
ML01FD06;margetuximab
ML01FD07;zanidatamab
ML01FE;epidermal growth factor receptor (EGFR) inhibitors
ML01FE01;cetuximab
ML01FE02;panitumumab
ML01FE03;necitumumab
ML01FF;PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors
ML01FF01;nivolumab
ML01FF02;pembrolizumab
ML01FF03;durvalumab
ML01FF04;avelumab
ML01FF05;atezolizumab
ML01FF06;cemiplimab
ML01FF07;dostarlimab
ML01FF08;prolgolimab
ML01FF09;tislelizumab
ML01FF10;retifanlimab
ML01FF11;sugemalimab
ML01FF12;serplulimab
ML01FF13;toripalimab
ML01FF14;camrelizumab
ML01FF15;envafolimab
ML01FG;vascular endothelial growth factor (VEGF/VEGFR) inhibitors
ML01FG01;bevacizumab
ML01FG02;ramucirumab
ML01FX;other monoclonal antibodies and antibody-drug conjugates
ML01FX01;edrecolomab
ML01FX02;gemtuzumab ozogamicin
ML01FX03;catumaxomab
ML01FX04;ipilimumab
ML01FX05;brentuximab vedotin
ML01FX06;dinutuximab beta
ML01FX07;blinatumomab
ML01FX08;elotuzumab
ML01FX09;mogamulizumab
ML01FX10;olaratumab
ML01FX11;bermekimab
ML01FX12;tafasitamab
ML01FX13;enfortumab vedotin
ML01FX14;polatuzumab vedotin
ML01FX15;belantamab mafodotin
ML01FX16;oportuzumab monatox
ML01FX17;sacituzumab govitecan
ML01FX18;amivantamab
ML01FX19;sabatolimab
ML01FX20;tremelimumab
ML01FX21;naxitamab
ML01FX22;loncastuximab tesirin
ML01FX23;tisotumab vedotin
ML01FX24;teclistamab
ML01FX25;mosunetuzumab
ML01FX26;mirvetuximab soravtansine
ML01FX27;epcoritamab
ML01FX28;glofitamab
ML01FX29;talquetamab
ML01FX31;zolbetuximab
ML01FX32;elranatamab
ML01FX33;tarlatamab
ML01FX34;odronextamab
ML01FX35;dapotomab deruxtecan
ML01FX36;patritumab deruxtecan
ML01FX37;linvoseltamab
ML01FY;combinations of monoclonal antibodies and antibody-drug conjugates
ML01FY01;pertuzumab and trastuzumab
ML01FY02;nivolumab and relatlimab
ML01FY03;prolgolimab and nurulimab
ML01X;other antineoplastic agents
ML01XA;platinum compounds
ML01XA01;cisplatin
ML01XA02;carboplatin
ML01XA03;oxaliplatin
ML01XA04;satraplatin
ML01XA05;polyplate
ML01XB;methylhydrazines
ML01XB01;procarbazine
ML01XD;sensitizers for photodynamic/radiation therapy
ML01XD01;porfimer sodium
ML01XD03;methylaminolevulinate
ML01XD04;aminolevulinic acid
ML01XD05;temoporfin
ML01XD06;efaproxiral
ML01XD07;padeliporfin
ML01XF;retinoids for cancer treatment
ML01XF01;tretinoin
ML01XF02;alitretinoin
ML01XF03;bexarotene
ML01XG;proteasome inhibitors
ML01XG01;bortezomib
ML01XG02;carfilzomib
ML01XG03;ixazomib
ML01XH;histone deacetylase (HDAC) inhibitors
ML01XH01;vorinostat
ML01XH02;romidepsin
ML01XH03;panobinostat
ML01XH04;belinostat
ML01XH05;entinostat
ML01XH06;tucidinostat
ML01XH07;resminostat
ML01XJ;hedgehog pathway inhibitors
ML01XJ01;vismodegib
ML01XJ02;sonidegib
ML01XJ03;glass degib
ML01XK;poly (ADP-ribose) polymerase (PARP) inhibitors
ML01XK01;olaparib
ML01XK02;niraparib
ML01XK03;rucaparib
ML01XK04;talazoparib
ML01XK05;veliparib
ML01XK06;pamiparib
ML01XK52;niraparib and abiraterone
ML01XL;antineoplastic cell and gene therapy
ML01XL01;sitimagen ceradenovec
ML01XL02;talimogen laherparepvec
ML01XL03;axicabtagen ciloleucel
ML01XL04;tisagenlecleucel
ML01XL05;ciltacabtagen autoleucel
ML01XL06;brexucabtagen autoleucel
ML01XL07;idecabtagen vicleucel
ML01XL08;lisocabtagene maraleucel
ML01XL09;table key
ML01XL10;nadofaragen firadenovec
ML01XL11;lifileucel
ML01XL12;obecabtagen autoleucel
ML01XM;isocitrate dehydrogenase (IDH) inhibitors
ML01XM01;enasidenib
ML01XM02;ivosidenib
ML01XM03;olutasidenib
ML01XM04;vorasidenib
ML01XU;other antineoplastic agents (continued)
ML01XX;other neoplastic substances
ML01XX01;amsacrine
ML01XX02;asparaginase
ML01XX03;altretamine
ML01XX05;hydroxycarbamide
ML01XX07;lonidamine
ML01XX08;pentostatin
ML01XX10;masoprocol
ML01XX11;estramustine
ML01XX16;mitoguazone
ML01XX18;tiazofurin
ML01XX23;mitotane
ML01XX24;pegaspargase
ML01XX27;arsenic trioxide
ML01XX29;denileukin diftitox
ML01XX33;celecoxib
ML01XX35;anagrelide
ML01XX36;oblimersen
ML01XX40;omacetaxine mepesuccinate
ML01XX41;eribulin
ML01XX44;aflibercept
ML01XX52;venetoclax
ML01XX53;vosaroxin
ML01XX57;plitidepsin
ML01XX58;epacadostat
ML01XX66;selinexor
ML01XX67;tagraxofusp
ML01XX69;lurbinectedin
ML01XX72;tazemetostat
ML01XX73;sotorasib
ML01XX74;belzutifan
ML01XX75;tebentafusp
ML01XX77;adagrasib
ML01XX78;navitoclax
ML01XX79;eflornithine
ML01XX80;imetelstat
ML01XX81;nirogacestat
ML01XX82;darinaparsin
ML01XX83;paratoluenesulfonamide
ML01XX84;pelabresib
ML01XX85;hydroxyoleic acid
ML01XX86;calaspargase pegol
ML01XY;combinations of antineoplastic agents
ML01XY01;cytarabine and daunorubicin
ML01XY04;bifikafusp alfa and onfecafusp alfa
ML02;endocrine therapy
ML02A;hormones and related substances
ML02AA;estrogens
ML02AA01;diethylstilbestrol
ML02AA02;polyestradiol phosphate
ML02AA03;ethinyl estradiol
ML02AA04;fosfestrol
ML02AB;gestagens
ML02AB01;megestrol
ML02AB02;medroxyprogesterone
ML02AB03;gestonorone
ML02AE;gonadotropin-releasing hormone analogs
ML02AE01;buserelin
ML02AE02;leuprorelin
ML02AE03;goserelin
ML02AE04;triptorelin
ML02AE05;histrelin
ML02AE51;leuprorelin and bicalutamide
ML02AX;other hormones
ML02B;hormone antagonists and similar substances
ML02BA;anti-estrogens
ML02BA01;tamoxifen
ML02BA02;toremifene
ML02BA03;fulvestrant
ML02BA04;elacestrant
ML02BB;anti-androgens
ML02BB01;flutamide
ML02BB02;nilutamide
ML02BB03;bicalutamide
ML02BB04;enzalutamide
ML02BB05;apalutamide
ML02BB06;darolutamide
ML02BG;aromatase inhibitors
ML02BG01;aminoglutethimide
ML02BG02;formestane
ML02BG03;anastrozole
ML02BG04;letrozole
ML02BG05;vorozol
ML02BG06;exemestane
ML02BX;other hormone antagonists and similar substances
ML02BX01;abarelix
ML02BX02;degarelix
ML02BX03;abiraterone
ML02BX04;relugolix
ML02BX53;abiraterone and corticosteroids
ML03;immunostimulants
ML03A;immunostimulants
ML03AA;colony stimulating factors
ML03AA02;filgrastim
ML03AA03;molgramostim
ML03AA09;sargramostim
ML03AA10;lenograstim
ML03AA12;ancestim
ML03AA13;pegfilgrastim
ML03AA14;lipegfilgrastim
ML03AA15;balugrastim
ML03AA16;empegfilgrastim
ML03AA17;pegteograstim
ML03AA18;efbemalenograstim alfa
ML03AA19;eflapegrastim
ML03AB;interferons
ML03AB01;interferon alpha natural
ML03AB02;interferon beta natural
ML03AB03;interferon gamma
ML03AB04;interferon alfa-2A
ML03AB05;interferon alfa-2B
ML03AB06;interferon alfa-N1
ML03AB07;interferon beta-1A
ML03AB08;interferon beta-1B
ML03AB09;interferon alfacon-1
ML03AB10;Peginterferon alfa-2B
ML03AB11;peginterferon alfa-2A
ML03AB12;albinterferon alfa-2B
ML03AB13;peginterferon beta-1A
ML03AB14;cepeginterferon alfa-2B
ML03AB15;ropeginterferon alfa-2b
ML03AB16;peginterferon alfacon-2
ML03AB17;sampeginterferon beta-1a
ML03AB60;peginterferon-alpha-2B, comb.
ML03AB61;peginterferon alfa-2A, combinations
ML03AC;interleukins
ML03AC01;aldesleukin
ML03AC02;oprelvekin
ML03AC03;nogapendekin alfa and inbakicept
ML03AX;other immunostimulants
ML03AX01;lentinan
ML03AX02;roquinimex
ML03AX03;bcg vaccine
ML03AX04;pegademase
ML03AX05;pidotimod
ML03AX07;poly I:C
ML03AX08;poly ICLC
ML03AX09;thymopentin
ML03AX10;immunocyanin
ML03AX11;tasonermin
ML03AX12;melanoma vaccine
ML03AX13;glatiramer acetate
ML03AX14;histamine dihydrochloride
ML03AX15;mifamurtide
ML03AX16;plerixafor
ML03AX17;sipuleucel-T
ML03AX18;cridanimod
ML03AX19;dasiprotimut-T
ML03AX21;elapegademase
ML03AX22;leniolisib
ML03AX23;motixapastid
ML03AX24;mavorixafor
ML04;immunosuppressants
ML04A;immunosuppressants
ML04AA;selective immunosuppressants
ML04AA03;antilymphocyte immunoglobulin
ML04AA04;antithymocyte immunoglobulin
ML04AA06;mycophenolic acid
ML04AA15;alefacept
ML04AA19;gusperimus
ML04AA22;abetimus
ML04AA24;abatacept
ML04AA28;belatacept
ML04AA32;apremilast
ML04AA40;cladribine
ML04AA41;imlifidase
ML04AA48;belumosudil
ML04AA58;efgartigimod alfa
ML04AA60;remibrutinib
ML04AA61;notrandom
ML04AB;tumor necrosis factor alpha (TNF-alpha) inhibitors
ML04AB01;etanercept
ML04AB02;infliximab
ML04AB03;afelimomab
ML04AB04;adalimumab
ML04AB05;certolizumab pegol
ML04AB06;golimumab
ML04AB07;opinercept
ML04AC;interleukin inhibitors
ML04AC01;daclizumab
ML04AC02;basiliximab
ML04AC03;anakinra
ML04AC04;rilonacept
ML04AC05;ustekinumab
ML04AC07;tocilizumab
ML04AC08;canakinumab
ML04AC09;briakinumab
ML04AC10;secukinumab
ML04AC11;siltuximab
ML04AC12;brodalumab
ML04AC13;ixekizumab
ML04AC14;sarilumab
ML04AC15;sirukumab
ML04AC16;guselkumab
ML04AC17;tildrakizumab
ML04AC18;risankizumab
ML04AC19;satralizumab
ML04AC20;netakimab
ML04AC21;bimekizumab
ML04AC22;spesolimab
ML04AC23;olokizumab
ML04AC24;mirikizumab
ML04AC25;levilimab
ML04AC26;goflikicept
ML04AC27;cendakimab
ML04AD;calcinurin inhibitors
ML04AD01;ciclosporin
ML04AD02;tacrolimus
ML04AD03;voclosporin
ML04AE;sphingosine 1-phosphate (S1P) receptor modulators
ML04AE01;fingolimod
ML04AE02;ozanimod
ML04AE03;siponimod
ML04AE04;ponesimod
ML04AE05;etrasimod
ML04AF;janus associated kinase (JAK) inhibitors
ML04AF01;tofacitinib
ML04AF02;baricitinib
ML04AF03;upadacitinib
ML04AF04;filgotinib
ML04AF05;itacitinib
ML04AF06;peficitinib
ML04AF07;deucravacitinib
ML04AF08;ritlecitinib
ML04AF09;deuruxolitinib
ML04AG;monoclonal antibodies
ML04AG01;muromonab-CD3
ML04AG02;efalizumab
ML04AG03;natalizumab
ML04AG04;belimumab
ML04AG05;vedolizumab
ML04AG06;alemtuzumab
ML04AG07;begelomab
ML04AG08;ocrelizumab
ML04AG09;emapalumab
ML04AG10;inebilizumab
ML04AG11;anifrolumab
ML04AG12;ofatumumab
ML04AG13;teprotumumab
ML04AG14;ublituximab
ML04AG15;divozilimab
ML04AG16;rozanolixizumab
ML04AG17;seniprutug
ML04AG18;sibeprenlimab
ML04AG19;axatilimab
ML04AH;mammalian target of rapamycin (mTOR) kinase inhibitors
ML04AH01;sirolimus
ML04AH02;everolimus
ML04AJ;complement inhibitors
ML04AJ01;eculizumab
ML04AJ02;ravulizumab
ML04AJ03;pegcetacoplan
ML04AJ04;sutimlimab
ML04AJ05;avacopan
ML04AJ06;zilucoplan
ML04AJ07;crovalimab
ML04AJ08;iptacopan
ML04AJ09;danicopan
ML04AJ10;vilobelimab
ML04AJ11;pozelimab
ML04AK;dihydroorotate dehydrogenase (DHODH) inhibitors
ML04AK01;leflunomide
ML04AK02;teriflunomide
ML04AL;neonatal fragment crystallizable receptor (FcRn) inhibitors
ML04AL03;nipocalimab
ML04AX;other immunosuppressants
ML04AX01;azathioprine
ML04AX02;thalidomide
ML04AX03;methotrexate
ML04AX04;lenalidomide
ML04AX05;pirfenidone
ML04AX06;pomalidomide
ML04AX07;dimethyl fumarate
ML04AX08;darvadstrocel
ML04AX09;diroximel fumarate
ML04AX10;tegomil fumarate
MM;Musculo-skeletal system
MM01;anti-inflammatory and antirheumatic agents
MM01A;anti-inflammatory/anti-rheumatic agents, non-steroid
MM01AA;butylpyrazolidines
MM01AA01;phenylbutazone
MM01AA02;mofebutazone
MM01AA03;oxyphenbutazone
MM01AA05;clofezone
MM01AA06;kebuzon
MM01AB;acetic acid derivatives and related substances
MM01AB01;indomethacin
MM01AB02;sulindac
MM01AB03;tolmetin
MM01AB04;zomepirac
MM01AB05;diclofenac
MM01AB06;alclofenac
MM01AB07;bumadizone
MM01AB08;etodolac
MM01AB09;lonazolac
MM01AB10;fentiazac
MM01AB11;acemetacin
MM01AB12;difenpyramid
MM01AB13;oxamethacin
MM01AB14;proglumetacin
MM01AB15;ketorolac
MM01AB16;aceclofenac
MM01AB17;bufexamac
MM01AB51;indomethacin, combinations
MM01AB55;diclofenac, combinations
MM01AC;oxicams
MM01AC01;piroxicam
MM01AC02;tenoxicam
MM01AC04;droxicam
MM01AC05;lornoxicam
MM01AC06;meloxicam
MM01AC56;meloxicam, combinations
MM01AE;propionic acid derivatives
MM01AE01;ibuprofen
MM01AE02;naproxen
MM01AE03;ketoprofen
MM01AE04;fenoprofen
MM01AE05;fenbufen
MM01AE06;benoxaprofen
MM01AE07;suprofen
MM01AE08;pirprofen
MM01AE09;flurbiprofen
MM01AE10;indoprofen
MM01AE11;tiaprofenic acid
MM01AE12;oxaprozin
MM01AE13;ibuproxam
MM01AE14;dexibuprofen
MM01AE15;flunoxaprofen
MM01AE16;alminoprofen
MM01AE17;dexketoprofen
MM01AE18;naproxcinod
MM01AE19;loxoprofen
MM01AE20;pelubiprofen
MM01AE51;ibuprofen, combinations
MM01AE52;naproxen and esomeprazole
MM01AE53;ketoprofen, combinations
MM01AE56;naproxen and misoprostol
MM01AE57;naproxen and diphenhydramine
MM01AG;phenamates
MM01AG01;mefenamic acid
MM01AG02;tolfenamic acid
MM01AG03;flufenamic acid
MM01AG04;meclofenamic acid
MM01AH;coxibs
MM01AH01;celecoxib
MM01AH02;rofecoxib
MM01AH03;valdecoxib
MM01AH04;parecoxib
MM01AH05;etoricoxib
MM01AH06;lumiracoxib
MM01AH07;polmacoxib
MM01AX;other anti-inflammatory/anti-rheumatic agents, non-steroidal
MM01AX01;nabumetone
MM01AX02;niflumic acid
MM01AX04;azapropazone
MM01AX05;glucosamine
MM01AX07;benzydamine
MM01AX12;glucosamine polyglycan sulfate
MM01AX13;proquazon
MM01AX14;orgotein
MM01AX17;nimesulide
MM01AX18;feprazone
MM01AX21;diacerein
MM01AX22;morniflumate
MM01AX23;tenidap
MM01AX24;oxaceprol
MM01AX25;chondroitin sulfate
MM01AX26;avocado and soybean oil, unsaponifiables
MM01AX68;feprazone, combinations
MM01B;anti-inflammatory/antirheumatic agents in combination.
MM01BA;anti-inflammatory/antirheumatic agents in combination with corticosteroids
MM01BA01;phenylbutazone and corticosteroids
MM01BA02;dipyrocetyl and corticosteroids
MM01BA03;acetylsalicylic acid and corticosteroids
MM01BX;other anti-inflammatory agents in combination
MM01C;specific antirheumatic agents
MM01CA;quinolines
MM01CA03;oxycinchophene
MM01CB;gold compounds
MM01CB01;aurothiomalate sodium
MM01CB02;aurothiosulfate sodium
MM01CB03;auranofin
MM01CB04;aurothioglucose
MM01CB05;aurothioprol
MM01CC;penicillamine and similar substances
MM01CC01;penicillamine
MM01CC02;bucillamine
MM01CX;other specific antirheumatic agents
MM02;remedies for joint and muscle pain, external use
MM02A;remedies for joint and muscle pain, external use
MM02AA;anti-inflammatory drugs, non-steroidal, topical use
MM02AA01;phenylbutazone
MM02AA02;mofebutazone
MM02AA03;clofezone
MM02AA04;oxyphenbutazone
MM02AA05;benzydamine
MM02AA06;etofenamate
MM02AA07;piroxicam
MM02AA08;felbinac
MM02AA09;bufexamac
MM02AA10;ketoprofen
MM02AA11;bendazac
MM02AA12;naproxen
MM02AA13;ibuprofen
MM02AA14;fentiazac
MM02AA15;diclofenac
MM02AA16;feprazone
MM02AA17;niflumic acid
MM02AA18;meclofenamic acid
MM02AA19;flurbiprofen
MM02AA21;tolmetin
MM02AA22;suxibuzone
MM02AA23;indomethacin
MM02AA24;nifenazone
MM02AA25;aceclofenac
MM02AA26;nimesulide
MM02AA27;dexketoprofen
MM02AA28;piketoprofen
MM02AA29;esflurbiprofen
MM02AA31;loxoprofen
MM02AB;capsaicin and similar agents
MM02AB01;capsaicin
MM02AB02;zucapsaicin
MM02AC;preparations with salicylic acid derivatives
MM02AX;other remedies for joint and muscle pain, topical
MM02AX02;tolazoline
MM02AX03;dimethyl sulfoxide
MM02AX05;hydrocilamide
MM02AX06;tolperisone
MM02AX10;various other remedies for joint and muscle pain, topical
MM03;muscle relaxants
MM03A;muscle relaxants, peripherally acting agents
MM03AA;curare alkaloids
MM03AA01;alcuron
MM03AA02;tubocurarine
MM03AA04;dimethyltubocurarine
MM03AB;choline derivatives
MM03AB01;suxamethon
MM03AC;other quaternary ammonium compounds
MM03AC01;pancuron
MM03AC02;gallamine
MM03AC03;vecuron
MM03AC04;atracurium
MM03AC05;hexafluron
MM03AC06;pipecuronium bromide
MM03AC07;doxacurium chloride
MM03AC08;fazadinium bromide
MM03AC09;rocuronium bromide
MM03AC10;mivacurium chloride
MM03AC11;cisatracurium
MM03AX;other muscle relaxants, peripherally acting
MM03AX01;botulinum toxin
MM03B;muscle relaxants, centrally acting agents
MM03BA;carbamic acid esters
MM03BA01;phenprobamate
MM03BA02;carisoprodol
MM03BA03;methocarbamol
MM03BA04;styramate
MM03BA05;febarbamate
MM03BA51;phenprobamate, combinations excl. psycholeptics
MM03BA52;carisoprodol, combinations excl. psycholeptics
MM03BA53;methocarbamol, combinations excl. psycholeptics
MM03BA71;phenprobamate, combinations with psycholeptics
MM03BA72;carisoprodol, combinations with psycholeptics
MM03BA73;methocarbamol, combinations with psycholeptics
MM03BB;oxazole, thiazine, triazine derivatives
MM03BB02;chlormezanone
MM03BB03;chlorzoxazone
MM03BB52;chlormezanone, combinations excl. psycholeptics
MM03BB53;chlorzoxazone, combinations excl. psycholeptics
MM03BB72;chlormezanone, combinations with psycholeptics
MM03BB73;chlorzoxazone, combinations with psycholeptics
MM03BC;ethers, chemically related to antihistamines
MM03BC01;orphenadrine (citrate)
MM03BC51;orphenadrine, combinations
MM03BX;other muscle relaxants, centrally acting
MM03BX01;baclofen
MM03BX02;tizanidine
MM03BX03;pridinol
MM03BX04;tolperisone
MM03BX05;thiocolchicoside
MM03BX06;mephenesin
MM03BX07;tetrazepam
MM03BX08;cyclobenzaprine
MM03BX09;eperizon
MM03BX30;phenyramidol
MM03BX53;pridinol, combinations
MM03BX55;thiocolchicoside, combinations
MM03C;muscle relaxants, direct acting agents
MM03CA;dantrolene and derivatives
MM03CA01;dantrolene
MM04;drugs for gouty arthritis
MM04A;drugs for gouty arthritis
MM04AA;agents that inhibit uric acid production
MM04AA01;allopurinol
MM04AA02;tisopurine
MM04AA03;febuxostat
MM04AA51;allopurinol, combinations
MM04AB;agents that increase uric acid excretion
MM04AB01;probenecid
MM04AB02;sulfinpyrazone
MM04AB03;benzbromarone
MM04AB04;isobromoindione
MM04AB05;lesinurad
MM04AC;agents without effect on uric acid metabolism
MM04AC01;colchicine
MM04AC02;cinchophene
MM04AC51;colchicine and probenecid
MM04AX;other drugs for gouty arthritis
MM04AX01;urate oxidase
MM04AX02;pegloticase
MM05;drugs for the treatment of bone diseases
MM05B;agents affecting bone structure and mineralization
MM05BA;bisphosphonates
MM05BA01;etidronic acid
MM05BA02;clodronic acid
MM05BA03;pamidronic acid
MM05BA04;alendronic acid
MM05BA05;tiludronic acid
MM05BA06;ibandronic acid
MM05BA07;risedronate
MM05BA08;zoledronic acid
MM05BB;bisphosphonates, combinations
MM05BB01;etidronic acid and calcium, sequence preparations
MM05BB02;risedronate and calcium, sequential preparations
MM05BB03;alendronic acid and colecalciferol
MM05BB04;risedronic acid, calcium and colecalciferol, sequential preparations
MM05BB05;alendronic acid, calcium and colecalciferol, sequential preparations
MM05BB06;alendronic acid and alfacalcidol, sequential preparations
MM05BB07;risedronate acid and colecalciferol
MM05BB08;zoledronic acid, calcium and cholecalciferol, sequential preparations
MM05BB09;ibandronic acid and colecalciferol
MM05BC;bone morphogenic proteins
MM05BC01;dibotermin alfa
MM05BC02;eptotermin alfa
MM05BX;other agents affecting bone structure and mineralization
MM05BX01;ipriflavone
MM05BX02;aluminum chloride hydrate
MM05BX03;strontium ranelate
MM05BX04;denosumab
MM05BX05;burosumab
MM05BX06;romosozumab
MM05BX07;vosoritid
MM05BX08;menatetrenone
MM05BX53;strontium ranelate and colecalciferol
MM09;other drugs for disorders of the musculoskeletal system
MM09A;other drugs for disorders of the musculoskeletal system
MM09AA;quinine and derivatives
MM09AA01;hydroquinine
MM09AA72;quinine, combinations with psycholeptics
MM09AB;enzymes
MM09AB01;chymopapain
MM09AB02;collagenase clostridium histolyticum
MM09AB03;bromelains
MM09AB52;trypsin, combinations
MM09AX;other drugs for disorders of the musculoskeletal system
MM09AX01;hyaluronic acid
MM09AX02;chondrocytes, autologous
MM09AX03;ataluren
MM09AX04;drisapersen
MM09AX05;aceneuramic acid
MM09AX06;eteplirsen
MM09AX07;nusinersen
MM09AX08;golodirsen
MM09AX09;onasemnogenabeparvovec
MM09AX10;rice diplam
MM09AX11;palovaroten
MM09AX12;wild lark
MM09AX13;casimersen
MM09AX14;givinostat
MM09AX15;delandistrogen moxaparvovec
MN;Nervous system
MN01;anesthetics
MN01A;anesthetics, general
MN01AA;ether
MN01AA01;ether (diethyl ether)
MN01AA02;vinyl ether
MN01AB;halogenated hydrocarbons
MN01AB01;halothane
MN01AB02;chloroform
MN01AB04;enflurane
MN01AB05;trichloroethylene
MN01AB06;isoflurane
MN01AB07;desflurane
MN01AB08;sevoflurane
MN01AF;barbiturates, uncompounded
MN01AF01;methohexital
MN01AF02;hexobarbital
MN01AF03;thiopental
MN01AG;barbiturates in combination with other substances
MN01AG01;narcobarbital
MN01AH;opioid anesthetics
MN01AH01;fentanyl
MN01AH02;alfentanil
MN01AH03;sufentanil
MN01AH04;phenoperidine
MN01AH05;anileridine
MN01AH06;remifentanil
MN01AH51;fentanyl, combinations
MN01AX;other general anesthetics
MN01AX03;ketamine
MN01AX04;propanidide
MN01AX05;alfaxalone
MN01AX07;etomidate
MN01AX10;propofol
MN01AX11;sodium oxybate
MN01AX13;nitrous oxide
MN01AX14;esketamine
MN01AX15;xenon
MN01AX63;nitrous oxide, comp.
MN01B;local anesthetics
MN01BA;aminobenzoic acid esters
MN01BA01;methabutethamine
MN01BA02;procaine
MN01BA03;tetracaine
MN01BA04;chloroprocaine
MN01BA05;benzocaine
MN01BA52;procaine, combinations
MN01BA53;tetracaine, combinations
MN01BB;amides
MN01BB01;bupivacaine
MN01BB02;lidocaine
MN01BB03;mepivacaine
MN01BB04;prilocaine
MN01BB05;butanilicain
MN01BB06;cinchocaine
MN01BB07;etidocaine
MN01BB08;articaine
MN01BB09;ropivacaine
MN01BB10;levobupivacaine
MN01BB20;combinations of amides
MN01BB51;bupivacaine, combinations
MN01BB52;lidocaine, combinations
MN01BB53;mepivacaine, combinations
MN01BB54;prilocaine, combinations
MN01BB57;etidocaine, combinations
MN01BB58;articaine, combinations
MN01BB59;bupivacaine and meloxicam
MN01BC;benzoic acid esters
MN01BC01;cocaine
MN01BX;other local anesthetics
MN01BX01;ethyl chloride
MN01BX02;dyclonine
MN01BX03;phenol
MN01BX04;capsaicin
MN02;analgesics
MN02A;opioids
MN02AA;natural opium alkaloids
MN02AA01;morphine
MN02AA02;opium
MN02AA03;hydromorphone
MN02AA04;nicomorphine
MN02AA05;oxycodone
MN02AA08;dihydrocodeine
MN02AA10;papaveretum
MN02AA11;oxymorphone
MN02AA51;morphine, combinations
MN02AA53;hydromorphone and naloxone
MN02AA55;oxycodone and naloxone
MN02AA56;oxycodone and naltrexone
MN02AA58;dihydrocodeine, combinations
MN02AA59;codeine, comb. excl. psycholeptics
MN02AA79;codeine, combinations with psycholeptics
MN02AB;phenylpiperidine derivatives
MN02AB01;ketobemidone
MN02AB02;pethidine
MN02AB03;fentanyl
MN02AB52;pethidine, combinations excl. psycholeptics
MN02AB72;pethidine, combinations with psycholeptics
MN02AC;diphenylpropylamine derivatives
MN02AC01;dextromoramide
MN02AC03;piritramide
MN02AC04;dextropropoxyphene
MN02AC05;bezitramide
MN02AC52;methadone, combinations excl. psycholeptics
MN02AC54;dextropropoxyphene, combinations excl. psycholeptics
MN02AC74;dextropropoxyphene, combinations with psycholeptics
MN02AD;benzomorphane derivatives
MN02AD01;pentazocine
MN02AD02;phenazocine
MN02AD51;pentazocine and naloxone
MN02AE;oripavine derivatives
MN02AE01;buprenorphine
MN02AF;morphinan derivatives
MN02AF01;butorphanol
MN02AF02;nalbuphine
MN02AG;opioids in combination with antispasmodics
MN02AG01;morphine and antispasmodics
MN02AG02;ketobemidone and antispasmodics
MN02AG03;pethidine and antispasmodics
MN02AG04;hydromorphone and antispasmodics
MN02AJ;opioids in combination with non-opioid analgesics
MN02AJ01;dihydrocodeine and paracetamol
MN02AJ02;dihydrocodeine and acetylsalicylic acid
MN02AJ03;dihydrocodeine and other non-opioid analgesics
MN02AJ06;codeine and paracetamol
MN02AJ07;codeine and acetylsalicylic acid
MN02AJ08;codeine and ibuprofen
MN02AJ09;codeine and other non-opioid analgesics
MN02AJ13;tramadol and paracetamol
MN02AJ14;tramadol and dexketoprofen
MN02AJ15;tramadol and other non-opioid analgesics
MN02AJ16;tramadol and celecoxib
MN02AJ17;oxycodone and paracetamol
MN02AJ18;oxycodone and acetylsalicylic acid
MN02AJ19;oxycodone and ibuprofen
MN02AJ22;hydrocodone and paracetamol
MN02AJ23;hydrocodone and ibuprofen
MN02AX;other opioids
MN02AX01;tilidine
MN02AX02;tramadol
MN02AX03;dezocine
MN02AX05;meptazinol
MN02AX06;tapentadol
MN02AX07;oliceridine
MN02AX51;tilidine and naloxone
MN02B;other analgesics and antipyretics
MN02BA;salicylic acid derivatives
MN02BA01;acetylsalicylic acid
MN02BA02;aloxiprine
MN02BA03;choline salicylate
MN02BA04;sodium salicylate
MN02BA05;salicylamide
MN02BA06;salicyloylsalicylic acid
MN02BA07;ethenzamide
MN02BA08;morpholine salicylate
MN02BA09;dipyrocetyl
MN02BA10;benorilate
MN02BA11;diflunisal
MN02BA12;potassium salicylate
MN02BA14;guacetisal
MN02BA15;carbasalate calcium
MN02BA16;imidazole salicylate
MN02BA51;acetylsalicylic acid, combinations excl. psycholeptics
MN02BA55;salicylamide, combinations excl. psycholeptics
MN02BA57;ethenzamide, combinations excl. psycholeptics
MN02BA59;dipyrocetyl, combinations excl. psycholeptics
MN02BA65;carbasalate calcium, combinations excl. psycholeptics
MN02BA67;magnesium salicylate, combinations excl. psycholeptics
MN02BA71;acetylsalicylic acid, combinations with psycholeptics
MN02BA75;salicylamide, combinations with psycholeptics
MN02BA77;etenzamide, combinations with psycholeptics
MN02BA79;dipyrocetyl, combinations with psycholeptics
MN02BB;pyrazolones
MN02BB01;phenazone
MN02BB02;metamizole sodium
MN02BB03;aminophenazone
MN02BB04;propyphenazone
MN02BB05;nifenazone
MN02BB51;phenazone, combinations excl. psycholeptics
MN02BB52;dipyrone, combinations excl. psycholeptics
MN02BB53;aminophenazone, combinations excl. psycholeptics
MN02BB54;propyphenazone, combinations excl. psycholeptics
MN02BB71;phenazone, combinations with psycholeptics
MN02BB72;dipyrone, combinations with psycholeptics
MN02BB73;aminophenazone, combinations with psycholeptics
MN02BB74;propyphenazone, combinations with psycholeptics
MN02BE;anilides
MN02BE01;paracetamol
MN02BE02;tolfenamic acid
MN02BE03;phenacetin
MN02BE04;bucetin
MN02BE05;propacetamol
MN02BE51;paracetamol, combinations excl. psycholeptics
MN02BE53;phenacetin, combinations excl. psycholeptics
MN02BE54;bucetin, combinations excl. psycholeptics
MN02BE71;paracetamol, combinations with psycholeptics
MN02BE73;phenacetin, combinations with psycholeptics
MN02BE74;bucetin, combinations with psycholeptics
MN02BF;gabapentinoids
MN02BF01;gabapentin
MN02BF02;pregabalin
MN02BF03;mirogabalin
MN02BG;other analgesics and antipyretics
MN02BG02;rimazolin
MN02BG03;glafenin
MN02BG04;floctafenine
MN02BG05;viminol
MN02BG06;nefopam
MN02BG07;flupirtine
MN02BG08;ziconotide
MN02BG09;methoxyflurane
MN02BG10;cannabinoids
MN02BG12;tanezumab
MN02C;anti-migraine drugs
MN02CA;ergot alkaloids
MN02CA01;dihydroergotamine
MN02CA02;ergotamine
MN02CA04;methysergide
MN02CA06;dihydroergocristine
MN02CA07;lisurid
MN02CA51;dihydroergotamine, combination preparations
MN02CA52;ergotamine, combination preparations
MN02CA56;dihydroergocristine, combinations
MN02CA72;ergotamine in combination with psycholeptics
MN02CB;corticosteroid derivatives
MN02CB01;flumedroxone
MN02CC;selective 5HT(1) receptor agonists
MN02CC01;sumatriptan
MN02CC02;naratriptan
MN02CC03;zolmitriptan
MN02CC04;rizatriptan
MN02CC05;almotriptan
MN02CC06;eletriptan
MN02CC07;frovatriptan
MN02CC08;lasmiditan
MN02CC51;sumatriptan and naproxen
MN02CD;calcitonin gene-related peptide (CGRP) antagonists
MN02CD01;erenumab
MN02CD02;galcanezumab
MN02CD03;fremanezumab
MN02CD04;unsecured mortgage
MN02CD05;eptinezumab
MN02CD06;rimegante
MN02CD07;atogepant
MN02CD08;zavegepant
MN02CX;other migraine drugs
MN02CX01;pizotifen
MN02CX02;clonidine
MN02CX03;iprazochrome
MN02CX05;dimethothiazine
MN02CX06;oxetorone
MN03;antiepileptics
MN03A;antiepileptics
MN03AA;barbiturates and derivatives
MN03AA01;methylphenobarbital
MN03AA02;phenobarbital
MN03AA03;primidone
MN03AA04;barbexaclon
MN03AA30;metharbital
MN03AB;hydantoin derivatives
MN03AB01;ethotoin
MN03AB02;phenytoin
MN03AB03;amino(diphenylhydantoin)valeric acid
MN03AB04;mephenytoin
MN03AB05;fosphenytoin
MN03AB52;phenytoin, combinations
MN03AB54;mephenytoin, combinations
MN03AC;oxazolidine derivatives
MN03AC01;paramethadione
MN03AC02;trimethadione
MN03AC03;ethadione
MN03AD;succinimide derivatives
MN03AD01;ethosuximide
MN03AD02;phensuximide
MN03AD03;mesuximide
MN03AD51;ethosuximide, combinations
MN03AE;benzodiazepine derivatives
MN03AE01;clonazepam
MN03AF;carboxamide derivatives
MN03AF01;carbamazepine
MN03AF02;oxcarbazepine
MN03AF03;rufinamide
MN03AF04;eslicarbazepine
MN03AG;fatty acid derivatives
MN03AG01;valproic acid
MN03AG02;valpromide
MN03AG03;aminobutyl acid
MN03AG04;vigabatrin
MN03AG05;progabid
MN03AG06;tiagabine
MN03AX;other antiepileptic drugs
MN03AX03;sultiam
MN03AX07;phenacemid
MN03AX09;lamotrigine
MN03AX10;felbamate
MN03AX11;topiramate
MN03AX13;pheneturide
MN03AX14;levetiracetam
MN03AX15;zonisamide
MN03AX17;stiripentol
MN03AX18;lacosamide
MN03AX19;carisbamate
MN03AX21;retigabine
MN03AX22;perampanel
MN03AX23;brivaracetam
MN03AX24;cannabidiol
MN03AX25;cenobamate
MN03AX26;fenfluramine
MN03AX27;ganaxolone
MN03AX30;beclamide
MN04;anti-parkinsonian agents
MN04A;anticholinergic drugs
MN04AA;tertiary amines with carbon chain
MN04AA01;trihexyphenidyl
MN04AA02;biperiden
MN04AA03;methixene
MN04AA04;procyclidine
MN04AA05;profenamine
MN04AA08;dexethimide
MN04AA09;phenglutarimide
MN04AA10;mezaticol
MN04AA11;bornaprin
MN04AA12;tropatepin
MN04AB;ethers, chemically related to antihistamines
MN04AB01;etanautin
MN04AB02;orphenadrine (chloride)
MN04AC;ethers of tropine or tropine derivatives
MN04AC01;benzatropine
MN04AC30;etybenzatropine
MN04B;dopaminergic drugs
MN04BA;dopa and dopa derivatives
MN04BA01;levodopa
MN04BA02;levodopa and decarboxylase inhibitor
MN04BA03;levodopa, decarboxylase inhibitor and COMT inhibitor
MN04BA04;melevodopa
MN04BA05;melevodopa and decarboxylase inhibitor
MN04BA06;ethyl levodopa and decarboxylase inhibitor
MN04BA07;phoslevodopa and decarboxylase inhibitor
MN04BB;adamantane derivatives
MN04BB01;amantadine
MN04BC;dopamine agonists
MN04BC01;bromocriptine
MN04BC02;pergolide
MN04BC03;dihydroergocryptine mesylate
MN04BC04;ropinirole
MN04BC05;pramipexole
MN04BC06;cabergoline
MN04BC07;apomorphine
MN04BC08;piribedil
MN04BC09;rotigotine
MN04BD;monoamine oxidase type B inhibitors
MN04BD01;selegiline
MN04BD02;rasagiline
MN04BD03;safinamide
MN04BX;other dopaminergic drugs
MN04BX01;tolcapone
MN04BX02;entacapone
MN04BX03;budipine
MN04BX04;opicapone
MN04C;other antiparkinsonian drugs
MN04CX;other antiparkinsonian drugs
MN04CX01;istradefylline
MN05;psycholeptics
MN05A;antipsychotics
MN05AA;phenothiazine with aliphatic side chain
MN05AA01;chlorpromazine
MN05AA02;levomepromazine
MN05AA03;promazine
MN05AA04;acepromazine
MN05AA05;triflupromazine
MN05AA06;cyamemazine
MN05AA07;chlorproethazine
MN05AB;phenothiazine with piperazine structure
MN05AB01;dixyrazine
MN05AB02;fluphenazine
MN05AB03;perphenazine
MN05AB04;prochlorperazine
MN05AB05;thiopropazate
MN05AB06;trifluoperazine
MN05AB07;acetophenazine
MN05AB08;thioproperazine
MN05AB09;butaperazine
MN05AB10;perazine
MN05AC;phenothiazine with piperidine structure
MN05AC01;pericyazine
MN05AC02;thioridazine
MN05AC03;mesoridazine
MN05AC04;pipothiazine
MN05AD;butyrophenone derivatives
MN05AD01;haloperidol
MN05AD02;trifluperidol
MN05AD03;melperon
MN05AD04;moperon
MN05AD05;pipamperon
MN05AD06;bromperidol
MN05AD07;benperidol
MN05AD08;droperidol
MN05AD09;fluanisone
MN05AD10;lumateperone
MN05AE;indole derivatives
MN05AE01;oxypertine
MN05AE02;molindon
MN05AE03;sertindole
MN05AE04;ziprasidone
MN05AE05;lurasidone
MN05AF;thioxanthene derivatives
MN05AF01;flupentixol
MN05AF02;clopenthixol
MN05AF03;chlorprothixene
MN05AF04;thiothixene
MN05AF05;zuclopenthixol
MN05AG;diphenylbutylpiperidine derivatives
MN05AG01;fluspirilen
MN05AG02;pimozide
MN05AG03;penfluridol
MN05AH;diazepines, oxazepines, thiazepines and oxepines
MN05AH01;loxapine
MN05AH02;clozapine
MN05AH03;olanzapine
MN05AH04;quetiapine
MN05AH05;asenapine
MN05AH06;clotiapine
MN05AH53;olanzapine and samidorphan
MN05AK;neuroleptics, for tardive dyskinesias
MN05AL;benzamides
MN05AL01;sulpiride
MN05AL02;sultopride
MN05AL03;tiapride
MN05AL04;remoxipride
MN05AL05;amisulpride
MN05AL06;veralipride
MN05AL07;levosulpiride
MN05AN;lithium
MN05AN01;lithium
MN05AX;other antipsychotics
MN05AX07;prothipendyl
MN05AX08;risperidone
MN05AX10;mosapramine
MN05AX11;zotepine
MN05AX12;aripiprazole
MN05AX13;paliperidone
MN05AX14;iloperidone
MN05AX15;cariprazine
MN05AX16;brexpiprazole
MN05AX17;pimavanserin
MN05B;anxiolytics
MN05BA;benzodiazepine derivatives
MN05BA01;diazepam
MN05BA02;chlordiazepoxide
MN05BA03;medazepam
MN05BA04;oxazepam
MN05BA05;clorazepate potassium
MN05BA06;lorazepam
MN05BA07;adinazolam
MN05BA08;bromazepam
MN05BA09;clobazam
MN05BA10;ketazolam
MN05BA11;prazepam
MN05BA12;alprazolam
MN05BA13;halazepam
MN05BA14;pinazepam
MN05BA15;camazepam
MN05BA16;nordazepam
MN05BA17;fludiazepam
MN05BA18;ethyl loflazepate
MN05BA19;etizolam
MN05BA21;clotiazepam
MN05BA22;cloxazolam
MN05BA23;tofisopam
MN05BA24;bentazepam
MN05BA25;mexazolam
MN05BA56;lorazepam, combinations
MN05BB;diphenylmethane derivatives
MN05BB01;hydroxyzine
MN05BB02;captodiam
MN05BB51;hydroxyzine, combinations
MN05BC;carbamates
MN05BC01;meprobamate
MN05BC03;emylcamate
MN05BC04;mebutamate
MN05BC51;meprobamate, combinations
MN05BD;dibenzo-bicyclo-octadiene derivatives
MN05BD01;benzoctamine
MN05BE;azaspirodecanedione derivatives
MN05BE01;buspirone
MN05BX;other anxiolytics
MN05BX01;mefenoxalone
MN05BX02;goat meat
MN05BX03;etifoxine
MN05BX04;fabomotizol
MN05BX05;lavender oil
MN05C;hypnotics and sedatives
MN05CA;barbiturates, uncompounded
MN05CA01;pentobarbital
MN05CA02;amobarbital
MN05CA03;butobarbital
MN05CA04;barbital
MN05CA05;aprobarbital
MN05CA06;secobarbital
MN05CA07;talbutal
MN05CA08;vinyl bital
MN05CA09;wine barbital
MN05CA10;cyclobarbital
MN05CA11;heptabarbital
MN05CA12;reposal
MN05CA15;methohexital
MN05CA16;hexobarbital
MN05CA19;thiopental
MN05CA20;etallobarbital
MN05CA21;allobarbital
MN05CA22;proxibarbal
MN05CB;barbiturates, combinations
MN05CB01;barbiturate combinations
MN05CB02;barbiturates in combination with other substances
MN05CC;aldehydes and derivatives
MN05CC01;chloral hydrate
MN05CC02;chloralodol
MN05CC03;acetyl glycinamide chloral hydrate
MN05CC04;dichloralphenazone
MN05CC05;paraldehyde
MN05CD;benzodiazepine derivatives
MN05CD01;flurazepam
MN05CD02;nitrazepam
MN05CD03;flunitrazepam
MN05CD04;estazolam
MN05CD05;triazolam
MN05CD06;lormetazepam
MN05CD07;temazepam
MN05CD08;midazolam
MN05CD09;brotizolam
MN05CD10;quazepam
MN05CD11;loprazolam
MN05CD12;doxefazepam
MN05CD13;cinolazepam
MN05CD14;remimazolam
MN05CD15;nimetazepam
MN05CE;piperidinedione derivatives
MN05CE01;glutethimide
MN05CE02;methyprylon
MN05CE03;pyrithyldione
MN05CF;benzodiazepine-related agents
MN05CF01;zopiclone
MN05CF02;zolpidem
MN05CF03;zaleplon
MN05CF04;eszopiclone
MN05CH;melatonin receptor agonists
MN05CH01;melatonin
MN05CH02;ramelteon
MN05CH03;tasimelteon
MN05CJ;orexin receptor antagonists
MN05CJ01;suvorexant
MN05CJ02;lemborexant
MN05CJ03;daridorexant
MN05CM;other hypnotics and sedatives
MN05CM01;methaqualone
MN05CM02;clomethiazole
MN05CM03;brominated
MN05CM04;carbromal
MN05CM05;scopolamine
MN05CM06;propiomazine
MN05CM07;triclophos
MN05CM08;ethchlorvynol
MN05CM09;valerian root
MN05CM10;hexapropymate
MN05CM11;bromides
MN05CM12;apron
MN05CM13;valnoctamide
MN05CM15;methylpentynol
MN05CM16;niaprazine
MN05CM18;dexmedetomidine
MN05CX;hypnotics and sedatives, combinations, excl. barbiturates
MN05CX01;meprobamate, combinations
MN05CX02;methaqualone, combinations
MN05CX03;methylpentynol, combinations
MN05CX04;clomethiazole, combinations
MN05CX05;emepron, combinations
MN05CX06;dipiperonylaminoethanol, combinations
MN06;psychoanaleptics
MN06A;antidepressants
MN06AA;non-selective monoamine re-uptake inhibitors
MN06AA01;desipramine
MN06AA02;imipramine
MN06AA03;imipramine oxide
MN06AA04;clomipramine
MN06AA05;opipramol
MN06AA06;trimipramine
MN06AA07;lofepramine
MN06AA08;dibenzine
MN06AA09;amitriptyline
MN06AA10;nortriptyline
MN06AA11;protriptyline
MN06AA12;doxepin
MN06AA13;iprindol
MN06AA14;melitracen
MN06AA15;butriptyline
MN06AA16;dosulepin
MN06AA17;amoxapine
MN06AA18;dimethacrine
MN06AA19;amineptin
MN06AA21;maprotiline
MN06AA23;quinupramine
MN06AB;selective serotonin re-uptake inhibitors
MN06AB02;zimeldine
MN06AB03;fluoxetine
MN06AB04;citalopram
MN06AB05;paroxetine
MN06AB06;sertraline
MN06AB07;alaproclat
MN06AB08;fluvoxamine
MN06AB09;etoperidone
MN06AB10;escitalopram
MN06AF;monoamine oxidase inhibitors, non-selective
MN06AF01;isocarboxazid
MN06AF02;nialamide
MN06AF03;phenelzine
MN06AF04;tranylcypromine
MN06AF05;iproniazide
MN06AF06;iproclozid
MN06AG;monoamine oxidase type A inhibitors
MN06AG02;moclobemide
MN06AG03;toloxatone
MN06AX;other antidepressants
MN06AX01;oxitriptan
MN06AX02;tryptophan
MN06AX03;mianserin
MN06AX04;nomifensine
MN06AX05;trazodone
MN06AX06;nefazodone
MN06AX07;minaprin
MN06AX08;bifemelan
MN06AX09;viloxazine
MN06AX10;oxaflozin
MN06AX11;mirtazapine
MN06AX12;bupropion
MN06AX13;medifoxamine
MN06AX14;tianeptine
MN06AX15;pivagabine
MN06AX16;venlafaxine
MN06AX17;milnacipran
MN06AX18;reboxetine
MN06AX19;gepiron
MN06AX21;duloxetine
MN06AX22;agomelatine
MN06AX23;desvenlafaxine
MN06AX24;vilazodone
MN06AX25;pericon
MN06AX26;vortioxetine
MN06AX27;esketamine
MN06AX28;levomilnacipran
MN06AX29;brexanolone
MN06AX31;zuranolone
MN06AX62;bupropion and dextromethorphan
MN06B;psychostimulants, agents for ADHD and nootropics
MN06BA;centrally acting sympathomimetics
MN06BA01;amphetamine
MN06BA02;dexamfetamine
MN06BA03;methamphetamine
MN06BA04;methylphenidate
MN06BA05;pemoline
MN06BA06;fencamfamine
MN06BA07;modafinil
MN06BA08;fenozolone
MN06BA09;atomoxetine
MN06BA10;fenetylline
MN06BA11;dexmethylphenidate
MN06BA12;lisdexamfetamine
MN06BA13;armodafinil
MN06BA14;solriamfetol
MN06BA15;dexmethylphenidate and serdexmethylphenidate
MN06BC;xanthine derivatives
MN06BC01;caffeine
MN06BC02;propentofylline
MN06BX;other psychostimulants and nootropics
MN06BX01;meclofenoxate
MN06BX02;pyritinol
MN06BX03;piracetam
MN06BX04;deanol
MN06BX05;fipexid
MN06BX06;citicoline
MN06BX07;oxiracetam
MN06BX08;pyrisudanol
MN06BX09;linopirdine
MN06BX10;nizophenone
MN06BX11;aniracetam
MN06BX12;acetylcarnitine
MN06BX13;idebenone
MN06BX14;prolintan
MN06BX15;pipradrol
MN06BX16;pramiracetam
MN06BX17;adrafinil
MN06BX18;vinpocetine
MN06BX21;temgicoluril
MN06BX22;phenibut
MN06BX53;piracetam and cinnarizine
MN06C;psycholeptics and psychoanaleptics in combination
MN06CA;antidepressants in combination with psycholeptics
MN06CA01;amitriptyline and psycholeptics
MN06CA02;melitracen and psycholeptics
MN06CA03;fluoxetine and psycholeptics
MN06CB;psychostimulants in combination with psycholeptics
MN06D;drugs for dementia
MN06DA;anticholinesterases
MN06DA01;tacrine
MN06DA02;donepezil
MN06DA03;rivastigmine
MN06DA04;galantamine
MN06DA05;ipidacrine
MN06DA06;benzgalantamine
MN06DA52;donepezil and memantine
MN06DA53;donepezil, memantine and ginkgo leaf
MN06DX;other antidementia drugs
MN06DX01;memantine
MN06DX02;gingko leaf
MN06DX03;aducanumab
MN06DX04;lecanemab
MN06DX05;donanemab
MN06DX06;blarcamesin
MN06DX07;hydromethylthionine
MN06DX30;combinations of other antidementia agents
MN07;other agents acting on the central nervous system
MN07A;parasympathomimetics
MN07AA;anticholinesterases
MN07AA01;neostigmine
MN07AA02;pyridostigmine
MN07AA03;distigmine
MN07AA30;ambenon
MN07AA51;neostigmine, combinations
MN07AB;choline esters
MN07AB01;carbacholine
MN07AB02;bethanechol
MN07AX;other parasympathomimetics
MN07AX01;pilocarpine
MN07AX02;choline alfoscerate
MN07AX03;cevimeline
MN07B;drugs for addictive disorders
MN07BA;drugs for nicotine addiction
MN07BA01;nicotine
MN07BA03;varenicline
MN07BA04;cytisine
MN07BB;drugs for alcohol dependence
MN07BB01;disulfiram
MN07BB02;calcium carbimide
MN07BB03;acamprosate
MN07BB04;naltrexone
MN07BB05;nalmefene
MN07BB06;ondelopran
MN07BC;drugs for opioid addiction
MN07BC01;buprenorphine
MN07BC02;methadone
MN07BC03;levacetylmethadol
MN07BC04;lofexidine
MN07BC05;levomethadone
MN07BC06;diamorphine
MN07BC51;buprenorphine, comb.
MN07C;medicines for dizziness
MN07CA;medicines for dizziness
MN07CA01;betahistine
MN07CA02;cinnarizine
MN07CA03;flunarizine
MN07CA04;acetylleucine
MN07CA52;cinnarizine, combinations
MN07X;other agents with effects on the nervous system
MN07XA;gangliosides and ganglioside derivatives
MN07XX;other agents acting on the nervous system
MN07XX01;tirilazad
MN07XX02;riluzole
MN07XX03;xaliproden
MN07XX04;sodium oxybate
MN07XX05;amifampridine
MN07XX06;tetrabenazine
MN07XX07;fampridine
MN07XX08;tafamidis
MN07XX10;laquinimod
MN07XX11;pitolisant
MN07XX12;patisiran
MN07XX13;valbenazine
MN07XX14;edaravon
MN07XX15;inotersen
MN07XX16;deutetrabenazine
MN07XX17;arimoclomol
MN07XX18;vutrisiran
MN07XX19;sodium phenylbutyrate and ursodeoxycoltaurin
MN07XX21;eplontersen
MN07XX22;two-footer
MN07XX23;troriluzole
MN07XX24;trophine time
MN07XX25;omaveloxolone
MN07XX26;pridopidine
MN07XX59;dextromethorphan, combinations
MP;Antiparasitic agents, insecticides and repellents
MP01;antiprotozoal agents
MP01A;agents for amoebic and other protozoal diseases
MP01AA;hydroxyquinoline derivatives
MP01AA01;broxyquinoline
MP01AA02;clioquinol
MP01AA04;chlorquinaldol
MP01AA05;tilbroquinol
MP01AA30;tilbroquinol and tiliquinol
MP01AA52;clioquinol, combinations
MP01AB;nitroimidazole derivatives
MP01AB01;metronidazole
MP01AB02;tinidazole
MP01AB03;ornidazole
MP01AB04;azanidazole
MP01AB05;propenidazole
MP01AB06;nimorazole
MP01AB07;secnidazole
MP01AB08;satranidazole
MP01AB51;metronidazole and furazolidone
MP01AB52;metronidazole and diloxanide
MP01AB53;tinidazole and diloxanide
MP01AC;dichloroacetamide derivatives
MP01AC01;diloxanide
MP01AC02;clefamide
MP01AC03;etofamide
MP01AC04;teclosan
MP01AR;arsenic compounds
MP01AR01;arthinol
MP01AR02;difetarson
MP01AR03;glycobiarsol
MP01AR53;glycobiarsol, combinations
MP01AX;other agents against amoebic diseases
MP01AX01;cinemaphone
MP01AX02;emetine
MP01AX04;phanquinone
MP01AX05;mepacrine
MP01AX06;atovaquone
MP01AX07;trimetrexate
MP01AX08;tenonitrozole
MP01AX09;dihydroemetine
MP01AX10;fumagillin
MP01AX11;nitazoxanide
MP01AX52;emetine, combinations
MP01B;antimalarials
MP01BA;aminoquinolines
MP01BA01;chloroquine
MP01BA02;hydroxychloroquine
MP01BA03;primaquine
MP01BA04;mepacrine
MP01BA06;amodiaquine
MP01BA07;tafenoquin
MP01BB;biguanides
MP01BB01;proguanil
MP01BB02;cycloguanilembonate
MP01BB51;proguanil and atovaquone
MP01BB52;chloroquine and proguanil
MP01BC;methanolquinolines
MP01BC01;quinine
MP01BC02;mefloquine
MP01BD;diaminopyrimidines
MP01BD01;pyrimethamine
MP01BD51;pyrimethamine, combinations
MP01BE;artemisinin and derivatives, uncompounded
MP01BE01;artemisinin
MP01BE02;artemether
MP01BE03;artesunate
MP01BE04;artemotil
MP01BE05;artenimol
MP01BF;artemisinin and derivatives, combinations
MP01BF01;artemether and lumefantrine
MP01BF02;artesunate and mefloquine
MP01BF03;artesunate and amodiaquine
MP01BF04;artesunate, sulfalene and pyrimethamine
MP01BF05;artenimol and piperaquine
MP01BF06;artesunate and pyronaridine
MP01BF07;artemisinin and piperaquine
MP01BF08;artemisinin and naphthoquine
MP01BF09;artesunate, sulfadoxine and pyrimethamine
MP01BX;other antimalarials
MP01BX01;halofantrine
MP01BX02;arterolan and piperaquine
MP01C;agents for leishmaniasis and trypanosomiasis
MP01CA;nitroimidazole derivatives
MP01CA02;benznidazole
MP01CA03;fexinidazole
MP01CB;antimony compounds
MP01CB01;meglumine antimonate
MP01CB02;sodium stibogluconate
MP01CC;nitrofuran derivatives
MP01CC01;nifurtimox
MP01CC02;nitrofural
MP01CD;arsenic compounds
MP01CD01;melarsoprol
MP01CD02;acetarsol
MP01CX;other agents for leishmaniasis and trypanosomiasis
MP01CX01;pentamidine isethionate
MP01CX02;suramin sodium
MP01CX03;eflornithine
MP01CX04;miltefosine
MP02;anthelmintics
MP02B;antifuges
MP02BA;quinoline derivatives
MP02BA01;praziquantel
MP02BA02;oxamniquin
MP02BA03;arpraziquantel
MP02BB;organic phosphorus compounds
MP02BB01;metrifonate
MP02BX;other anti-trematodes
MP02BX01;bithionol
MP02BX02;niridazole
MP02BX03;stephen
MP02BX04;triclabendazole
MP02C;antinematode agents
MP02CA;benzimidazole derivatives
MP02CA01;mebendazole
MP02CA02;thiabendazole
MP02CA03;albendazole
MP02CA04;cyclobendazole
MP02CA05;flubendazole
MP02CA06;fenbendazole
MP02CA51;mebendazole, combinations
MP02CA53;albendazole and ivermectin
MP02CB;piperazine derivatives
MP02CB01;piperazine
MP02CB02;diethylcarbamazine
MP02CC;tetrahydropyrimidine derivatives
MP02CC01;pyrantel
MP02CC02;oxanthel
MP02CE;imidazothiazole derivatives
MP02CE01;levamisole
MP02CF;avermectins
MP02CF01;ivermectin
MP02CX;other antinematodes
MP02CX01;pyrvinium
MP02CX02;bephenium
MP02CX03;moxidectin
MP02D;anticestodal agents
MP02DA;salicylic acid derivatives
MP02DA01;niclosamide
MP02DX;other anticestodal agents
MP02DX01;desaspidine
MP02DX02;dichlorophen
MP03;ectoparasiticides, including scabies agents, insecticides and repellents
MP03A;ectoparasite agents, including scabies agents
MP03AA;sulfur-containing agents
MP03AA01;dixanthogen
MP03AA02;potassium polysulfide
MP03AA03;mesulfen
MP03AA04;disulfiram
MP03AA05;thiram
MP03AA54;disulfiram, combinations
MP03AB;chlorine-containing agents
MP03AB01;clofenotane
MP03AB02;lindane
MP03AB51;clofenotane, combinations
MP03AC;pyrethrins, incl. synthetic compounds
MP03AC01;pyrethrum
MP03AC02;bioallethrin
MP03AC03;phenothrin
MP03AC04;permethrin
MP03AC51;pyrethrum, combinations
MP03AC52;bioallethrin, combinations
MP03AC53;phenothrin, combinations
MP03AC54;permethrin, combinations
MP03AX;other ectoparasiticides, incl. scabies agents
MP03AX01;benzyl benzoate
MP03AX02;copper oleinate
MP03AX03;malathion
MP03AX04;quassia
MP03AX05;dimeticone
MP03AX06;benzyl alcohol
MP03AX07;abametapir
MP03B;insecticides and repellents
MP03BA;pyrethrins
MP03BA01;cyfluthrin
MP03BA02;cypermethrin
MP03BA03;decamethrin
MP03BA04;tetramethrin
MP03BX;other insecticides and repellents
MP03BX01;diethyltoluamide
MP03BX02;dimethylphthalate
MP03BX03;dibutyl phthalate
MP03BX04;dibutyl succinate
MP03BX05;dimethylcarbate
MP03BX06;ethohexadiol
MR;Respiratory system
MR01;medicines for diseases of the nasal cavity
MR01A;decongestants and other nasal decongestants for topical use
MR01AA;sympathomimetics, uncompounded
MR01AA02;cyclopentamine
MR01AA03;ephedrine
MR01AA04;phenylephrine
MR01AA05;oxymetazoline
MR01AA06;tetryzoline
MR01AA07;xylometazoline
MR01AA08;naphazoline
MR01AA09;tramazolin
MR01AA10;metizoline
MR01AA11;tuaminoheptane
MR01AA12;phenoxazoline
MR01AA13;thymazolin
MR01AA14;adrenaline
MR01AA15;indanazoline
MR01AB;sympathomimetics, comb. excl. corticosteroids
MR01AB01;phenylephrine
MR01AB02;naphazoline
MR01AB03;tetryzoline
MR01AB05;ephedrine
MR01AB06;xylometazoline
MR01AB07;oxymetazoline
MR01AB08;tuaminoheptane
MR01AC;antiallergic agents, excl. corticosteroids
MR01AC01;cromoglycic acid
MR01AC02;levocabastine
MR01AC03;azelastine
MR01AC04;antazoline
MR01AC05;sphaluminic acid
MR01AC06;thonzylamine
MR01AC07;nedocromil
MR01AC08;olopatadine
MR01AC51;cromoglycinic acid, combinations
MR01AD;corticosteroids
MR01AD01;beclomethasone
MR01AD02;prednisolone
MR01AD03;dexamethasone
MR01AD04;flunisolide
MR01AD05;budesonide
MR01AD06;betamethasone
MR01AD07;tixocortol
MR01AD08;fluticasone
MR01AD09;mometasone
MR01AD11;triamcinolone
MR01AD12;fluticasone furoate
MR01AD13;ciclesonide
MR01AD52;prednisolone, combinations
MR01AD53;dexamethasone, combinations
MR01AD57;tixocortol, combinations
MR01AD58;fluticasone, combinations
MR01AD59;mometasone, combinations
MR01AD60;hydrocortisone, comb.
MR01AX;other drugs for diseases of the nasal cavity
MR01AX01;calcium hexamine thiocyanate
MR01AX02;retinol
MR01AX03;ipratropium bromide
MR01AX05;rhithiomethane
MR01AX06;mupirocin
MR01AX07;hexamidine
MR01AX08;framycetin
MR01AX09;hyaluronic acid
MR01AX10;various other agents for diseases of the nasal cavity
MR01AX30;combinations of other agents for diseases of the nasal cavity
MR01B;nasal decongestants for systemic use
MR01BA;sympathomimetics
MR01BA01;phenylpropanolamine
MR01BA02;pseudoephedrine
MR01BA03;phenylephrine
MR01BA51;phenylpropanolamine, combinations
MR01BA52;pseudoephedrine, combinations
MR01BA53;phenylephrine, comb.
MR02;throat remedies
MR02A;throat remedies
MR02AA;antiseptics
MR02AA01;ambazon
MR02AA02;dequalone
MR02AA03;dichlorobenzyl alcohol
MR02AA05;chlorhexidine
MR02AA06;cetylpyridine
MR02AA09;benzethonium
MR02AA10;myristyl benzalkone
MR02AA11;chlorquinaldol
MR02AA12;hexylresorcinol
MR02AA13;acriflavine chloride
MR02AA14;oxyquinoline
MR02AA15;povidone-iodine
MR02AA16;benzalkonium
MR02AA17;cetrimonium
MR02AA18;hexamidine
MR02AA19;phenol
MR02AA20;various antiseptics
MR02AA21;octenidine
MR02AB;antibiotics
MR02AB01;neomycin
MR02AB02;tyrothricin
MR02AB03;fusafungine
MR02AB04;bacitracin
MR02AB30;gramicidin
MR02AD;local anesthetics
MR02AD01;benzocaine
MR02AD02;lidocaine
MR02AD03;cocaine
MR02AD04;dyclonine
MR02AD05;ambroxol
MR02AX;other throat remedies
MR02AX01;flurbiprofen
MR02AX02;ibuprofen
MR02AX03;benzydamine
MR03;drugs for obstructive pulmonary disease
MR03A;adrenergics for inhalation
MR03AA;alpha- and beta-adrenoceptor agonists
MR03AA01;adrenaline
MR03AB;non-selective beta-adrenoceptor agonists
MR03AB02;isoprenaline
MR03AB03;orciprenaline
MR03AC;selective beta-2-adrenoceptor agonists
MR03AC02;salbutamol
MR03AC03;terbutaline
MR03AC04;fenoterol
MR03AC05;rimiterol
MR03AC06;hexoprenaline
MR03AC07;isoetarin
MR03AC08;pirbuterol
MR03AC09;tretoquinol
MR03AC10;carbuterol
MR03AC11;tulobuterol
MR03AC12;salmeterol
MR03AC13;formoterol
MR03AC14;clenbuterol
MR03AC15;reproterol
MR03AC16;procaterol
MR03AC17;bitolterol
MR03AC18;indacaterol
MR03AC19;olodaterol
MR03AH;combinations of adrenergics
MR03AK;adrenergics combinations with corticosteroids/other agents, excl. anticholinergics
MR03AK01;adrenaline and other agents for obstructive pulmonary disease
MR03AK02;isoprenaline and other agents for obstructive pulmonary disease
MR03AK04;salbutamol and sodium cromoglycine
MR03AK05;reproterol and sodium cromoglycic acid
MR03AK06;salmeterol and fluticasone
MR03AK07;formoterol and budesonide
MR03AK08;formoterol and beclomethasone
MR03AK09;formoterol and mometasone
MR03AK10;vilanterol and fluticasone furoate
MR03AK11;formoterol and fluticasone
MR03AK12;salmeterol and budesonide
MR03AK13;salbutamol and beclomethasone
MR03AK14;indacaterol and mometasone
MR03AK15;salbutamol and budesonide
MR03AL;adrenergics in combination with anticholinergics incl. triple-drug combinations with corticosteroids
MR03AL01;fenoterol and ipratropium bromide
MR03AL02;salbutamol and ipratropium bromide
MR03AL03;vilanterol and umeclidinium bromide
MR03AL04;indacaterol and glycopyrronium bromide
MR03AL05;formoterol and aclidinium bromide
MR03AL06;olodaterol and tiotropium bromide
MR03AL07;formoterol and glycopyrronium bromide
MR03AL08;vilanterol, umeclidinium bromide and fluticasone furoate
MR03AL09;formoterol, glycopyrronium bromide and beclomethasone
MR03AL10;formoterol and tiotropium bromide
MR03AL11;formoterol, glycopyrronium bromide and budesonide
MR03AL12;indacaterol, glycopyrroinium bromide and mometasone
MR03B;other drugs for obstructive pulmonary disease, inhalation
MR03BA;glucocorticoids
MR03BA01;beclomethasone
MR03BA02;budesonide
MR03BA03;flunisolide
MR03BA04;betamethasone
MR03BA05;fluticasone
MR03BA06;triamcinolone
MR03BA07;mometasone
MR03BA08;ciclesonide
MR03BA09;fluticasone furoate
MR03BB;anticholinergics
MR03BB01;ipratropium bromide
MR03BB02;oxitropium bromide
MR03BB03;stramonium preparations
MR03BB04;tiotropium bromide
MR03BB05;aclidinium bromide
MR03BB06;glycopyrronium bromide
MR03BB07;umeclidinium bromide
MR03BB08;revefenacin
MR03BB54;tiotropium bromide, combinations
MR03BC;antiallergic agents, excl corticosteroids
MR03BC01;cromoglycic acid
MR03BC03;nedocromil
MR03BX;other drugs for obstructive pulmonary disease, inhalation
MR03BX01;fenspiride
MR03BX02;ensifentrin
MR03C;adrenergics for systemic use
MR03CA;alpha- and beta-adrenoceptor agonists
MR03CA02;ephedrine
MR03CB;non-selective beta-adrenoceptor agonists
MR03CB01;isoprenaline
MR03CB02;methoxyphenamine
MR03CB03;orciprenaline
MR03CB51;isoprenalin, comb.
MR03CB53;orciprenaline, combinations
MR03CC;selective beta-2-adrenoceptor agonists
MR03CC02;salbutamol
MR03CC03;terbutaline
MR03CC04;fenoterol
MR03CC05;hexoprenaline
MR03CC06;isoetarin
MR03CC07;pirbuterol
MR03CC08;procaterol
MR03CC09;tretoquinol
MR03CC10;carbuterol
MR03CC11;tulobuterol
MR03CC12;bambuterol
MR03CC13;clenbuterol
MR03CC14;reproterol
MR03CC15;formoterol
MR03CC53;terbutaline, combinations
MR03CC63;clenbuterol and ambroxol
MR03CK;adrenergics and other agents for obstructive pulmonary disease
MR03D;other systemic agents for obstructive pulmonary disease
MR03DA;xanthines
MR03DA01;diprophyllin
MR03DA02;choline theophylline
MR03DA03;proxyphylline
MR03DA04;theophylline
MR03DA05;aminophylline
MR03DA06;etamiphylline
MR03DA07;theobromine
MR03DA08;bamifylline
MR03DA09;acephylline piperazine
MR03DA10;buphylline
MR03DA11;doxofylline
MR03DA12;mepyramine-theophylline acetate
MR03DA20;combinations of xanthines
MR03DA51;diprophylline, combinations
MR03DA54;theophylline, combinations excl. psycholeptics
MR03DA55;aminophylline, combinations
MR03DA57;theobromine, combinations
MR03DA74;theophylline, combinations with psycholeptics
MR03DB;xanthines and adrenergics
MR03DB01;diprophylline and adrenergics
MR03DB02;choline theophylline and adrenergics
MR03DB03;proxyphyllin and adrenergics
MR03DB04;theophylline and adrenergics
MR03DB05;aminophylline and adrenergics
MR03DB06;etamiphylline and adrenergics
MR03DC;leukotriene receptor antagonists
MR03DC01;zafirlukast
MR03DC02;pranlukast
MR03DC03;montelukast
MR03DC04;ibudilast
MR03DC53;montelukast, combinations
MR03DX;other systemic agents for obstructive pulmonary disease
MR03DX01;amlexanox
MR03DX02;eprozinol
MR03DX03;fenspiride
MR03DX05;omalizumab
MR03DX06;serato dust
MR03DX07;roflumilast
MR03DX08;reslizumab
MR03DX09;mepolizumab
MR03DX10;benralizumab
MR03DX11;tezepelumab
MR03DX12;depemokimab
MR05;cough and cold remedies
MR05C;expectorantia, excl. comb. with antitussives
MR05CA;expectorantia
MR05CA01;tyloxapol
MR05CA02;potassium iodide
MR05CA03;guaifenesin
MR05CA04;ipecacuanha
MR05CA05;althaea root
MR05CA06;senega
MR05CA07;antimony pentasulfide
MR05CA08;creosote
MR05CA09;guaiacolsulfonate
MR05CA10;combinations of expectorants
MR05CA11;levoverbenone
MR05CA12;ivy leaf
MR05CA13;cineole
MR05CB;mucolytics
MR05CB01;acetylcysteine
MR05CB02;bromhexine
MR05CB03;carbocisteine
MR05CB04;eprazinone
MR05CB05;mesna
MR05CB06;ambroxol
MR05CB07;overhead
MR05CB08;domiodol
MR05CB09;letostein
MR05CB10;combinations of mucolytics
MR05CB11;stepronin
MR05CB13;dornase alfa (deoxyribonuclease)
MR05CB14;neltenexin
MR05CB15;erdostein
MR05CB16;mannitol
MR05D;antitussives, excl. comb. with expectorants
MR05DA;opium alkaloids and derivatives
MR05DA01;ethylmorphine
MR05DA03;hydrocodone
MR05DA04;codeine
MR05DA05;opium alkaloids with morphine
MR05DA06;normethadone
MR05DA07;noscapine
MR05DA08;pholcodine
MR05DA09;dextromethorphan
MR05DA10;thebacon
MR05DA11;dimemorphine
MR05DA12;acetyldihydrocodeine
MR05DA20;combinations of opium alkaloids and derivatives
MR05DB;other antitussives
MR05DB01;benzonatate
MR05DB02;benproperin
MR05DB03;clobutinol
MR05DB04;isoaminyl
MR05DB05;pentoxyverine
MR05DB07;oxolamine
MR05DB09;oxeladin
MR05DB10;clofedanol
MR05DB11;pipa acetate
MR05DB12;bibenzonium bromide
MR05DB13;butamirate
MR05DB14;fedrilate
MR05DB15;zipeprol
MR05DB16;dibunate
MR05DB17;droxypropyn
MR05DB18;prenoxdiazine
MR05DB19;dropropizine
MR05DB20;combinations of other antitussives
MR05DB21;cloperastin
MR05DB22;meprothixol
MR05DB23;piperidione
MR05DB24;tipedin
MR05DB25;morclofon
MR05DB26;nepinalon
MR05DB27;levodropropizine
MR05DB28;dimethoxanate
MR05DB29;gefapixant
MR05F;antitussives and expectorants in combination
MR05FA;opium derivatives and expectorants
MR05FA01;opium derivatives and mucolytics
MR05FA02;opium derivatives and expectorants
MR05FB;other antitussives and expectorants
MR05FB01;antitussives and mucolytics
MR05FB02;antitussives and expectorants
MR05X;other cold remedies
MR06;antihistamines for systemic use
MR06A;antihistamines for systemic use
MR06AA;aminoalkyl ethers
MR06AA01;bromazine
MR06AA02;diphenhydramine
MR06AA04;clemastine
MR06AA06;chlorphenoxamine
MR06AA07;diphenylpyraline
MR06AA08;carbinoxamine
MR06AA09;doxylamine
MR06AA10;trimethobenzamide
MR06AA11;dimenhydrinate
MR06AA52;diphenhydramine, combinations
MR06AA54;clemastine, combinations
MR06AA56;chlorphenoxamine, combinations
MR06AA57;diphenylpyraline, combinations
MR06AA59;doxylamine, combinations
MR06AA61;dimenhydrinate, combinations
MR06AB;substituted alkylamines
MR06AB01;brompheniramine
MR06AB02;dexchlorpheniramine
MR06AB03;dimethindene
MR06AB04;chlorpheniramine
MR06AB05;pheniramine
MR06AB06;dexbrompheniramine
MR06AB07;talastine
MR06AB51;brompheniramine, combinations
MR06AB52;dexchlorpheniramine, combinations
MR06AB54;chlorpheniramine, combinations
MR06AB56;dexbrompheniramine, combinations
MR06AC;substituted ethylenediamines
MR06AC01;mepyramine
MR06AC02;histapyrrodin
MR06AC03;chloropyramine
MR06AC04;tripelennamine
MR06AC05;methapyrylene
MR06AC06;thonzylamine
MR06AC52;histapyrrodin, combinations
MR06AC53;chloropyramine, combinations
MR06AD;phenothiazine derivatives
MR06AD01;alimemazine
MR06AD02;promethazine
MR06AD03;thiethylperazine
MR06AD04;methdilazine
MR06AD05;hydroxyethylpromethazine
MR06AD06;thiazinam
MR06AD07;mequitazine
MR06AD08;oxomemazine
MR06AD09;isothipendyl
MR06AD52;promethazine, combinations
MR06AD55;hydroxyethylpromethazine, combinations
MR06AE;piperazine derivatives
MR06AE01;buclizine
MR06AE03;cyclizine
MR06AE04;chlorcyclizine
MR06AE05;meclozine
MR06AE06;oxatomide
MR06AE07;cetirizine
MR06AE09;levocetirizine
MR06AE51;buclizine, combinations
MR06AE53;cyclizine, combinations
MR06AE55;meclozine, combinations
MR06AK;combinations of antihistamines
MR06AX;other antihistamines for systemic use
MR06AX01;bamipin
MR06AX02;cyproheptadine
MR06AX03;thenalidine
MR06AX04;phenindamine
MR06AX05;antazolin
MR06AX07;triprolidine
MR06AX08;pyrrobutamine
MR06AX09;azatadine
MR06AX11;astemizole
MR06AX12;terfenadine
MR06AX13;loratadine
MR06AX15;mebhydrolin
MR06AX16;deptropin
MR06AX17;ketotifen
MR06AX18;acrivastin
MR06AX19;azelastine
MR06AX21;tritoqualin
MR06AX22;ebastine
MR06AX23;pimethixene
MR06AX24;epinastine
MR06AX25;mizolastine
MR06AX26;fexofenadine
MR06AX27;desloratadine
MR06AX28;rupatadine
MR06AX29;bilastine
MR06AX31;quifenadine
MR06AX32;sequifenadine
MR06AX53;thenalidine, combination preparations
MR06AX58;pyrrobutamine, combination preparations
MR07;other drugs for diseases of the respiratory system
MR07A;other drugs for diseases of the respiratory system
MR07AA;lung surfactants
MR07AA01;colfosceril palmitate
MR07AA02;natural phospholipids
MR07AA30;combinations of different pulmonary surfactants
MR07AB;respiratory stimulants
MR07AB01;doxapram
MR07AB02;nikethamide
MR07AB03;pentetrazole
MR07AB04;etamivan
MR07AB05;bemegrid
MR07AB06;prethcamid
MR07AB07;almitrine
MR07AB08;dimeflin
MR07AB09;mepix anox
MR07AB52;niketamide, combinations
MR07AB53;pentetrazole, combinations
MR07AX;other agents acting on the respiratory system
MR07AX01;nitrogen oxide
MR07AX02;ivacaftor
MR07AX30;ivacaftor and lumacaftor
MR07AX31;ivacaftor and tezacaftor
MR07AX32;ivacaftor, tezacaftor and elexacaftor
MR07AX33;deutivacaftor, tezacaftor and vanzacaftor
MS;Sensory organs
MS01;ophthalmology
MS01A;anti-infectives
MS01AA;antibiotics
MS01AA01;chloramphenicol
MS01AA02;chlortetracycline
MS01AA03;neomycin
MS01AA04;oxytetracycline
MS01AA05;tyrothricin
MS01AA07;framycetin
MS01AA09;tetracycline
MS01AA10;natamycin
MS01AA11;gentamicin
MS01AA12;tobramycin
MS01AA13;fusidic acid
MS01AA14;benzylpenicillin
MS01AA15;dihydrostreptomycin
MS01AA16;rifamycin
MS01AA17;erythromycin
MS01AA18;polymyxin B
MS01AA19;ampicillin
MS01AA20;antibiotics in combination with other substances
MS01AA21;amikacin
MS01AA22;micronomicin
MS01AA23;netilmycin
MS01AA24;kanamycin
MS01AA25;azidamphenicol
MS01AA26;azithromycin
MS01AA27;cefuroxime
MS01AA28;vancomycin
MS01AA29;dibekacin
MS01AA30;combinations of different antibiotics
MS01AA31;cefmenoxime
MS01AA32;bacitracin
MS01AB;sulfonamides
MS01AB01;sulfamethizole
MS01AB02;sulfafurazole
MS01AB03;sulfadicramide
MS01AB04;sulfacetamide
MS01AB05;sulfaphenazole
MS01AD;antiviral agents
MS01AD01;idoxuridine
MS01AD02;trifluridine
MS01AD03;acyclovir
MS01AD05;interferon
MS01AD06;vidarabine
MS01AD07;famciclovir
MS01AD08;fomivirsen
MS01AD09;ganciclovir
MS01AE;fluoroquinolones
MS01AE01;ofloxacin
MS01AE02;norfloxacin
MS01AE03;ciprofloxacin
MS01AE04;lomefloxacin
MS01AE05;levofloxacin
MS01AE06;gatifloxacin
MS01AE07;moxifloxacin
MS01AE08;besifloxacin
MS01AE09;tosufloxacin
MS01AX;other anti-infectives
MS01AX01;mercury compounds
MS01AX02;silver compounds
MS01AX03;zinc compounds
MS01AX04;nitrofural
MS01AX05;bibrocathol
MS01AX06;resorcinol
MS01AX07;sodium borate
MS01AX08;hexamidine
MS01AX09;chlorhexidine
MS01AX10;sodium propionate
MS01AX14;dibromopropamidine
MS01AX15;propamidine
MS01AX16;picloxydine
MS01AX18;povidone-iodine
MS01AX24;polyhexanide
MS01AX25;lotilaner
MS01B;anti-inflammatory drugs
MS01BA;corticosteroids, uncompounded
MS01BA01;dexamethasone
MS01BA02;hydrocortisone
MS01BA03;cortisone
MS01BA04;prednisolone
MS01BA05;triamcinolone
MS01BA06;betamethasone
MS01BA07;fluorometholone
MS01BA08;medryson
MS01BA09;clobetasone
MS01BA10;alclometasone
MS01BA11;desonide
MS01BA12;formocortal
MS01BA13;rimexolone
MS01BA14;loteprednol
MS01BA15;fluocinolone acetonide
MS01BA16;difluprednate
MS01BA17;clobetasol
MS01BB;corticosteroids and mydriatics in combination
MS01BB01;hydrocortisone and mydriatics
MS01BB02;prednisolone and mydriatics
MS01BB03;fluorometholone and mydriatics
MS01BB04;betamethasone and mydriatics
MS01BC;anti-inflammatory agents, non-steroidal
MS01BC01;indomethacin
MS01BC02;oxyphenylbutazone
MS01BC03;diclofenac
MS01BC04;flurbiprofen
MS01BC05;ketorolac
MS01BC06;piroxicam
MS01BC07;bendazac
MS01BC08;salicylic acid
MS01BC09;pranoprofen
MS01BC10;nepafenac
MS01BC11;bromfenac
MS01C;anti-inflammatories and anti-infectives in combination
MS01CA;corticosteroids and anti-infectives in combination
MS01CA01;dexamethasone and anti-infectives
MS01CA02;prednisolone and anti-infectives
MS01CA03;hydrocortisone and anti-infectives
MS01CA04;fluocortolone and anti-infectives
MS01CA05;betamethasone and anti-infectives
MS01CA06;fludrocortisone and anti-infectives
MS01CA07;fluorometholone and anti-infectives
MS01CA08;methylprednisolone and anti-infectives
MS01CA09;chlorprednisone and anti-infectives
MS01CA10;fluocinolone acetonide and anti-infectives
MS01CA11;clobetason and anti-infectives
MS01CA12;loteprednol and anti-infectives
MS01CB;corticosteroids, anti-infectives, sympathomimetics in combination
MS01CB01;dexamethasone
MS01CB02;prednisolone
MS01CB03;hydrocortisone
MS01CB04;betamethasone
MS01CB05;fluorometholone
MS01CC;anti-inflammatories, non-steroids and anti-infectives in combination
MS01CC01;diclofenac and anti-infectives
MS01CC02;indomethacin and anti-infectives
MS01E;antiglaucoma agents and miotics
MS01EA;sympathomimetics for glaucoma treatment
MS01EA01;adrenaline
MS01EA02;dipivefrin
MS01EA03;apraclonidine
MS01EA04;clonidine
MS01EA05;brimonidine
MS01EA51;adrenaline, combinations
MS01EA55;brimonidine and ripasudil
MS01EB;parasympathomimetics
MS01EB01;pilocarpine
MS01EB02;carbachol
MS01EB03;ecothiopath
MS01EB04;demecarium
MS01EB05;physostigmine
MS01EB06;neostigmine
MS01EB07;fluostigmine
MS01EB08;aceclidine
MS01EB09;acetylcholine
MS01EB10;paraoxon
MS01EB51;pilocarpine, combinations
MS01EB58;aceclidine, combinations
MS01EC;carbonic anhydrase inhibitors
MS01EC01;acetazolamide
MS01EC02;diclofenamide
MS01EC03;dorzolamide
MS01EC04;brinzolamide
MS01EC05;methazolamide
MS01EC54;brinzolamide, combinations
MS01ED;beta-blockers
MS01ED01;timolol
MS01ED02;betaxolol
MS01ED03;levobunolol
MS01ED04;metipranolol
MS01ED05;carteolol
MS01ED06;befunolol
MS01ED51;timolol, combinations
MS01ED52;betaxolol, combinations
MS01ED54;metipranolol, combinations
MS01ED55;carteolol, comb.
MS01EE;prostaglandin analogues
MS01EE01;latanoprost
MS01EE02;unoprostone
MS01EE03;bimatoprost
MS01EE04;travoprost
MS01EE05;tafluprost
MS01EE06;latanoprostenbunod
MS01EE51;latanoprost and netarsudil
MS01EE52;latanoprost and dorzolamide
MS01EX;other antiglaucoma agents
MS01EX01;guanethidine
MS01EX02;dapiprazole
MS01EX05;netarsudil
MS01EX06;omidenepag
MS01EX07;ripasudil
MS01F;mydriatics and cycloplegics
MS01FA;anticholinergics
MS01FA01;atropine
MS01FA02;scopolamine
MS01FA03;methylscopolamine
MS01FA04;cyclopentolate
MS01FA05;homatropine
MS01FA06;tropicamide
MS01FA54;cyclopentolate, combinations
MS01FA56;tropicamide, combinations
MS01FB;sympathomimetics excl. antiglaucoma agents
MS01FB01;phenylephrine
MS01FB02;ephedrine
MS01FB03;ibopamine
MS01FB51;phenylephrine and ketorolac
MS01G;decongestants and antiallergics
MS01GA;sympathomimetics used as decongestants
MS01GA01;naphazoline
MS01GA02;tetryzoline
MS01GA03;xylometazoline
MS01GA04;oxymetazoline
MS01GA05;phenylephrine
MS01GA06;oxedrine
MS01GA07;brimonidine
MS01GA51;naphazoline, combinations
MS01GA52;tetryzoline, combinations
MS01GA53;xylometazoline, combinations
MS01GA55;phenylephrine, combinations
MS01GA56;oxedrine, combinations
MS01GX;other antiallergics
MS01GX01;cromoglycic acid
MS01GX02;levocabastine
MS01GX03;sphaluminic acid
MS01GX04;nedocromil
MS01GX05;lodoxamide
MS01GX06;emedastine
MS01GX07;azelastine
MS01GX08;ketotifen
MS01GX09;olopatadine
MS01GX10;epinastine
MS01GX11;alcaftadine
MS01GX12;cetirizine
MS01GX13;bilastine
MS01GX51;cromoglycic acid, combinations
MS01H;local anesthetics
MS01HA;local anesthetics
MS01HA01;cocaine
MS01HA02;oxybuprocaine
MS01HA03;tetracaine
MS01HA04;proxymetacaine
MS01HA05;procaine
MS01HA06;cinchocaine
MS01HA07;lidocaine
MS01HA08;chloroprocaine
MS01HA30;combinations of local anesthetics
MS01J;diagnostics
MS01JA;dyes
MS01JA01;fluorescein
MS01JA02;rose bengal sodium
MS01JA51;fluorescein, combinations
MS01JX;other ophthalmological diagnostics
MS01K;surgical aids
MS01KA;viscoelastic substances
MS01KA01;hyaluronic acid
MS01KA02;hypromellose
MS01KA51;hyaluronic acid, combinations
MS01KX;other surgical aids
MS01KX01;chymotrypsin
MS01KX02;trypan blue
MS01L;agents for ocular vascular disorders
MS01LA;antineovascularization agents
MS01LA01;verteporfin
MS01LA02;anecortav
MS01LA03;pegaptanib
MS01LA04;ranibizumab
MS01LA05;aflibercept
MS01LA06;brolucizumab
MS01LA07;abiciparpegol
MS01LA08;bevacizumab
MS01LA09;faricimab
MS01X;other ophthalmological agents
MS01XA;other ophthalmological agents
MS01XA01;guaiazulene
MS01XA02;retinol
MS01XA03;sodium chloride, hypertonic
MS01XA04;potassium iodide
MS01XA05;sodium edetate
MS01XA06;ethylmorphine
MS01XA07;alum
MS01XA08;acetylcysteine
MS01XA09;iodoheparinate
MS01XA10;inosine
MS01XA11;nandrolone
MS01XA12;dexpanthenol
MS01XA13;alteplase
MS01XA14;heparin
MS01XA15;ascorbic acid
MS01XA18;ciclosporin
MS01XA19;limbal stem cells, autologous
MS01XA20;artificial tears and other inert agents
MS01XA21;mercaptamine
MS01XA22;ocriplasmin
MS01XA23;sirolimus
MS01XA24;cenegermin
MS01XA25;lifitegrast
MS01XA26;riboflavin
MS01XA27;voretigenneparvovec
MS01XA28;varenicline
MS01XA29;sepofarsen
MS01XA31;pegcetacoplan
MS01XA32;avacincaptad pegol
MS01XA33;diquafosol
MS02;otologic
MS02A;anti-infectives
MS02AA;anti-infectives
MS02AA01;chloramphenicol
MS02AA02;nitrofural
MS02AA03;boric acid
MS02AA04;aluminum acetotartrate
MS02AA05;clioquinol
MS02AA06;hydrogen peroxide
MS02AA07;neomycin
MS02AA08;tetracycline
MS02AA09;chlorhexidine
MS02AA10;acetic acid
MS02AA11;polymyxin B
MS02AA12;rifamycin
MS02AA13;miconazole
MS02AA14;gentamicin
MS02AA15;ciprofloxacin
MS02AA16;ofloxacin
MS02AA17;fosfomycin
MS02AA18;cefmenoxime
MS02AA30;anti-infectives, combinations
MS02B;corticosteroids
MS02BA;corticosteroids
MS02BA01;hydrocortisone
MS02BA03;prednisolone
MS02BA06;dexamethasone
MS02BA07;betamethasone
MS02BA08;fluocinolone acetonide
MS02C;corticosteroids and anti-infectives in combination
MS02CA;corticosteroids and anti-infectives in combination
MS02CA01;prednisolone and anti-infectives
MS02CA02;flumethasone and anti-infectives
MS02CA03;hydrocortisone and anti-infectives
MS02CA04;triamcinolone and anti-infectives
MS02CA05;fluocinolone acetonide and anti-infectives
MS02CA06;dexamethasone and anti-infectives
MS02CA07;fludrocortisone and anti-infectives
MS02D;other otologics
MS02DA;analgesics and anesthetics
MS02DA01;lidocaine
MS02DA02;cocaine
MS02DA03;phenazone
MS02DA04;cinchocaine
MS02DA30;combinations of analgesics and anesthetics
MS02DC;indifferent preparations
MS03;ophthalmology and otology
MS03A;anti-infectives
MS03AA;anti-infectives
MS03AA01;neomycin
MS03AA02;tetracycline
MS03AA03;polymyxin B
MS03AA04;chlorhexidine
MS03AA05;hexamidine
MS03AA06;gentamicin
MS03AA07;ciprofloxacin
MS03AA08;chloramphenicol
MS03AA30;anti-infectives, combinations
MS03B;corticosteroids
MS03BA;corticosteroids
MS03BA01;dexamethasone
MS03BA02;prednisolone
MS03BA03;betamethasone
MS03C;corticosteroids and anti-infectives in combination
MS03CA;corticosteroids and anti-infectives in combination
MS03CA01;dexamethasone and anti-infectives
MS03CA02;prednisolone and anti-infectives
MS03CA04;hydrocortisone and anti-infectives
MS03CA05;fludrocortisone and anti-infectives
MS03CA06;betamethasone and anti-infectives
MS03CA07;methylprednisolone and anti-infectives
MS03D;other ophthalmology and otology
MV;Miscellaneous
MV01;allergens
MV01A;allergens
MV01AA;allergen extracts
MV01AA01;allergen extract from feathers
MV01AA02;allergen extract from grass pollen
MV01AA03;allergen extract from house dust mites
MV01AA04;allergen extract from mold and yeast
MV01AA05;allergen extract from tree pollen
MV01AA07;allergen extract from insects
MV01AA08;allergen extract from food
MV01AA09;allergen extract from textiles
MV01AA10;allergen extract from flowers
MV01AA11;animal allergen extract
MV01AA20;various allergen extracts
MV03;all other therapeutic products
MV03A;all other therapeutic products
MV03AB;antidotes
MV03AB01;ipecacuanha
MV03AB02;nalorphine
MV03AB03;edetat
MV03AB04;pralidoxime
MV03AB05;prednisolone and promethazine
MV03AB06;thiosulfate
MV03AB08;sodium nitrite
MV03AB09;dimercaprol
MV03AB13;obidoxime
MV03AB14;protamine
MV03AB15;naloxone
MV03AB16;ethanol
MV03AB17;methylthionine chloride
MV03AB18;potassium permanganate
MV03AB19;physostigmine
MV03AB20;copper sulfate
MV03AB21;potassium iodide
MV03AB22;amyl nitrite
MV03AB23;acetylcysteine
MV03AB24;digitalis antitoxin
MV03AB25;flumazenil
MV03AB26;DL-methionine
MV03AB27;4-dimethylaminophenol
MV03AB29;cholinesterase
MV03AB31;Perlin blue
MV03AB32;glutathione
MV03AB33;hydroxocobalamin
MV03AB34;fomepizole
MV03AB35;sugammadex
MV03AB36;phentolamine
MV03AB37;idarucizumab
MV03AB38;andexanet alfa
MV03AB54;pralidoxime and atropine
MV03AC;iron-chelating agents
MV03AC01;deferoxamine
MV03AC02;deferiprone
MV03AC03;deferasirox
MV03AE;agents for the treatment of hyperkalemia and hyperphosphatemia
MV03AE01;polystyrene sulfonate
MV03AE02;sevelamer
MV03AE03;lanthanum carbonate
MV03AE04;calcium acetate and magnesium carbonate
MV03AE05;sucroferricoxyhydroxide
MV03AE06;colestilan
MV03AE07;calcium acetate
MV03AE08;ferricitrate
MV03AE09;patiromercalcium
MV03AE10;sodium zirconium cyclosilicate
MV03AF;detoxifying agents for cytostatic treatment
MV03AF01;mesna
MV03AF02;dexrazoxane
MV03AF03;calcium folinate
MV03AF04;calcium levofolinate
MV03AF05;amifostine
MV03AF06;sodium folinate
MV03AF07;rasburicase
MV03AF08;palifermin
MV03AF09;glucarpidase
MV03AF10;sodium levofolinate
MV03AF11;arginine and lysine
MV03AF12;trilaciclib
MV03AG;agents for the treatment of hypercalcemia
MV03AG01;sodium cellulose phosphate
MV03AG05;sodium phosphate
MV03AH;agents for the treatment of hypoglycemia
MV03AH01;diazoxide
MV03AK;tissue adhesives
MV03AM;anti-embolism agents
MV03AN;medical gases
MV03AN01;oxygen
MV03AN02;carbon dioxide
MV03AN03;helium
MV03AN04;nitrogen
MV03AN05;medical air
MV03AX;other therapeutic products
MV03AX02;nalfurafine
MV03AX03;cobicistat
MV03AX04;difelikefalin
MV03AZ;nerve depressants
MV03AZ01;ethanol
MV04;diagnostics
MV04B;urine tests
MV04C;other diagnostics
MV04CA;tests for diabetes
MV04CA01;tolbutamide
MV04CA02;glucose
MV04CB;fat absorption tests
MV04CB01;vitamin A concentrates
MV04CC;tests for bile duct patency
MV04CC01;sorbitol
MV04CC02;magnesium sulfate
MV04CC03;sincalid
MV04CC04;cerule time
MV04CD;tests for pituitary function
MV04CD01;metyrapone
MV04CD03;sermorelin
MV04CD04;corticoliberin
MV04CD05;somatorelin
MV04CD06;macimorelin
MV04CE;liver function capacity tests
MV04CE01;galactose
MV04CE02;sulfobromphthalein
MV04CE03;methacetin (13-C)
MV04CF;tuberculosis diagnostics
MV04CF01;tuberculin
MV04CG;tests for gastric secretion
MV04CG01;cation exchangers
MV04CG02;betazol
MV04CG03;histamine phosphate
MV04CG04;pentagastrin
MV04CG05;methylthionine chloride
MV04CG30;caffeine and sodium benzoate
MV04CH;tests for kidney function and ureteral lesions
MV04CH01;inulin and other polyfructosans
MV04CH02;indigo carmine
MV04CH03;phenolsulphonphthalein
MV04CH04;alsactide
MV04CH30;aminohippuric acid
MV04CJ;tests for thyroid function
MV04CJ01;thyrotrophin
MV04CJ02;protirelin
MV04CK;tests for pancreatic function
MV04CK01;secretin
MV04CK02;pancreozymin (cholecystokinin)
MV04CK03;bentiromid
MV04CL;tests for allergic diseases
MV04CM;tests for fertility disorders
MV04CM01;gonadorelin
MV04CX;other diagnostics
MV04CX01;indocyanine green
MV04CX02;folic acid
MV04CX03;methacholine
MV04CX04;mannitol
MV04CX05;13-C-urea
MV04CX06;hexaminolevulinate
MV04CX07;edrophonium
MV04CX08;carbon monoxide
MV04CX09;patent blue
MV04CX10;pafolacyanin
MV04CX11;lithium chloride
MV04CX12;xenon
MV04CX13;pegulicianin
MV06;general nutrients
MV06A;dietary preparations for the treatment of obesity
MV06AA;low-energy diets
MV06B;protein supplement
MV06C;preparations for infants
MV06CA;nutrients without phenylalanine
MV06D;other nutritional supplements
MV06DA;carbohydrate/protein/mineral/vitamin, comb.
MV06DB;fat/carbohydrate/protein/mineral/vitamin, comb.
MV06DC;carbohydrates
MV06DC01;glucose
MV06DC02;fructose
MV06DD;amino acids,incl. combinations with polypeptides
MV06DE;amino acids/carbohydrate/mineral/vitamin, comb.
MV06DF;milk substitutes
MV06DX;other combinations of nutrients
MV07;all other non-therapeutic products
MV07A;all other non-therapeutic products
MV07AA;patches
MV07AB;solvents and thinners, incl. rinsing fluids
MV07AC;blood transfusion, auxiliary products
MV07AD;blood tests, ancillary products
MV07AN;incontinence equipment
MV07AR;sensitivity tests, disk and tablets
MV07AS;ostomy equipment
MV07AT;cosmetics
MV07AV;technical disinfectants
MV07AX;washing agents etc.
MV07AY;other non-therapeutic auxiliary products
MV07AZ;chemicals and reagents for analytical use
MV08;contrast agents
MV08A;X-ray contrast agents, iodinated
MV08AA;water doppler, nephrotropic, high osmotic x-ray contrast agent.
MV08AA01;diatrizoic acid
MV08AA02;metrizoic acid
MV08AA03;iodamide
MV08AA04;iothalamic acid
MV08AA05;ioxytalamic acid
MV08AA06;ioglycic acid
MV08AA07;acetrizoic acid
MV08AA08;iocarmic acid
MV08AA09;methiodal
MV08AA10;diodon
MV08AB;water doppler, nephrotropic, lavasm. x-ray contrast agent.
MV08AB01;metrizamide
MV08AB02;iohexol
MV08AB03;ioxaglic acid
MV08AB04;iopamidol
MV08AB05;iopromide
MV08AB06;iotrolan
MV08AB07;ioversol
MV08AB08;iopentol
MV08AB09;iodixanol
MV08AB10;iomeprol
MV08AB11;iobitridol
MV08AB12;ioxilan
MV08AC;water-soluble, hepatotropic X-ray contrast agents.
MV08AC01;iodoxamic acid
MV08AC02;iotroxic acid
MV08AC03;ioglycamic acid
MV08AC04;adipiodon
MV08AC05;iobenzamic acid
MV08AC06;iopanoic acid
MV08AC07;iocetamic acid
MV08AC08;sodium iopodate
MV08AC09;tyropanoic acid
MV08AC10;calcium iopodate
MV08AD;non-water-soluble X-ray contrast agents
MV08AD01;ethyl esters of iodinated fatty acids
MV08AD02;iopydol
MV08AD03;propyliodone
MV08AD04;iophendylate
MV08B;X-ray contrast agents, non-iodinated
MV08BA;barium sulfate-containing X-ray contrast agents
MV08BA01;barium sulfate with suspending agents
MV08BA02;barium sulfate without suspending agents
MV08C;contrast agents for magnetic resonance imaging
MV08CA;paramagnetic contrast agents
MV08CA01;gadopentetic acid
MV08CA02;gadoterinic acid
MV08CA03;gadodiamide
MV08CA04;gadoteridol
MV08CA05;mangafodipir
MV08CA06;gadoversetamide
MV08CA07;ferriammonium citrate
MV08CA08;gadobenic acid
MV08CA09;gadobutrol
MV08CA10;gadoxetine acid
MV08CA11;gadofosveset
MV08CA12;gadopiclenol
MV08CB;superparamagnetic contrast agents
MV08CB01;ferumoxsil
MV08CB02;ferristone
MV08CB03;iron oxide, nanoparticles
MV08CX;other contrast agents for magnetic resonance imaging
MV08CX01;perflubron
MV08D;ultrasound contrast agents
MV08DA;ultrasound contrast agents
MV08DA01;perflutren, human albumin microspheres
MV08DA02;galactose microparticles
MV08DA03;perflenapent
MV08DA04;perflutren, phospholipid microspheres
MV08DA05;sulfur hexafluoride, phospholipid microspheres
MV08DA06;perflubutane, phospholipid microspheres
MV09;radiopharmaceuticals for diagnostic use
MV09A;central nervous system
MV09AA;technetium(99m-Tc) compounds
MV09AA01;technetium(99m-Tc)-examethazim
MV09AA02;technetium(99m-Tc)-bisate
MV09AB;iodine(123-I) compounds
MV09AB01;iodo(123-I)-iophetamine
MV09AB02;iodo(123-I)-iolopride
MV09AB03;iodo(123-I)-ioflupane
MV09AX;other diagnostic radiopharmaceuticals for the central nervous system
MV09AX01;indium(111-In)-pentetate
MV09AX03;iodo (124-I) 2beta-carbomethoxy-3beta-(4 iodophenyl)-tropane
MV09AX04;flutemetamol (18-F)
MV09AX05;florbetapir (18-F)
MV09AX06;florbetaben (18-F)
MV09AX07;flortaucipir (18-F)
MV09B;skeleton
MV09BA;technetium(99m-Tc) compounds
MV09BA01;technetium(99m-Tc)-oxidronate
MV09BA02;technetium(99m-Tc)-medronate
MV09BA03;technetium(99m-Tc)-pyrophosphate
MV09BA04;technetium(99m-Tc)-diphosphonepropanedicarboxylic acid
MV09C;renal system
MV09CA;technetium(99m-Tc) compounds
MV09CA01;technetium(99m-Tc)-pentetate
MV09CA02;technetium(99m-Tc)-succimer
MV09CA03;technetium(99m-Tc)-mertiatide
MV09CA04;technetium(99m-Tc)-glucoheptonate
MV09CA05;technetium(99m-Tc)-gluconate
MV09CA06;technetium (99m-Tc) ethylenedicysteine
MV09CX;other diagnostic radiopharmaceuticals for renal system
MV09CX01;iodine(123-I)-iodohippurate
MV09CX02;iodine(131-I)-iodohippurate
MV09CX03;iodo(125-I)-iothalamate
MV09CX04;chromium(51-Cr)-edetate
MV09D;hepatic and reticuloendothelial system
MV09DA;technetium(99m-Tc) compounds
MV09DA01;technetium(99m-Tc)-disofenine
MV09DA02;technetium(99m-Tc)-etiphenine
MV09DA03;technetium(99m-Tc)-lidofenine
MV09DA04;technetium(99m-Tc)-mebrophenine
MV09DA05;technetium(99m-Tc)-galtifenine
MV09DB;technetium(99m-Tc), particles and colloids
MV09DB01;technetium(99m-Tc)-nanocolloid
MV09DB02;technetium(99m-Tc) microcolloid
MV09DB03;technetium(99m-Tc) millimicrospheres
MV09DB04;technetium(99m-Tc)-tin colloid
MV09DB05;technetium(99m-Tc)-sulfur-colloid
MV09DB06;technetium(99m-Tc)-rhenium sulfide colloid
MV09DB07;technetium(99m-Tc)-phytate
MV09DX;other diag.radiopharma. for hep.and ret.endothelial.system
MV09DX01;selenium(75-Se)-tauroselcholic acid
MV09E;respiratory system
MV09EA;technetium(99m-Tc), inhalation
MV09EA01;technetium(99m-Tc)-pentetate
MV09EA02;technetium(99m-Tc)-technegas
MV09EA03;technetium(99m-Tc)-nanocolloid
MV09EB;technetium(99m-Tc), particles for injection
MV09EB01;technetium(99m-Tc)-macrosalb
MV09EB02;technetium(99m-Tc) microspheres
MV09EX;other diagnostic radiopharmaceuticals for the respiratory system
MV09EX01;krypton(81m-Kr) gas
MV09EX02;xenon(127-Xe) gas
MV09EX03;xenon(133-Xe) gas
MV09F;thyroid
MV09FX;various thyroid diagnostic radiopharmaceuticals
MV09FX01;technetium(99m-Tc)-pertechnetate
MV09FX02;iodine(123-I)-sodium iodide
MV09FX03;iodine(131-I)-sodium iodide
MV09FX04;sodium iodide(124-I)
MV09G;cardiovascular system
MV09GA;technetium(99m-Tc) compounds
MV09GA01;technetium(99m-Tc)-sestamibi
MV09GA02;technetium(99m-Tc)-tetrofosmin
MV09GA03;technetium(99m-Tc)-teboroxime
MV09GA04;technetium(99m-Tc)-human albumin
MV09GA05;technetium(99m-Tc)-furifosmin
MV09GA06;technetium(99m-Tc)-stanno-agent labeled cells
MV09GA07;technetium(99m-Tc)-apcitide
MV09GB;iodine(125-I) compounds
MV09GB01;iodine(125-I)-human fibrinogen
MV09GB02;iodine(125-I)-human albumin
MV09GX;other diagnostic radiopharmaceuticals for the cardiovascular system
MV09GX01;thallium(201-Tl) chloride
MV09GX02;indium(111-In)-imciromab
MV09GX03;chromium(51-Cr)-chromate labeled cells
MV09GX04;rubidium (82-Rb) chloride
MV09GX05;ammonia (13-N)
MV09H;inflammation and infection detection
MV09HA;technetium(99m-Tc) compounds
MV09HA01;technetium(99m-Tc)-human immunoglobulin
MV09HA02;technetium(99m-Tc)-exametazime labeled cells
MV09HA03;technetium(99m-Tc)-antigranulocyte antibody
MV09HA04;technetium(99m-Tc)-sulesomab
MV09HB;indium(111-In) compounds
MV09HB01;indium(111-In)-oxinate labeled cells
MV09HB02;indium(111-In)-tropolone labeled cells
MV09HX;other diagn.radiopharma.t.detect.of inflamm.and infect.
MV09HX01;gallium(67-Ga) citrate
MV09I;tumor detection
MV09IA;technetium(99m-Tc) compounds
MV09IA01;technetium(99m-Tc)-anticarcinoembryonic antigen antibody
MV09IA02;technetium(99m-Tc) anti-melanoma antibody
MV09IA03;technetium(99m-Tc)-pentavalent succimer
MV09IA04;technetium(99m-Tc)-votumumab
MV09IA05;technetium(99m-Tc)-depreotide
MV09IA06;technetium(99m-Tc)-arcitumomab
MV09IA07;technetium(99m-Tc)-hydrazine nicotinic acid-octreotide
MV09IA08;technetium(99m-Tc)-etarfolate
MV09IA09;technetium(99m-Tc)-tilmanocept
MV09IA10;technetium (99m-Tc)-tropholastat chloride
MV09IB;indium(111-In) compounds
MV09IB01;indium(111-In)-pentetreotide
MV09IB02;indium(111-In)-satumomabpendetide
MV09IB03;indium(111-In)-antiovarian carcinoma antibody
MV09IB04;indium(111-In)-capromabendite
MV09IX;other diagnostic radiopharmaceuticals for tumor detection
MV09IX01;iodo(123-I)-iobenguane
MV09IX02;iodo(131-I)-iobenguane
MV09IX03;iodine(125-I)-CC49 monoclonal antibody
MV09IX04;fludeoxyglucose(18-F)
MV09IX05;fluorodopa(18-F)
MV09IX06;sodium fluoride(18-F)
MV09IX07;fluorocholine (18f)
MV09IX08;fluoroethylcholine(18-F)
MV09IX09;gallium (68-Ga) edotreotide
MV09IX10;fluoroethyl-L-tyrosine (18-F)
MV09IX11;fluoroestradiol (18-F)
MV09IX12;fluciclovine (18-F)
MV09IX13;methionine (11-c)
MV09IX14;gallium (68-Ga) gozetotide
MV09IX15;copper (64-Cu) dotatate
MV09IX16;piflufolastat (18-F)
MV09IX17;fluorine (18-F) PSMA-1007
MV09IX18;flotufolastat(18-F)
MV09IX19;vidoflufolastat (18-F)
MV09X;other radiopharmaceuticals for diagnostic use
MV09XA;iodine(131-I) compounds
MV09XA01;iodo(131-I)-norcholesterol
MV09XA02;iodo(131-I)-19-cholesterol
MV09XA03;iodine(131-I)-human albumin
MV09XX;various radiopharmaceuticals for diagnostic use
MV09XX01;cobalt(57-Co)-cyanocobalamin
MV09XX02;cobalt(58-Co)-cyanocobalamin
MV09XX03;selenium(75-Se)-norcholesterol
MV09XX04;iron(59-Fe)-ferricitrate
MV10;radiopharmaceuticals for therapeutic use
MV10A;anti-inflammatory drugs
MV10AA;yttrium(90-Y) compounds
MV10AA01;yttrium(90-Y)-citrate colloid
MV10AA02;yttrium(90-Y)-ferric hydroxide colloid
MV10AA03;yttrium(90-Y)-silicate colloid
MV10AX;other anti-inflammatory therapeutic radiopharmaceuticals
MV10AX01;phosphorus(32-P)-chromium phosphate colloid
MV10AX02;samarium(153-Sm)-hydroxyapatite colloid
MV10AX03;dysprosium(165-Dy) colloid
MV10AX04;erbium(169-Er)-citrate colloid
MV10AX05;rhenium(186-Re)-sulfide colloid
MV10AX06;gold(198-Au) colloid
MV10B;pain palliation (bone-seeking agents)
MV10BX;various radiopharmaceuticals for pain palliation
MV10BX01;strontium(89-Sr) chloride
MV10BX02;samarium(153-Sm)-ethylenediaminetetramethylenephosphonic acid
MV10BX03;rhenium(186-Rh)-etidronate
MV10X;other radiopharmaceuticals for therapeutic use
MV10XA;iodine(131-I) compounds
MV10XA01;iodine(131-I)-sodium iodide
MV10XA02;iodo(131-I)-iobenguane
MV10XA03;iodine(131-I)-omburtamab
MV10XA04;iodine(131-I)-apamistamab
MV10XA53;tositumomab/iodine(131-I)-tositumomab
MV10XX;miscellaneous radiopharmaceuticals for therapeutic use
MV10XX01;phosphorus(32-P)-sodium phosphate
MV10XX02;ibritumomab tiuxetan(90-Y)
MV10XX03;radium(223-Ra) dichloride
MV10XX04;lutetium(177-Lu)-oxodotreotide
MV10XX05;lutetium(177-Lu)-vipivotide tetraxetane
MV20;surgical dressings
